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Abstract 
Background: As the global population ages, the prevalence of age-related disorders, such as 
dementia, is increasing. Dementia is a condition of progressive deterioration of cognitive ability that 
leads to functional deficits. The primary subtype of dementia is Alzheimer’s disease (AD). Currently, 
there is no cure for AD or other major forms of dementia (e.g., vascular dementia) so prevention is 
the best approach for reducing the burden of these conditions. Emotions experienced across the 
lifespan may affect the development of dementia and AD, given their high involvement in cognitive, 
cardiovascular and psychosocial processes. Emotions may be neuroprotective by promoting the 
development of cognitive resources that allow resistance to pathologic changes in the brain. 
Alternatively, emotions may be neuropathogenic by contributing to vascular risk factors and evoking 
the stress response. The objective of this study is to investigate a potential novel association of 
emotional expressivity in early adulthood with dementia and AD in late life.  
Methods: Data from the Nun Study, a longitudinal study of 678 religious sisters who were aged 75+ 
at baseline in 1991, were used for the investigation. Data include annual cognitive and physical 
assessments, post-mortem brain autopsies and historical documents obtained from convent archives. 
Archival autobiographies handwritten in early adulthood (mean age=22) were available for 180 U.S.-
born participants. Autobiographies were scored for emotional expressivity, as well as for idea density, 
a measure of written language skills known to be associated with dementia and AD. Emotional 
expressivity was classified as high (i.e., top two quartiles) or low (i.e., bottom two quartiles) based on 
within-convent ranking of number of emotion words. Dementia was diagnosed if individuals 
displayed an inability to perform activities of daily living, and cognitive impairment on a battery of 
neuropsychological tests, according to standard criteria. A diagnosis of AD required evidence of 
dementia and AD neuropathology. Samples were selected for the analysis of dementia (n=149) and 
AD (n=85) based on the availability of data on dementia, AD neuropathology and all covariates of 
interest, and on restriction by low education. 
Positive, negative, and overall emotional expressivity (i.e., the sum of positive and negative 
emotion words) were investigated in association with both dementia and AD using multivariate 
logistic regression analysis. Additional analyses were performed to investigate the association of 
emotional expressivity with dementia. These included dividing the negative emotional expressivity 
variable into three (as opposed to two) categories, and testing the interaction between positive and 
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negative expressivity in association with dementia. All final models were stratified by idea density 
and adjusted for age and apolipoprotein E-ε4 (APOE-ε4). 
Results: The association of emotional expressivity with dementia and AD was modified by idea 
density. Among individuals with high idea density, those with high emotional expressivity, regardless 
of valence (i.e., overall, positive and negative), were consistently at an increased risk of dementia and 
AD compared to those with low emotional expressivity. In particular, overall emotional expressivity 
was significantly associated with dementia in this subgroup (odds ratio [OR]=2.60, 95% confidence 
interval [CI]=1.04-7.11). Among individuals with low idea density, those with high overall and 
negative emotional expressivity were at a decreased risk of dementia and AD compared to individuals 
with low emotional expressivity. Positive emotional expressivity was associated with an increased 
risk of dementia and AD. None of the associations of emotional expressivity with dementia or AD 
were significant in the low idea density subgroup.  
 The associations did not reach statistical significance among individuals with low idea 
density in the additional analysis of emotional expressivity with dementia. However, among 
individuals with high idea density, moderate, but not high, negative emotional expressivity was 
associated with an increased risk of dementia (OR=3.59, 95% CI=1.13-11.89). Furthermore, high 
negative emotional expressivity was associated with an increased risk of dementia among individuals 
with low positive emotional expressivity (OR=8.17, 95% CI=1.66-58.96).  
Discussion: The results support emotional expressivity in early adulthood as a potential predictor of 
dementia and AD in late adulthood. Idea density, a known risk factor of dementia and AD, modifies 
the association. High emotional expressivity, regardless of valence, is associated with an increased 
risk of dementia and AD when cognitive risk is otherwise low (i.e., high idea density), whereas 
overall and negative expressivity are associated with a decreased risk of dementia and AD when 
cognitive risk is high (i.e., low idea density). Furthermore, as predicted, the effect of negative 
emotional expressivity was modified by positive emotional expressivity: negative expressivity was 
only associated with an increased risk of dementia when positive expressivity was low, suggesting 
that positive emotions may counteract the adverse effects of negative emotions. Taken all together, 
the results provide evidence for a potential association of emotional expressivity in early adulthood 
with dementia and AD in late life. These findings suggest the importance of emotional expressivity as 
a predictor of long-term health outcomes, including dementia and AD. As such, emotions may serve 
as a potential target for future dementia and AD prevention strategies.  
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Chapter 1 
Introduction 
As the global population ages, the prevalence of age-related disorders, such as dementia, is 
increasing. In 2008, half a million Canadians suffered from dementia (Alzheimer Society of Canada, 
2010), a medical syndrome defined by substantial cognitive deterioration that leads to loss of function and 
subsequently, loss of independence (American Psychiatric Association [APA], 2013). Within the next 25 
years, the number of people with dementia is projected to more than double, with the associated annual 
care costs estimated to reach $153 billion (Alzheimer Society of Canada, 2010). Currently, the leading 
subtype of dementia is Alzheimer’s disease (AD), a neurodegenerative disease that involves progressive 
loss of neuronal structure and function within the brain (APA, 2013). Vascular dementia (VaD) is the 
second most common subtype of dementia and sometimes co-occurs with AD (i.e., mixed dementia), 
given the large vascular involvement in both diseases (APA, 2013). Despite no known cure for these 
underlying forms of dementia, several factors that affect risk have been identified. In particular, factors 
pertaining to cognitive development (e.g., Middleton & Yaffe, 2010), psychosocial behaviour (e.g., 
Fratiglioni & Wang, 2007; Rothman & Mattson, 2010) and cardiovascular function (e.g., Snowdon et al., 
1997) are associated with the risk of dementia, AD and VaD. Investigation of such factors informs 
prevention strategies in an effort to lessen the burden of dementia on affected individuals and society as a 
whole.  
Emotions play a pivotal role in cognitive, psychosocial and cardiovascular aspects of health and as 
a result may be associated with the development of dementia, AD and VaD over the long term. Emotional 
experiences may contribute to these outcomes in two ways. First, emotions affect cognitive development 
and may have a neuroprotective effect to resist pathologic changes to brain tissues. In particular, positive 
emotions broaden attention, exploration and social networking, which enrich cognitive resources 
(Fredrickson, 2004) and may in turn enhance the ability to maintain cognitive function even if 
neurodegeneration occurs. Second, emotions affect cardiovascular and endocrine activity and may have a 
neuropathogenic effect that contributes to the development of AD and VaD pathology: negative emotions 
tend to elevate cardiovascular function and evoke the stress response, leading to conditions that are 
known risk factors for AD and VaD. Taken all together, cognitive, social and physical aspects of 
emotional experiences across the lifespan have the potential to either protect against the development of 
dementia, or cause the neurodegeneration associated with AD and VaD.  
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The aim of the current research is to investigate the association of emotional expressivity in early 
adulthood with the risk of dementia and AD. Previous literature on this association is limited so the 
objective of the current study is to establish if an association exists, based on hypothesized mechanisms. 
Measures of emotional expressivity will be based on single autobiographical entries written in young 
adulthood that were obtained through a longitudinal study on health and aging called the Nun Study. 
Previous literature suggests that isolated events of emotional expressivity, such as an autobiography or a 
photograph, are indicative of long-term emotional tendencies that affect late-life health outcomes 
(Danner, Snowdon, & Friesen, 2001; Harker & Keltner, 2001; Pennebaker, 1997). Thus, emotional 
expressivity scores from the Nun Study autobiographies, as a reflection of emotional tendencies, will be 
studied in relation to the development of dementia and AD. The potential influence of vascular and 
genetic risk factors will also be assessed in order to clarify the association. Low prevalence of VaD in the 
sample population prevents the investigation of its relationship with emotional expressivity separately; 
however, it is included in the classification of all-cause dementia and is closely associated with AD 
neuropathology. As such VaD will be discussed in the literature review in parallel with AD to support the 
argument of a potential effect of emotional expressivity on development of dementia and its subtypes. 
Given the relative novelty of the current investigation, the primary objective is to establish whether 
emotional expressivity contributes to the development of dementia and its most prevalent subtype, AD. 
Such findings will set the stage for future studies to investigate the mechanisms underlying any observed 
associations. Advancement in the understanding of risk factors associated with dementia and AD could 
help to inform prevention strategies, which are especially important in the case of these devastating 
diseases. There is currently no cure for these conditions so efforts to avoid their onset are crucial. 
Effective strategies that help to prevent or delay the onset of dementia and AD could significantly reduce 
the projected burden of these diseases at both individual and societal levels.  
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Chapter 2 
Literature Review 
2.1 The Aging Population and Age-Related Diseases  
Globally, the population of older adults, aged 60 years and older, is growing rapidly. Over the first 
half of this century, the number of adults over the age of 60 is expected to triple and it is estimated to 
surpass 2 billion by 2050 (United Nations [UN], 2013). A similar trend can be seen in the Canadian 
population: projections suggest that the number of Canadians aged 65 and over will increase from 4.7 
million in 2009 to between 11.9 and 15.0 million by 2061 (Statistics Canada, 2010). The population of 
very old persons, aged 80 and over, is experiencing the fastest growth of any age group worldwide. While 
the population of those aged 60 and older is expected to triple by 2100, the number of people aged 80 and 
over will increase seven-fold over the same time period (UN, 2013). By 2050, 1 in 5 persons aged 60 or 
over will be above the age of 80 (UN, 2013). In Canada, the number of individuals aged 80 years or older 
is expected to reach 5.1 million by 2061 (Statistics Canada, 2010). These statistics indicate a major, 
never-before-seen shift in age distribution. This will be the first time in history that the greatest proportion 
of the global population is at or above mid-life.  
The trend toward an increased proportion of older adults globally has serious implications. With 
old age comes increased risk of disability, the loss of cognitive or physical function that causes 
difficulties in activities of daily living. Disability results from changes in structure and function of the 
body that may be determined by genetics, or by lifestyle factors such as physical activity, social 
engagement, cognitive stimulation, and habits formed across the lifespan. Lifetime experiences, which 
accumulate to influence the state of bodily functions, determine disability. Although disability is not 
inevitable, risk increases with age.  
An especially devastating, and increasingly prevalent, form of disability among the aging 
population is dementia, a syndrome characterized by progressive loss of cognitive function. Dementia is 
caused by disruption of normal physiological processes within the brain resulting in loss of memory, 
recognition, and the ability to communicate and learn new information (see section 2.2.1). In 2010, the 
overall estimate of worldwide prevalence of dementia was 4.7% of those aged 60 and older, although this 
number was between 5 and 7% in the majority of regions (Prince et al., 2013). Prevalence of dementia is 
highly dependent on age (Prince et al., 2013). Thus, a shift in the world population toward older ages 
suggests an increase in dementia cases over the coming decades.  
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Projections of global dementia prevalence are alarming. Currently, there are 35.6 million cases of 
dementia worldwide (Prince et al., 2013). By 2050, this number is expected to rise to 115.4 million, with 
the highest rate of growth in low- to moderate-income countries (Prince et al., 2013). This is cause for 
concern because caring for older adults who are not able to carry out activities of daily living and who 
may have behavioural symptoms, such as aggression and wandering, can be costly. Between 2008 and 
2038, the cumulative cost associated with dementia care is projected to reach $872 billion in Canada 
alone (Alzheimer Society of Canada, 2010), putting great demands on the economy. This trend will be 
seen worldwide.  
Of equal importance to the price tag of formal dementia care, the personal time spent by caregivers 
in assisting dementia patients with daily tasks and other services is substantial. In 2008, Canadians 
provided 231 million hours of informal (unpaid) care to people living with dementia. This time demand is 
expected to triple by 2038 (Alzheimer Society of Canada, 2010). Furthermore, the upward shift in age 
distribution over time will result in a larger proportion of the population being affected by dementia. In 
Europe, the number of “working-aged” persons (aged 15-64) is expected to decrease from 69 to 21 for 
every individual with dementia over the next forty years (Wancata, Musalek, Alexandrowicz, & 
Krautgartner, 2003), leaving fewer people in younger generations to provide care. The shifting of the 
proportion of eligible caregivers to dependents could have dire implications on society as a whole, and 
requires immediate attention to slow or reverse the expected impact.  
Efforts to reduce the threat of dementia can be improved through better understanding of the 
etiologic factors that contribute to the disorder. Currently, the two leading subtypes of dementia are 
Alzheimer’s disease (AD) and vascular dementia (VaD), respectively contributing approximately 60-80% 
(Alzheimer's Association, 2010) and 16% (van der Flier & Scheltens, 2005) of dementia cases in adults 
aged 65 or over. AD and VaD are both neurodegenerative diseases of characteristic damage to brain 
tissue that lead to functional decline and dementia (see subsequent sections for further details). The 
pathologic changes characteristic of these two conditions have been found to overlap in some cases of 
dementia (see section 2.5.1). Similar to dementia, risk of AD and VaD increases significantly with age. 
As such, prevalence of both is expected to increase as the population ages. By 2050, 1 in 85 individuals 
worldwide will have AD, 8.8 million of whom will be living in North America (Brookmeyer, Johnson, 
Ziegler-Graham, & Arrighi, 2007). The prevalence of AD and VaD is doubling every 4.3 and 5.3 years, 
respectively (Ganguli, 2011). Given the large contribution of these subtypes to the overall prevalence of 
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dementia, exploration of mechanisms by which they affect brain function and cognition will help to 
advance the overall understanding of dementia. 
Further awareness of the etiology of dementia will guide development of interventions to decrease 
the forecasted threat. Projections have shown that efforts to delay onset or slow the progression of 
dementia could significantly reduce the prevalence of dementia in the future (Jorm, Dear, & Burgess, 
2005). A global intervention to effectively delay onset of AD by one year would result in 11.8 million 
fewer cases than is estimated for 2050 if the current trends continue (Brookmeyer et al., 2007). Recent 
studies have shown that improvements in education and better prevention of risk factors such as vascular 
disease may help to reduce incidence rates (Larson, Yaffe, & Langa, 2013). Such estimations are 
promising and are a driving force behind efforts to identify causes of these conditions. A better 
understanding of dementia and its underlying diseases will contribute to the development of strategies to 
limit the looming global epidemic.  
 
2.2 Dementia 
 Overview 
Dementia is a complex clinical syndrome characterized by progressive deterioration of cognition 
from a previous level of ability, leading to a wide range of functional deficits. Dementia is most 
commonly associated with memory impairment, but also includes decline of executive function as well as 
loss of functionality in language, speech, motor skills and coordination (APA, 2013). As symptoms 
increase in severity, individuals frequently experience behavioural and psychological symptoms, such as 
agitation, aggression, disinhibition, sleep disturbance, and wandering (Mirakhur, Craig, Hart, McIlroy, & 
Passmore, 2004). Depression, anxiety and other affective disorders are also common comorbidities found 
in individuals living with dementia (Burns & Iliffe, 2009).   
Dementia can be reversible or irreversible, depending on the underlying cause. Symptoms of 
reversible dementia subside if the underlying cause is identified and successfully treated (Tripathi & 
Vibha, 2009). In contrast, irreversible dementias are untreatable, although some interventions slow the 
progression of decline. Eventually, cognitive faculties decline to the point where assistance is required for 
basic activities of daily living (ADLs), such as eating, dressing and bathing. Manifestation of symptoms 
varies widely and depends on factors such as individual experience, coexisting health factors and the 
underlying cause.  
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 Etiology of Dementia 
Dementia, itself, is not a definitive diagnosis; rather, it is a set of symptoms (i.e., a syndrome) that 
warrant further investigation to determine its cause. As such, all-cause dementia is an umbrella term often 
used to describe all dementias when the causes are unspecified. Abnormalities in the brain that lead to 
dementia can result from a wide range of diseases and disorders featuring distinct pathologies. Potentially 
reversible causes of dementia include neurosurgical conditions (e.g., subdural hematoma), neuroinfections 
and inflammations (e.g., meningitis), metabolic conditions (e.g., hypothyroidism), and other causes (e.g., 
depression, drugs and alcohol, sleep apnea) (Tripathi & Vibha, 2009). The four leading subtypes of 
irreversible dementia, which account for 90% of all dementia cases, are AD, VaD, frontotemporal 
dementia and Lewy body dementia (Grand, Caspar, & MacDonald, 2011; Tedeschi, Cirillo, Tessitore, & 
Cirillo, 2008). Of these, AD and VaD are the most prominent and will be discussed in more detail 
elsewhere (AD, section 2.3; VaD, section 2.4). Each subtype of dementia causes a distinct pattern of 
decline, useful in differentiating one from another in a clinical setting.  
The rate and pattern of dementia progression are dependent on the underlying disease and specific 
neuropathology causing the dementia. For example, dementia associated with AD appears gradually and 
decline is progressive, while the onset of VaD is sudden and decline is stepwise (Grand et al., 2011). 
These patterns coincide with the effect of each disease on brain tissue: AD features gradual build-up of 
protein deposits, while VaD results from acute incidents of brain infarcts or other vascular lesions. Such 
variations in disease progression are helpful in forming diagnoses in a clinical setting.  
In addition, cognitive and behavioural deficits in individuals with dementia occur based on the area 
of the brain that is affected. Dementia can be divided into two main types (i.e., cortical and subcortical), 
which correspond to the affected region and clinical manifestation. Cortical dementia is defined by early 
and severe memory disturbances, aphasia, apraxia and agnosia, and is consistent with AD diagnosis 
(Román, 2005). AD pathology appears first in the hippocampus, amygdala and posterior cingulate gyrus 
of the temporal and parietal lobes, coinciding with brain regions controlling memory, language and 
perception (Jacobs, Van Boxtel, Jolles, Verhey, & Uylings, 2012; Tedeschi et al., 2008). Conversely, 
subcortical dementia is distinguished by slowed cognitive and motor function as well as dysfunction of 
gait, speech, affect and mood, symptoms that may be associated with VaD (Román, 2005). These 
examples illustrate how clinicians move beyond the initial diagnosis of dementia to identify the 
underlying cause. 
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 Diagnosis of Dementia 
Early detection of dementia is important for effective planning and, when appropriate, 
administration of therapeutic treatment (Burns & Iliffe, 2009; Mathias & Burke, 2009). In addition, early 
detection and treatment of potentially reversible dementias provides the best chance for successful 
recovery (Feldman et al., 2008). Typically, an initial complaint by the patient or a caregiver of memory 
loss or some other aspect of mental decline will prompt a series of global cognitive screening tests. These 
tests determine deficits in various domains of cognition and may include the Mini-Mental State Exam 
(MMSE; Folstein, Folstein, & McHugh, 1975) or the elongated version, the modified MMSE (3MS; Teng 
& Chui, 1987); the Global Deterioration Scale (GDS; Reisberg, Ferris, de Leon, & Crook, 1982); or the 
Montreal Cognitive Assessment (MoCA; Nasreddine et al., 2005). In addition to cognitive assessments, 
the diagnostic process relies on assessment of patient history, caregiver interview, physical examination, 
basic laboratory tests and neuroimaging (Feldman et al., 2008). As dementia is a syndrome with various 
etiologies, many of these tests are used to identify the cause and to rule out other explanations for the 
decline that are unrelated to dementia.  
Diagnostic criteria for dementia, such as those outlined in the Diagnostic and Statistical Manual of 
Mental Disorders, now in the fifth edition (DSM-5; APA, 2013), and in the International Classification of 
Diseases, 10th edition (ICD-10; World Health Organization, 1992), are used to identify dementia. 
However, the DSM-5 and the ICD-10 criteria are not typically used alone because dementia as a 
syndrome can have various symptoms and causes that the criteria do not adequately address. The ICD-10 
presents a broad definition of “unspecified dementia” and the DSM-5 only defines “neurocognitive 
disorders” (i.e., dementia) in the context of the underlying disease. Fulfillment of ICD or DSM criteria 
paired with clinical judgment leads to a formal diagnosis of dementia (Breitner, 2006), but appropriate 
treatment relies on identification of the underlying cause. As such, a diagnosis of dementia is typically 
followed by further investigation of patient history and a clinical work-up using various other criteria that 
have been developed to identify the specific subtypes (e.g., AD or VaD). 
 
2.3 Alzheimer’s Disease (AD) 
 Overview 
AD is the leading form of dementia, accounting for an estimated 60-80% of cases of dementia 
worldwide (Alzheimer's Association, 2010) and approximately 63% in Canada (Alzheimer Society of 
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Canada, 2010). AD is characterized by irreversible brain pathology featuring beta-amyloid (Aβ ) plaques 
and neurofibrillary tangles (NFTs), which contribute to neurodegeneration and cell death (Maccioni, 
Muñoz, & Barbeito, 2001). As brain tissue damage occurs, clinical symptoms of dementia appear 
gradually and progressively. First, memory loss and other cognitive deficits appear, followed by loss of 
functional and communicative abilities and eventual loss of mobility, thereby increasing susceptibility to 
infection and death (Grand et al., 2011; Thies, Bleiler, & Alzheimer's Association, 2013). In addition, 
prevalence of depression and depressive symptoms is high among individuals with AD (Burns & Iliffe, 
2009). On average, affected individuals experience cognitive decline for several years before death; a 
systematic review of mortality in dementia and AD reports a median length of survival ranging from 7 to 
10 years after onset of AD-related dementia (Todd, Barr, Roberts, & Passmore, 2013). 
Models of AD progression suggest that pathology likely develops insidiously over many years 
before cognitive decline is observed. AD biomarkers may be found in the blood, brain and cerebrospinal 
fluid twenty years or more before cognitive symptoms appear (Jack et al., 2010; Jack et al., 2013; Thies et 
al., 2013). As AD pathology advances, cognitive and functional abilities decline gradually such that 
clinical diagnosis of dementia associated with AD is preceded by two phases. First, preclinical AD 
indicates the presence of AD biomarkers, suggesting potential brain pathology, with no obvious cognitive 
symptoms (Sperling et al., 2011). The second phase describes a transitional state between intact cognition 
and diagnosis of dementia, often termed mild cognitive impairment (MCI; Petersen et al., 2001). MCI is 
either amnestic, where the primary complaint is memory loss with otherwise mostly intact cognitive 
function, or non-amnestic, where decline occurs in one or more cognitive domains other than memory. 
Amnestic MCI has been found to precede AD-type dementia (Petersen et al., 2001; Riley, Snowdon, & 
Markesbery, 2002; Tedeschi et al., 2008). Approximately 40-60% of individuals who are diagnosed with 
MCI convert to AD (Tedeschi et al., 2008), a large proportion of which are likely amnestic MCI cases. 
Furthermore, incidence of AD is much higher in individuals with amnestic MCI (10 to 15% per year) 
when compared to healthy individuals (1 to 2% per year) (Petersen et al., 2001). Although preclinical AD 
and MCI are not definitive stages of AD, identification of these two conditions may be advantageous for 
early administration of therapeutic interventions (Petersen et al., 2001; Rentz et al., 2013).  
Therapeutic interventions for AD are limited. They do not change the course of AD pathology, but 
rather modify cognitive and behavioural symptoms so that the functional decline is delayed. 
Pharmaceutical treatments include cholinesterase inhibitors, such as rivastigmine, donepezil and 
galantamine; and a glutamate regulator, memantine. These drugs help to counteract changes in brain 
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chemistry that are characteristic of AD so that cognitive function is maintained despite some neuronal 
damage (Bendlin et al., 2010). In most cases, treatment can delay or improve symptoms for 
approximately 6 to 12 months (Grand et al., 2011); however, cognitive and functional decline are 
inevitable as the disease progresses and neuronal damage becomes extensive. Efforts are currently 
directed toward understanding the underlying causes of AD pathology so that effective treatments can be 
developed to prevent disease progression. 
 Etiology of Alzheimer’s Disease 
The two main biomarkers of AD pathology are neuritic Aβ plaques and NFTs. However, the role of 
each of these factors is unclear. Both Aβ plaques and NFTs have been found in some cognitively intact 
older adults, suggesting that the presence of Aβ and NFTs alone is not enough to cause cognitive 
impairment. Furthermore, Aβ and NFTs differ in their association with clinical symptoms and diagnosis 
of AD. Aβ deposition is highly related to AD pathology, but less so to cognitive decline associated with 
AD (Jack et al., 2010; Maccioni et al., 2001). Conversely, NFTs are highly associated with cognitive 
decline in AD, but are not unique to AD pathology; other neurodegenerative diseases, such as 
frontotemporal dementia, also feature neurofibrillary degeneration (Iqbal, Liu, Gong, Alonso Adel, & 
Grundke-Iqbal, 2009; Mohandas & Rajmohan, 2009). Despite these inconsistencies, cognitive decline is 
the result when the density and location of Aβ plaques and NFTs reach some indeterminate threshold 
(Price et al., 2009). Thus, a combination of accumulated Aβ plaques and NFTs forms the traditionally 
accepted model of AD neuropathology on which diagnostic criteria are based (see Section 2.3.3).  
Substantial progress has been made in the understanding of molecular processes leading to the 
neuritic plaques and tangles that are characteristic of AD. Extracellular Aβ plaques are by-products of 
abnormal proteolysis of an axonal transmembrane protein, amyloid precursor protein (APP; Maccioni et 
al., 2001). Cerebral amyloid angiopathy, which is characterized by deposition of Aβ at the blood-brain 
barrier, may also contribute to AD pathology (Jeynes & Provias, 2011). Aβ accumulation is believed to 
trigger changes in signaling pathways likely involving cyclin-dependent protein kinase (Cdk5) and 
glycogen synthase kinase (Gsk3b) enzymes that lead to production of NFTs (Maccioni et al., 2001). 
Indeed, current laboratory and neuroimaging techniques indicate that amyloid is typically the first 
biomarker detected in individuals who eventually develop AD (Jack et al., 2010; Jack et al., 2013) and 
may appear approximately ten years before neurodegeneration occurs (Villemagne et al., 2013).  
Molecular studies have shown that abnormal function of Cdk5 and Gsk3b enzymes leads to 
deregulated phosphorylation of tau proteins, which are structural support proteins normally associated 
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with neuronal microtubules. The resulting hyperphosphorylation of tau prevents their integration into 
microtubules, thereby compromising the structural integrity of the cells, and leading to neurodegeneration 
and formation of NFTs by the unincorporated tau proteins (Maccioni et al., 2001). However, discoveries 
of tau-related neurodegeneration in the absence of Aβ (e.g., Knopman et al., 2013) have led some to 
rethink the validity of the amyloid cascade hypothesis, positing that Aβ deposition and tau-related 
neurodegeneration may occur independently in the development of AD (see Landau & Frosch, 2014 for 
discussion). Most recently, findings of Jack and colleagues (2014) support the amyloid cascade by 
showing that, although Aβ deposition and hippocampal neurodegeneration occur independently, 
neurodegeneration is accelerated in the presence of Aβ. Regardless of the pathway, what is certain is that 
the progressive accumulation of Aβ plaques and NFTs leads to irreversible neuronal degeneration and 
eventual death associated with AD.  
As AD progresses, plaques and tangles spread throughout various regions of the brain 
corresponding to clinical symptoms of dementia (see section 2.2.1). In particular, AD pathology has been 
highly associated with the neocortex, hippocampus, amygdala and basal nucleus of Meynert (Wenk, 
2003). Although Aβ plaque distribution varies between individuals with AD, NFTs follow a relatively 
predictable pattern of spread throughout the brain. The dispersion of NFTs throughout the brain is 
described with Braak staging (Braak & Braak, 1991). Braak staging is divided into six progressive phases 
of NFT involvement beginning in the transentorhinal region of the cortex and moving into the 
hippocampus, including the entorhinal region, and eventually involving the isocortical region (Braak & 
Braak, 1991). NFT pathology is highly associated with dementia (Giannakopoulos et al., 2003; SantaCruz 
et al., 2011). However, some cases with advanced Braak staging but no dementia have also been 
identified (SantaCruz et al., 2011), demonstrating the complexity of causal factors of AD.  
The only known causes of AD are genetic mutations that lead to AD pathology. Autosomal 
dominant mutations in genes coding for APP-processing presenilins (PS1 and PS2), and in the APP gene 
itself, cause accumulation of Aβ1-42, which is an insoluble form of Aβ (Maccioni et al., 2001). These 
mutations are sufficient to cause AD pathology (Ferrer, 2012). However, such causes account for only 2% 
of all cases of AD (Bird, 2008). These genetic mutations are more likely to cause early-onset AD, where 
symptoms appear before the age of 65. Thirteen percent of early-onset cases are attributable to mutations 
in PS1, PS2 or APP genes (Bird, 2008). The epsilon-4 allele of the gene coding for apolipoprotein E 
(APOE) is also associated with AD. However, APOE-ε4 is neither necessary nor sufficient for AD 
pathology (Bird, 2008) so is considered to be a risk factor, and not a cause.  
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Beyond the aforementioned genetic factors, the cause of non-inherited, “sporadic” AD is not clear. 
Sporadic AD has been linked to factors such as brain trauma, impaired immune function, abnormal 
cholesterol and lipid metabolism, atherosclerosis and cardiovascular disease (see section 2.5.2.5), but 
causal mechanisms remain unclear. AD etiology is likely multi-factorial, making the definition of specific 
causes problematic, although many risk factors have been identified (see section 2.5.2).  
 Diagnosis of Alzheimer’s Disease 
A definite diagnosis of AD requires both clinical symptoms of dementia and neuropathological 
evidence of the disease. Currently, imaging and laboratory techniques remain imperfect so diagnosis 
during life relies on patient and caregiver interviews, patient history, neuropsychological assessments and 
exclusion of other potential conditions. As such, the clinical diagnosis remains presumptive until 
pathological evidence of the disease can be confirmed at postmortem autopsy. Several sets of criteria have 
been developed to support AD diagnosis, including clinical criteria developed by the National Institute of 
Neurological and Communicative Disorders and Stroke, and the Alzheimer’s Disease and Related 
Disorders Association (NINCDS-ADRDA; McKhann et al., 1984); neuropathologic criteria by the 
National Institute on Aging and the Reagan Institute (NIA-RI; The National Institute on Aging, and 
Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of 
Alzheimer's Disease, 1997); and both clinical and neuropathologic criteria put forth by the Consortium to 
Establish a Registry for Alzheimer’s Disease (CERAD; Mirra et al., 1991; Morris et al., 1989). These 
diagnostic protocols have their own strengths and limitations and vary in their usefulness in clinical and 
research settings.  
AD biomarkers, Aβ plaques and NFT-associated tau proteins can be identified in laboratory 
specimens and neuroimaging techniques. Abnormally low levels of Aβ42 and high levels of tau in 
cerebrospinal fluid (CSF) samples are found to approximate AD diagnosis as evidenced by correlations 
with post-mortem brain autopsies and with clinical symptoms (Jack et al., 2010). Furthermore, ante-
mortem PET imaging using Pittsburgh compound B (PiB), which binds to Aβ42, has been associated with 
plaque loads in most individuals with confirmed AD pathology (Jack et al., 2010). However, these 
diagnostic techniques are not consistent: CSF-tau is also found in other diseases and Aβ observed in CSF 
and PiB-PET imaging does not capture all cases of AD (Jack et al., 2010). Thus, current diagnostic 
criteria do not rely on these biomarkers, but rather focus on clinical symptoms and neuropathology to 
form a diagnosis.  
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In order to establish a definite diagnosis of AD, evidence of both neuropsychological (i.e., 
dementia) and neuropathological (i.e., Aβ plaques and NFTs) components is required. However, 
neuropathology cannot be determined in the clinical setting, preventing definitive diagnoses of AD from 
being made during life. The NINCDS-ADRDA working group has addressed this problem through the 
development of criteria that classify AD as “possible” or “probable” based on appearance and progression 
of symptoms (McKhann et al., 1984; McKhann et al., 2011). These criteria are typically used in clinical 
trials and clinical research. Pathophysiological evidence, such as that obtained from CSF levels and PiB-
PET imaging, may be incorporated to increase or decrease the level of certainty of AD for research 
purposes, but is not recommended for standard clinical diagnoses (Jack et al., 2011; McKhann et al., 
2011). The updated NINCDS-ADRDA criteria employ the NIA-RI criteria to establish a definitive 
diagnosis of AD: a diagnosis is confirmed if the NINCDS-ADRDA criteria for “probable” AD, as well as 
AD neuropathology according to NIA-RI criteria, are fulfilled (McKhann et al., 2011).  
The NIA-RI focuses on determination of postmortem neuropathological evidence for the diagnosis 
of AD (The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for 
the Neuropathological Assessment of Alzheimer's Disease, 1997). The protocol requires identification of 
both neuritic plaques and NFTs to establish a pathological diagnosis of AD. Neuritic plaques are 
quantified using CERAD criteria (described below), while NFT spread is classified by Braak staging (see 
Section 2.3.2). However, a particular weakness of the NIA-RI criteria is that they do not adequately 
address pathology in which levels of NFTs and Aβ plaques are inconsistent (e.g., CERAD “frequent” and 
Braak stage 0-II, CERAD “infrequent” and Braak stage V-VI; Nelson, Kukull, & Frosch, 2010).  
An updated version of the NIA-RI guidelines also accounts for potential pathology associated with 
preclinical AD and MCI in an attempt to provide a more complete picture of disease progression 
throughout the various stages (Hyman et al., 2012). Genetic and biomarker data can be used to support 
neuropathological findings in a research setting, but do not further define the disease state so are not 
deemed necessary (Hyman et al., 2012). The identification of co-morbid brain pathology is also 
recognized in this protocol and should be considered when assessing clinical and pathological correlations 
of AD (Hyman et al., 2012). As mentioned previously, correlations between clinical neuropsychological 
criteria (e.g., NINCDS-ADRDA) and post-mortem neuropathology according to the NIA-RI criteria form 
a definitive diagnosis of AD.  
The CERAD protocol incorporates clinical, neuropsychological, neuropathological and behavioural 
data to provide an all-encompassing diagnosis of AD (Fillenbaum et al., 2008). For clinical determination 
 13 
of the disease, a battery of tests is recommended to assess cognitive processes such as memory, language, 
visuospatial ability, concentration and orientation (Morris et al., 1989). CERAD also provides 
neuropathological criteria for Aβ plaque load so that diagnosis of AD can be confirmed at post-mortem 
autopsy. A semi-quantitative approach to documentation of the density of neuritic plaques, which are Aβ 
plaques directly associated with neuronal degeneration, is used (Mirra, 1997). However, NFTs, which are 
a well-recognized component of AD, are not considered for diagnosis using CERAD criteria. This 
presents a gap in the ability to fully understand the disease and therefore, CERAD is not typically used for 
research with a focus on AD neuropathology. Overlapping neurodegenerative disorders such as 
Parkinson’s disease and dementia with Lewy bodies are accounted for in the original set of criteria 
(Mirra, 1997), but the protocol has not been updated to reflect the most recent understanding of such 
comorbidities (Fillenbaum et al., 2008). Given that it defines both neuropsychological and 
neuropathological criteria, the CERAD protocol is widely used for diagnosis of AD in the clinical setting. 
 
2.4 Vascular Dementia (VaD) 
 Overview 
Commonly co-occuring with AD (see Section 2.5.1), vascular dementia (VaD) is a subtype of 
dementia resulting from vascular damage to brain tissue. VaD lacks a clear definition because of the 
variability with which damage can occur (Grand et al., 2011). The condition may result from a range of 
circulatory disorders that lead to vascular complications such as infarcts, hemorrhaging and lesions in 
various areas of the brain (Grinberg & Heinsen, 2010). Such variation in the location and extent of 
damage and the resulting symptoms associated with VaD makes classification of the disease challenging. 
As with dementia of other subtypes, the major clinical symptoms of VaD include an irreversible 
decline from previous cognitive and functional ability that may lead to emotional and behavioural 
disturbance, challenges with ADLs and ultimate loss of independence (Román, 2005). However, 
characteristics that may distinguish VaD from other forms of dementia include abrupt onset, fluctuation 
of symptoms, history of stroke and hypertension, possible focal neurological signs and symptoms, 
stepwise deterioration, complaints of poor physical health, emotional instability and more severe 
symptoms of depression than are found in AD (Grand et al., 2011; Groves et al., 2000). Symptom 
presentation is highly dependent on the underlying pathology causing VaD. 
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Following onset of symptoms of VaD, treatment is limited to symptom management. Cholinergic 
drug therapies used in AD, such as rivastigmine, donepezil, galantamine, and memantine may also 
partially delay VaD symptoms, although studies investigating treatment efficacy have been inconsistent 
(Korczyn, Vakhapova, & Grinberg, 2012). Other treatments, such as anxiolytics, antidepressants and 
anticonvulsants, have been used to treat non-cognitive symptoms (Korczyn et al., 2012), but none are 
known to reverse or suspend the degeneration caused by VaD. Among VaD cases, the cause of death is 
most often cerebrovascular disease and the average length of survival after onset of symptoms is 3.9 years 
(Fitzpatrick, Kuller, Lopez, Kawas, & Jagust, 2005). Thus, preventative measures to reduce the 
cardiovascular risk factors that underlie VaD etiology may be the most effective way to reduce the 
occurrence of the disease, and its influence on the development of AD (Monsuez, Gesquiere-Dando, & 
Rivera, 2011). 
 Etiology of Vascular Dementia 
VaD is caused by a wide range of cardiovascular abnormalities, and thus has several etiologic 
factors that affect the presentation of symptoms. Damage to brain tissue occurs as a result of ischemic or 
hemorrhagic cerebrovascular diseases, or of cardiovascular or circulatory disturbances (Román, 2005). 
Vessel disorders such as atherosclerosis, small vessel disease and cerebral amyloid angiopathy cause 
cerebrovascular lesions in the form of white matter lesions, cerebral hemorrhages or brain infarcts (Thal, 
Grinberg, & Attems, 2012). Cognitive impairment ensues when the extent of damage is sufficient to 
disrupt normal neuronal function. However, the cognitive and functional symptoms vary based on the size 
and location of the lesion.  
As the name suggests, white matter lesions are characterized by damage to white matter, which is 
the axon-rich area of the brain. These lesions include demyelination, axon loss, astrogliosis, and 
microglial activation (Thal et al., 2012). The deterioration of neuronal connections causes psychomotor 
slowing, memory impairment and neuropsychiatric symptoms, such as depression and apathy (Grand et 
al., 2011; Thal et al., 2012). VaD associated with white matter lesions progresses subtly as a result of 
gradual white matter degeneration. 
Conversely, a stroke, defined by a disruption of blood supply to the brain resulting in acute tissue 
damage, can lead to sudden onset of VaD. Strokes can be hemorrhagic or ischemic. Hemorrhagic strokes 
occur when vessel walls in the brain rupture, allowing blood to invade brain tissue (Thal et al., 2012). 
Vessel ruptures result when the integrity of vessel walls is compromised. Arterial hypertension associated 
with small vessel disease is the most common cause of cerebral hemorrhage, followed by cerebral 
 15 
amyloid angiopathy, which is characterized by deposition of Aβ proteins in cerebral blood vessels (Thal 
et al., 2012). Bleeding in large or small vessels may cause dementia through displacement of brain tissue 
and disruption of neuronal function. Symptoms and severity of hemorrhagic stroke are dependent on 
which, and to what extent, brain regions are affected (Thal et al., 2012). 
Ischemic strokes, which are the most common type of stroke, are characterized by brain tissue 
death due to insufficient blood flow. Areas of brain tissue death, known as infarcts, may lead to severe 
loss of cognitive function and thus diagnosis of VaD. Cerebral infarcts, the most common cause of VaD, 
typically result from atherosclerosis and related embolic or thrombotic events. However, when associated 
with AD pathology (see section 2.3.1), small vessel disease or cerebral amyloid angiopathy can also lead 
to infarction (Thal et al., 2012). Brain infarcts may also cause cerebral hemorrhage if tissue necrosis is 
severe enough to allow extravascular leakage of blood (Román, 2002).  
Brain infarcts vary in size, shape, location and cognitive influence. Multi-infarct dementia (MID), a 
subtype of VaD, is the result of multiple infarcts in cortical or subcortical regions of the brain that impair 
cognition (Grand et al., 2011). Such impairments are experienced across various domains, depending on 
the location of the infarcts (Grand et al., 2011). Strategic infarct dementia, another subtype of VaD, 
occurs when a single infarct produces focal damage in a functionally critical region (Román, 2002), 
leading to impairment in some cognitive domains, while others remain intact (Grand et al., 2011). As a 
result of the wide variation of etiologic factors contributing to VaD, development of clear 
neuropathologic criteria has been difficult.  
VaD can develop sporadically or from inherited genetic mutations (familial). The majority of cases 
of familial VaD are due to cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL), caused by a mutation in the Notch 3 gene leading to small vessel 
disease (Grand et al., 2011). Sporadic VaD, associated with vessel disorders and vascular lesions derived 
from environmental factors, is much more common than familial VaD. Identification of potential 
underlying causes of VaD, familial or sporadic, are important to form a diagnosis of the disease. 
 Diagnosis of Vascular Dementia 
Diagnostic criteria such as the Hachinski Ischemic Scale (HIS; Hachinski et al., 1975), the DSM-5 
(American Psychiatric Association, 2013) and the National Institute of Neurologic Disorders and Stroke-
Association Internationale pour la Recherche et l’Enseignement et Neurosciences (NINDS-AIREN) 
criteria (Román et al., 1993) outline the essential components required for clinical diagnosis of VaD. The 
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HIS, a 13-item instrument, is used to differentiate VaD from other dementia subtypes and focuses on 
clinical symptoms as opposed to pathological evidence. Conversely the DSM-5 and the NINDS-AIREN 
criteria, in addition to excluding other causes of dementia, require evidence of vascular lesions through 
neuroimaging techniques (i.e., CT, MRI; Grand et al., 2011; Román, 2002). The most widely used system 
for clinical diagnosis, developed by the NINDS-AIREN, also requires that the location of the lesions 
corresponds to the specific symptoms as a plausible mechanism for VaD to be confirmed (Román, 2002).  
Diagnostic criteria for VaD rely on cognitive tests to determine presence of dementia (see section 
2.2.3). Wide variations in clinical symptoms of VaD, based on the location of cerebrovascular lesions, 
require assessment of several cognitive domains. For example, vascular damage in subcortical tissue leads 
to deficiencies in executive function that can be detected by tests such as the clock drawing test (for 
review, see Agrell & Dehlin, 1998), rather than the MMSE, which is better suited to assess cortical 
functions such as memory (Román, 2005). Assessments that focus on specific cognitive domains can be 
used to map tissue damage, allowing more accurate diagnoses. In addition, Mathias and Burke (2009) 
found significant differences in results of delayed story recall (memory) and emotional recognition 
(perception) between patients with AD and VaD, suggesting opportunities for differentiation of the two 
diseases. This is especially valuable based on the fact that significant overlap of neurodegenerative and 
vascular pathology has been found, making distinction between VaD and AD difficult.  
 
2.5 Dementia, AD and VaD 
 Mixed Dementia 
Mixed dementia is diagnosed when evidence of both AD and VaD pathology are found 
concurrently. Mixed dementia differs from “pure” AD and “pure” VaD in that the dementia is caused by a 
combination of neurodegenerative and vascular pathology and the contribution of each is unclear 
(Jellinger, 2002; Jellinger, 2007; Nadeau & Black, 2010). Poor understanding has made classification of 
the disease difficult, and agreement among researchers is low. Mixed dementia is reported to comprise 
from 0 to 58% of all dementia cases (Jellinger, 2007; Zekry, Hauw, & Gold, 2002), with more recent 
estimates suggesting the prevalence of mixed pathology to comprise about half of all dementia cases 
(Schneider, Arvanitakis, Leurgans, & Bennett, 2009). Lack of a clear definition of what constitutes a 
diagnosis of mixed dementia is a likely explanation for the disagreement in reported prevalence.  
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Several conflicting models have been used to describe the role of AD and vascular pathologies in 
mixed dementia. Some view vascular pathology as a confounder, rather than an equal entity, in the 
relationship between AD pathology and dementia (Román et al., 1993). Others suggest that AD pathology 
is a result of vascular factors and should be considered a vascular disorder (de la Torre, 2002). 
Alternatively, others have found no correlation between vascular pathology and AD, and report an 
additive effect of the two pathologies in causing dementia (Schneider, Wilson, Bienias, Evans, & Bennett, 
2004). Indeed, cognitive impairment is more severe in AD patients when cerebrovascular lesions are 
present, when compared to patients at the same stage of AD pathology in the absence of vascular lesions 
(Snowdon et al., 1997). Although the two may not be directly linked, co-occurence of AD and VaD 
pathology is not surprising, given that they share many of the same risk factors.  
 Common Risk and Protective Factors 
2.5.2.1 Demographic Factors 
Age is a major risk factor for all-cause dementia, AD and VaD. Susceptibility to neuronal and 
vascular tissue damage naturally increases with age. As time progresses, Aβ deposition, minor vascular 
events, lesions and inflammation accumulate to increase risk of dementia. Indeed, the risk of all subtypes 
of irreversible dementia increases with age (Lopez-Pousa, Vilalta-Franch, Llinas-Regla, Garre-Olmo, & 
Román, 2004). Only 6 to 7% of cases of AD are diagnosed before age 65 (Gorelick, 2004) and incidence 
increases exponentially with age. Likewise, the incidence of VaD is ten times greater in adults aged 80 or 
over as compared to those between 60 and 69 years of age (Leys, Pasquier, & Parnetti, 1998).  
In addition to age, sex may be associated with risk of both AD and VaD, although this point is 
debated. Women have been found to be at greater risk of developing AD than men in some studies (Gao, 
Hendrie, Hall, & Hui, 1998), but not in others (Corrada, Brookmeyer, Paganini-Hill, Berlau, & Kawas, 
2010; Tyas, Manfreda, Strain, & Montgomery, 2001). A pooled analysis of four cohort studies found an 
age effect: women over the age of 85 were at a greater risk of AD when compared to men in the same age 
group, but the incidence rates did not differ between sexes for any other age group (Andersen et al., 
1999). Sex-related differences in risk may also vary by location: European studies have found that women 
are at increased risk of AD, while American studies did not find any association (Edland, Rocca, Petersen, 
Cha, & Kokmen, 2002). Conversely, females may be at lower risk of VaD across all age groups 
(Ruitenberg, Ott, van Swieten, Hofman, & Breteler, 2001), although sex differences are not always found 
(Andersen et al., 1999). Since risk due to sex is complicated by other factors, such as age, education, 
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hormone levels, APOE-ε4 status, comorbidities and lifestyle, it is likely not a meaningful risk factor on its 
own (Bendlin et al., 2010; Chen, Lin, & Chen, 2009). 
2.5.2.2 Genetic Factors 
A family history of AD was one of the earliest established risk factors for the disease (Graves, 
2004). Having a parent with AD may increase an individual’s risk up to six-fold (Bendlin et al., 2010). 
Aside from the autosomal dominant mutations that directly cause AD and VaD (see sections 2.3.2 and 
2.4.2), other genetic factors increase the likelihood of these outcomes. In particular, the APOE gene, 
which codes for a transport protein involved in cholesterol regulation, affects the risk of AD: the ε2 allele 
has a protective effect, but the ε4 allele increases risk by a graded dose effect (Corder et al., 1993). One 
copy of the ε4 allele increases risk slightly, while ε4 homozygosity is associated with the highest risk of 
AD (Corder et al., 1993). Approximately 40% of AD cases have at least one APOE-ε4 allele compared to 
15% of the general population, and cases with the allele typically experience earlier onset of the disease 
(Bendlin et al., 2010). APOE-ε4 has also been identified as a significant risk factor for VaD in some 
studies (Chuang et al., 2010; Hebert et al., 2000), but not in others (Korczyn et al., 2012). Despite 
inconsistent evidence, a link between APOE-ε4 and risk of VaD is plausible, as APOE-ε4 increases the 
risk of atherosclerotic disease and may play a role in cognitive decline after incidence of stroke, two 
health conditions that are associated with VaD (Korczyn et al., 2012). 
2.5.2.3 Cognitive Factors  
Cognitively stimulating activities have a protective effect against development of AD and VaD in 
late adulthood (Ferri et al., 2014). Such findings may be explained by the cognitive reserve theory, which 
states that a high level of cognitive activity over time enhances the capacity to resist the decline typically 
associated with brain damage (Stern, 2002; Stern, 2012). According to this theory, cognitive factors such 
as educational attainment and skills-building contribute to development of efficient synaptic connections 
and complex neuronal networks that allow the brain to compensate in the event of neurodegeneration 
(Stern, 2002). The underlying pathology may be present but clinical symptoms do not appear or are 
reduced or delayed. Indeed, studies have shown inconsistencies between clinical dementia and degree of 
AD or cerebrovascular neuropathology: in some cases, individuals have maintained relatively intact 
cognition during life despite discovery of extensive neuropathology at post-mortem autopsy (Davis, 
Schmitt, Wekstein, & Markesbery, 1999; Price et al., 2009; SantaCruz et al., 2011). Furthermore, the rate 
of cognitive decline in late life is inversely associated with lifetime cognitive activity, independent of 
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underlying neuropathology (Wilson et al., 2013). These findings suggest that a high level of cognitive 
development throughout life protects against the decline of aging and neuropathology.  
 Other mentally stimulating activities, such as complex occupations, social engagement and 
leisure activities, are also protective against dementia. High complexity of work involving people and 
objects significantly reduced the risk of dementia and VaD, but not AD, in the Canadian Study of Health 
and Aging (Kröger et al., 2008). A study on Swedish twins found that complex work involving interaction 
with people was associated with lower odds of AD (odds ratio [OR]=0.83, 95% confidence interval 
[CI]=0.70-0.98) and all-cause dementia (OR=0.86, 95% CI=0.76-0.98) after adjusting for age, sex and 
education (Andel et al., 2005). Alternatively, high levels of stress that often accompany complex jobs 
may contribute to AD and dementia risk (Wang, Wahlberg, Karp, Winblad, & Fratiglioni, 2012), thereby 
obscuring the effect of work complexity on cognitive outcomes.  
Leisure activities involving mental or physical stimulation are also thought to be protective against 
dementia, AD and VaD. Mental activities, such as seeking new experiences, exchanging ideas, travelling, 
working on odd jobs, and knitting have been associated with decreased odds of dementia or AD (for 
review, see Fratiglioni & Wang, 2007). A prospective cohort study of non-demented older adults found a 
significantly reduced risk of dementia with increased participation in cognitive activities, such as reading 
or writing for pleasure, doing crosswords or playing a musical instrument (Verghese et al., 2003). This 
association was similar for both AD and VaD, instead of dementia, as the outcome.  
The protective benefits of cognitive stimulation against the development of dementia reach into 
early adulthood. Consistent with cognitive reserve theory, indicators of adolescent cognitive performance, 
such as mental ability (Whalley et al., 2000) and written language skills (Riley, Snowdon, Desrosiers, & 
Markesbery, 2005; Snowdon et al., 1996b), have been linked to cognitive function and AD in old age. 
Indeed, low idea density, a measure of written language skills, in autobiographies written in early 
adulthood was strongly associated with MCI, dementia, higher Braak stage, and lower brain weight over 
fifty years later in the Nun Study (Riley et al., 2005). Formal educational attainment is protective against 
dementia. Low levels of education are associated with an increased risk of all-cause dementia and 
specifically AD (EClipSE Collaborative Members et al., 2010; Evans et al., 1997; Fratiglioni et al., 1997; 
Gatz, Prescott, & Pedersen, 2006; Karp et al., 2004; Launer et al., 1999; Ott et al., 1999; Qiu, Backman, 
Winblad, Aguero-Torres, & Fratiglioni, 2001; Stern et al., 1994). Investigation of the association has been 
less extensive in individuals with VaD: low levels of education were associated with an increased risk of 
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post-stroke dementia (Pohjasvaara, Erkinjuntti, Vataja, & Kaste, 1997), but not with VaD in an Italian 
population (Ravaglia et al., 2005). 
2.5.2.4 Psychosocial Factors 
Social engagement, in the form of close confidants, sports, and cultural activities at age 30 and 50, 
was associated with a reduced risk of dementia (Seidler, Bernhardt, Nienhaus, & Frolich, 2003), although 
data may have been subject to recall and proxy biases based on the case-control nature of the study. 
Among longitudinal studies, social factors such as marital status, living arrangements, close friendships, 
and parenthood all have an effect on dementia, with more social connections associated with lower risk of 
dementia (Fratiglioni & Wang, 2007). A decline in social engagement from mid- to late-life has been 
associated with dementia (Saczynski et al., 2006), suggesting that individuals who, serving as their own 
controls for optimal social engagement, had lower engagement in late life were at higher risk of 
developing dementia. An alternative interpretation of these findings might suggest that social withdrawal 
is a prodromal sign of dementia (Saczynski et al., 2006). 
Findings have suggested that the quality of social interactions may better predict dementia risk: 
supportive, engaging relationships, as opposed to superficial ones, may offer greater protection. Indeed, 
emotional support is associated with better cognitive function (Seeman, Lusignolo, Albert, & Berkman, 
2001) and is more protective against cognitive decline than is practical support through help with daily 
tasks (Ellwardt, Aartsen, Deeg, & Steverink, 2013). Social ties and emotional support are also found to 
protect against post-stroke cognitive decline (Glymour, Weuve, Fay, Glass, & Berkman, 2008), an effect 
that may be mediated by feelings of loneliness (Ellwardt et al., 2013). Indeed, Holwerda and colleagues 
(2014) found self-reported loneliness (i.e., perceived social isolation), but not objective social isolation, to 
increase the risk of dementia. In another study, adjustment for cognitive activity reduced the effect of 
loneliness in older adulthood on the risk of AD (Wilson et al., 2007). Altogether, these findings suggest 
that emotionally supportive and mentally stimulating relationships may reduce the risk of dementia, AD 
and VaD, while loneliness may increase the risk. 
A growing body of literature suggests that personality characteristics may affect dementia 
outcomes. Indeed, high neuroticism, the tendency to experience negative emotions (e.g., anxiety, anger 
and sadness), was associated with an approximately three-fold increase in AD risk compared to 
individuals with low neuroticism (Terracciano et al., 2014; for review, see Prina, Pender, Ferri, Mazzotti, 
& Albanese, 2014). Similarly, stress, anxiety and depression may contribute to the risk of dementia, AD 
and VaD. A longitudinal study of Swedish women found that self-reported frequent psychological stress 
 21 
at multiple time points throughout mid- and late-life was associated with an increased risk of dementia 
and AD (Johansson et al., 2010). Chronic psychological distress has also been identified as a risk factor 
for AD in the Religious Orders Study (Wilson et al., 2003). High proneness to distress increases the 
likelihood of developing AD by 2.7 times when compared to those not prone to distress (Rothman & 
Mattson, 2010). Several studies have suggested that a history of severe or prolonged trauma may increase 
the risk of cognitive decline and dementia (Johnston, 2000; Sapolsky, 2000). Prisoner of war survivors 
who have a history of posttraumatic stress disorder show significant deficits in several aspects of 
cognition including memory, attention and executive function (Golier et al., 2002; Joffe, Brodaty, 
Luscombe, & Ehrlich, 2003; Sutker, Vasterling, Brailey, & Allain Jr., 1995). However, this association is 
not found consistently, leading some to suggest that cognitive deficits in prisoners of war may be 
attributed to depression rather than to stress (Sulway et al., 1996).  
Indeed, depression is widely acknowledged as a contributor to cognitive decline (Gatz, Tyas, St. 
John, & Montgomery, 2005). The population attributable risk due to depression is estimated to be 10.6% 
of AD cases worldwide (Barnes & Yaffe, 2011). Two meta-analyses found that depression is significantly 
associated with risk of all-cause dementia, AD and VaD (Diniz, Butters, Albert, Dew, & Reynolds, 2013; 
Jorm, 2000). Another study found depressive symptoms to be correlated with NFT and Aβ plaque loads 
in MCI (Lavretsky et al., 2009). However, these findings obscure the fact that depression is the most 
common cause of reversible dementia (Tripathi & Vibha, 2009), raising the question as to the true 
directionality of the observed association. Studies reviewed in the aforementioned meta-analyses on 
depression and dementia (Diniz et al., 2013; Jorm, 2000) were prospective cohort studies, which allowed 
temporal associations to be made. However, the average follow-up was only five or six years (Diniz et al., 
2013), while AD pathology may be seen up to twenty years prior to clinical manifestation (Jack et al., 
2010). Along these lines, researchers (Gallagher et al., 2011; Olariu et al., 2001; Ringman et al., 2004) 
have suggested that depression and anxiety in MCI may be prodromal symptoms of AD rather than risk 
factors. This argument is supported by the fact that depression, and affective disorders in general, are 
commonly found as symptoms of dementia. Long-term, prospective studies would be beneficial to clarify 
this association.  
2.5.2.5 Factors Related to Physical Health 
Several health conditions, particularly cardiovascular and metabolic irregularities, have been 
identified as risk factors for dementia, AD and VaD. Cerebrovascular disease, atherosclerosis, 
hypercholesteremia and hypertension are highly associated with VaD (Gorelick, 2004) and are also risk 
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factors for AD and all-cause dementia (Bendlin et al., 2010; Reitz & Mayeux, 2014). Cerebrovascular 
diseases, including various types of infarcts and lesions, lead to brain tissue damage that may cause VaD 
(Reitz & Mayeux, 2014). In a meta-analysis, incidence of post-stroke dementia was 7.4% among 
individuals who had experienced a single stroke (Pendlebury & Rothwell, 2009). Cerebrovascular disease 
contributes to development of AD as well (Toledo et al., 2013). Damage to brain tissue may lead to 
abnormal Aβ deposition, AD-related inflammatory response or inappropriate activation of Cdk5, one of 
the proteins involved in tau phosphorylation and production of NFTs (Reitz & Mayeux, 2014).  
Substantial evidence links blood pressure to risk of AD and VaD (for review, see Qiu, Winblad, & 
Fratiglioni, 2005). However, the effect of blood pressure on these types of dementia is complex and varies 
by age and disease. Extreme hypertension (≥160/95) in participants between age 42 and 68 (“midlife”) 
has been significantly associated with risk of developing dementia and AD (Qiu et al., 2005). 
Approximately 5% of cases of AD worldwide are attributed to midlife hypertension (Barnes & Yaffe, 
2011). Conversely, hypotension late in life is associated with increased risk of AD, most likely due to 
cerebral hypoperfusion leading to neuronal damage (Qiu et al., 2005). Risk of VaD due to hypertension 
may vary by sex (Hebert et al., 2000), or may be limited to untreated hypertension (Launer et al., 2000) or 
systolic blood pressure only (Yamada et al., 2003). Taken all together, evidence indicates that blood 
pressure is an important risk factor for dementia, AD and VaD. 
Metabolic syndrome, the co-occurrence of several reversible metabolic disorders (e.g., 
hypertension, dyslipidemia, glucose intolerance, and obesity), may be a risk factor for VaD (Raffaitin et 
al., 2009; Yaffe, Weston, Blackwell, & Krueger, 2009), although this association has not been found 
consistently (Forti et al., 2010). The relationship between metabolic syndrome and cognitive impairment 
is mediated by high levels of inflammatory proteins interleukin 6 and C-reactive protein (Yaffe et al., 
2004), but further research is needed to clarify the association (Reitz & Mayeux, 2014).  
The link between metabolic syndrome and dementia, AD and VaD is likely significant since many 
of the individual components of the syndrome, including dyslipidemia, diabetes mellitus, and body mass 
index (BMI), have been found to contribute to the risk of dementia and underlying conditions. 
Dyslipidemia increases the risk of vascular diseases, which are underlying factors in both VaD and AD 
(Korczyn et al., 2012; Raffaitin et al., 2009). Similarly, diabetes may contribute to development of AD 
and VaD through vascular associations (e.g., stroke, hypertension and dyslipidemia; for review, see Reitz 
& Mayeux, 2014). A meta-analysis of eight prospective cohort studies from Canada, USA and Europe 
estimated the relative risk of all-cause dementia, AD and VaD in individuals with diabetes to be 1.47 
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(95% CI=1.25-0.73), 1.39 (95% CI=1.16-1.66) and 2.38 (95% CI=1.79-3.18), respectively (Lu, Lin, & 
Kuo, 2009). Worldwide, 2.4% of cases of AD may be attributed to diabetes mellitus (Barnes & Yaffe, 
2011). The effect of BMI on risk of dementia is U-shaped: both underweight and obesity pose an 
increased risk (Beydoun, Beydoun, & Wang, 2008). Furthermore, midlife overweight and obesity 
increase the risk of both AD and VaD, independent of stroke, cardiovascular disease and diabetes. This 
association is graded, such that individuals who are obese in midlife have a greater risk of developing 
VaD and AD compared to those who are overweight (Whitmer, Gunderson, Quesenberry, Zhou, & Yaffe, 
2007). Indeed, the population attributable risk of midlife obesity is 2.0% of the global prevalence of AD 
(Barnes & Yaffe, 2011).  
Physical activity has a potential protective effect against dementia and its subtypes. In a systematic 
review, 11 out of 14 studies reviewed found that physical activity significantly decreased risk of dementia 
or AD (Fratiglioni & Wang, 2007). A similar protective effect is also found for VaD. A meta-analysis of 
five studies that investigated the relationship between physical activity and VaD demonstrated an OR of 
0.62 (CI=0.42-0.92; Aarsland, Sardahaee, Anderssen, Ballard, & Alzheimer's Society Systematic Review 
group, 2010). The prevalence of AD worldwide would be reduced by 12.7% if physical activity was 
universal (Barnes & Yaffe, 2011). The inverse relationships of physical activity with dementia and its 
subtypes are not surprising given the positive effect that physical activity has on cardiovascular health, a 
contributing factor to both AD and VaD pathology. 
2.5.2.6 Other Factors 
Other lifestyle factors that influence the risk of dementia, AD and VaD include smoking cigarettes, 
alcohol consumption, and diet. Moderate or heavy smoking in mid-life is associated with an increased 
risk of AD (Tyas et al., 2003) and VaD (Korczyn et al., 2012). Alcohol consumption may affect the risk 
of all-cause dementia and AD, although the association is not straightforward. Smoking and alcohol use 
may interact to affect risk (Tyas, Koval, & Pederson, 2000). Moderate consumption of red wine was 
found to decrease risk of dementia and AD in both French (Larrieu, Letenneur, Helmer, Dartigues, & 
Barberger-Gateau, 2004) and American (Luchsinger, Tang, Siddiqui, Shea, & Mayeux, 2004) 
populations. However, other types of alcohol do not seem to have the same effect (Luchsinger et al., 
2004). In terms of nutrition, the Mediterranean diet and other diets that contain antioxidant-rich fruits and 
vegetables as well as sources of polyunsaturated fats, such as fish and seafood, provide several 
cardiovascular, inflammatory and neuronal benefits and are associated with decreased risk of all 
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dementias, including AD and VaD (Hebert et al., 2000; Larrieu et al., 2004; Lourida et al., 2013; Reitz, 
Brayne, & Mayeux, 2011; Scarmeas, Stern, Mayeux, & Luchsinger, 2006). 
2.5.2.7 Risk Across the Lifespan 
Risk factors for dementia, AD and VaD may be cumulative across the lifespan. Furthermore, 
adverse conditions encountered during growth and development, even as early as at conception, have 
been associated with cognitive decline in late life. Such findings indicate that chronic dysfunction or acute 
physiological disruption at critical developmental points across the lifespan may contribute to 
neuropathology. However, reversal of these risk factors may lower the risk of eventual AD or VaD. For 
example, treatment of cardiovascular risk factors, such as antihypertensive therapy, has been associated 
with decreased risk of dementia (Monsuez et al., 2011). Alternatively, other factors such as mentally 
stimulating hobbies, close social relationships and physical activity, as described previously, have been 
found to be protective against the effects of neurodegeneration. As such, identification and reversal of 
lifetime risk factors in addition to interventions focused on enhancement of protective factors across the 
lifespan may help to delay the onset or slow the progression of disease and thereby decrease the burden of 
dementia, and, in particular, AD. 
 
2.6 Emotions 
Emotions are a driving force in many life events and are the result of conscious or subconscious 
appraisal of situations. As a result of such appraisal, emotions function to assign contextual value as well 
as to stimulate mental and physical responses (Dolan, 2002; Farb, Chapman, & Anderson, 2013). Each 
emotion is comprised of a highly specific set of responses (Farb et al., 2013), but they are commonly 
grouped together based on positive or negative valence, that is, the attractiveness or aversiveness of a 
stimulus (Dolan, 2002; Frijda, 1986). Similarly, emotions can be described by the arousal level, or 
significance, of a stimulus (i.e., high or low) such that highly arousing cues, regardless of valence, are 
more likely to receive perceptive awareness and as a result, elicit more intense responses (Dolan, 2002). 
The valence-arousal model categorizes emotions based on hedonic value and bodily activation (Feldman-
Barrett, 1998). Emotions within the same valence demonstrate relatively consistent patterns of brain 
region activity and associated physiologic responses (Anders, Lotze, Erb, Grodd, & Birbaumer, 2004). 
Thus, this model is useful in describing underlying physiological effects of emotions. Positive and 
negative emotions differ in direction of attention, behavioural tendencies and autonomic nervous system 
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activation (Anders et al., 2004). These differences present unique adaptive benefits such that positive and 
negative emotions are not equal and opposite, but rather are complementary to allow the best response to 
the situation at hand.  
Appropriate response to environmental stimuli relies on three key functions of emotions: sensory 
gating, defined as the control of perceptions and attention; knowledge integration, which involves the 
cognitive organization of complex events and determination of stimuli relevance; and embodied 
expression, or the physical representation of the emotion that is experienced (Farb et al., 2013). These 
functions, which are highly integrated in daily psychological and physiological function, may be the basis 
for a potential effect of emotional experience across the lifespan on development of dementia and AD in 
late life.  
Emotional processing relies on the orchestration of cognitive and physical functions. Cognitive 
appraisal and physical action lead to immediate internalization and communication of, and response to, 
emotional stimuli while further psychological consideration assigns context to the situation. Meanwhile, 
processes involving learning and memory formation are engaged for efficient recognition and 
management in future encounters. Intricate neural pathways spanning several brain regions, including the 
limbic system and the reticular formation in the brainstem, regulate the emotional response (Lindquist, 
Wager, Kober, Bliss-Moreau, & Barrett, 2012; Noback, Strominger, Demarest, & Ruggiero, 2005). 
Emotional processing that occurs within these regions of the brain subsequently triggers physiological 
responses through stimulation of the ANS. The interplay between each of these key components, 
including the limbic system, the reticular formation and the ANS, have implications in cognitive, 
behavioural and physical processes that may contribute to the risk of dementia, AD and VaD.  
 Cognitive Effects of Emotions  
2.6.1.1 The Limbic System 
Brain regions associated with emotions, including the thalamus and parts of the limbic system (e.g., 
the amygdala and hippocampus) are commonly affected in AD and other forms of dementia, and may 
present a link between emotions and the risk of dementia. The limbic system, which governs emotions 
and memory, is comprised of a neural circuit spanning cortical and subcortical areas of the brain (Noback 
et al., 2005). Bidirectional reciprocal pathways throughout the limbic system guide emotional processes 
including stimulus appraisal, learning, memory formation and activation of effector systems for 
appropriate physical response (Noback et al., 2005; Purves, 2001; Cahill & McGaugh, 1998). Notably, 
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the amygdala is responsible for integrating sensory and cognitive inputs in the processing of emotions, 
and is most commonly associated with implicit (i.e., unconscious) memory formation involving negative 
emotions, such as fear conditioning (Phelps & LeDoux, 2005), given the high priority of response to 
threatening situations associated with negative emotions. However, the amygdala has also been 
implicated in positive reward conditioning in some individuals (Canli et al., 2002). Furthermore, the 
amygdala is likely indirectly involved in the regulation of cognitive functions such as attention, 
perception and explicit memory formation (LeDoux, 2007). These cognitive influences may have 
implications for the development of dementia and AD. Indeed, atrophy of the amygdala is associated with 
AD neuropathology; however, it is less clearly associated with the clinical symptoms of the disease 
(Horinek, Varjassyova & Hort, 2007). Potential mechanisms by which emotion-regulated cognitive 
functions, such as perception, attention, learning and memory formation, may affect cognitive reserve and 
the development of dementia and AD, are discussed below. 
2.6.1.2 Perception and Attention 
As discussed, one of the key functions of emotions is sensory gating, which is the control of 
perception and attentional direction in the presence of an emotional stimulus. Highly arousing stimuli are 
more likely to induce an emotional response thereby enhancing perception, attention and memory 
associated with the specific cue (for review, see Dolan, 2002). For example, emotion-inducing images are 
perceived to be more vivid than neutral images (Todd, Talmi, Schmitz, Susskind, & Anderson, 2012) and 
negative facial expressions draw attention quicker than neutral faces (Frischen, Eastwood, & Smilek, 
2008), suggesting that emotionally salient stimuli receive preferential perceptive and attentive awareness 
(see review by Vuilleumier, 2005). Furthermore, valence differentially affects attention and perception: 
negative stimuli are associated with greater direct attention and impairment of peripheral awareness when 
compared to positive valence stimuli (Fredrickson & Branigan, 2005). This association between valence 
and attention is likely modulated by the arousal level of the stimulus (Fernandes, Koji, Dixon, & Aquino, 
2011). In addition, the pre-existing mood of an individual at the time of emotional stimulation also 
contributes to attention: positive moods increase peripheral perception, whereas negative moods yield 
acute attentional focus (see review by Farb et al., 2013). Emotion-directed attention and perception 
influence exchanges with, and analysis of, environmental stimuli. Such interactions with the surroundings 
provide the basis for higher cognitive processing including learning, memory, decision-making and 
problem solving, which may have implications for the development of dementia by contributing to 
cognitive reserve over the long-term.  
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2.6.1.3 Learning and Memory 
After initial sensory gating, a second function of emotions is adaptive knowledge integration, in 
which motivational relevance is assigned to stimuli in order to facilitate cognitive organization of 
emotional experiences (Farb et al., 2013). That is, information conveyed in the environment is further 
appraised for contextual meaning and stored in the memory for future retrieval. Indeed, emotional 
memories of high personal relevance are most likely to be retained and higher levels of arousal evoke 
more vivid memories (for review, see Holland & Kensinger, 2010). Emotional valence also affects the 
way in which events are remembered; memories of positive emotional valence are more likely to include 
global, “big-picture” characteristics while negative memories tend to feature more specific details 
(Holland & Kensinger, 2010). Such patterns of memory formation may partially determine the value of 
the memories in the context of cognitive reserve theory. Global memories that result from positive 
emotional experiences may have broad application for future reference in a variety of situations, thereby 
building reserve. On the other hand, negative-emotion memories that are detail-oriented may only apply 
in highly specific contexts.  
2.6.1.4 Decision-Making and Problem-Solving 
Differences in memory formation and retrieval based on emotional experiences may in turn, affect 
decision-making and problem solving over the long term. Indeed, negative moods signal that the current 
environment is problematic and focus is placed on each situation-specific detail in order to make 
decisions (for review, see Schwarz, 2000). Alternatively, positive mood allows referral to, and 
manipulation of, pre-existing knowledge (Schwarz, 2000). These patterns of information retrieval based 
on emotional state play a role in decision-making and problem solving. Positive affect consistently 
enhances creative problem solving, suggesting that the neuropsychological effect of positive emotions 
allows for cognitive flexibility and access to a larger number of more innovative thoughts (for review, see 
Ashby, Isen, & Turken, 1999). In a randomized controlled trial, physicians in whom positive emotions 
were induced through receipt of a small bag of candy generated correct hypotheses for a diagnosis in 
significantly less time when compared with control groups who did not receive an emotion-inducing 
treatment (Estrada, Isen, & Young, 1997). However, the length of time to confirm the diagnosis did not 
differ between the treatment and control groups, suggesting that individuals with positive emotions took 
more time to explore various explanations after establishing a hypothesis (Estrada et al., 1997). Similarly, 
students asked to perform a computational problem-solving task did not differ in the time it took to 
complete the task, but rather differed in strategies for completion: those with induced negative emotions 
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tended to take more time to collect all information before attempting a solution when compared to those 
with induced positive emotions and to controls (Spering, Wagener, & Funke, 2005). While both positive 
and negative emotions function similarly to obtain relevant information for decision-making and problem 
solving, differences in retrieval strategies may have wider implications on cognitive development. 
Negative emotions are associated with retrieval of task-specific details and may limit cognitive 
development. In contrast, positive emotions allow cognitive flexibility, creativity and exploration that 
may confer long-term benefits and protect against expression of clinical symptoms in the event of 
neuropathology. 
2.6.1.5 The Broaden-and-Build Theory 
The differences in development of cognitive resources as a result of positive and negative emotions 
may be attributed to behavioural tendencies associated with each emotional valence. The broaden-and-
build theory (Fredrickson, 1998; Fredrickson, 2001; Fredrickson, 2004) explains this phenomenon in 
terms of momentary thought-action repertoires, such that positive emotions increase the tendency to play, 
explore, try new things and interact with people and objects in the environment. Although this broadened 
mindset presents an increased potential for distractibility that may detract from cognitive efficiency 
(Dreisbach & Goschke, 2004), persistent positive emotions lead to the discovery of new, creative 
thoughts and actions. Over time, such exploration likely contributes to the accumulation of enhanced 
brain functions and the development of a wide array of cognitive resources (for reviews, see Fredrickson, 
2001; Fredrickson, 2004). This relationship between positive affect and the development of cognitive 
functions presents a potential link between emotional well-being across the lifespan and decreased risk of 
dementia of various subtypes. Over time, broadened thought-action repertoires may contribute to 
cognitive flexibility and compensatory mechanisms consistent with cognitive reserve theory. As such, 
positive emotions may be protective against cognitive decline and dementia due to AD and VaD 
pathology. Alternatively, negative emotions may limit such opportunities for development by narrowing 
focus and defaulting to specific action tendencies, thus detracting from the development of new skills 
(Fredrickson, 2001).  
 Psychosocial Effects of Emotions 
2.6.2.1 The Reticular Formation 
Cognitive processing of an emotion may be achieved in seconds to several minutes depending on 
quality and perceived urgency of the stimulus. Upon appraisal of environmental stimuli, appropriate 
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physiological and motor responses are activated via the reticular formation (Purves, 2001). A wide range 
of functions including sleep and alertness, cardiovascular function, respiration, pain and voluntary motor 
control are modulated and coordinated by this bundle of nerves in the brainstem, spanning from the 
thalamus and hypothalamus to the spinal cord (Noback et al., 2005; Purves, 2001). Constant processing of 
neuronal signals by the reticular formation allows dynamic and precise responses that are based on the 
quality and novelty of both somatic and cerebral nerve inputs. Such physical responses guide both 
autonomic nervous system function as well as approach and withdrawal behaviours, which depend on the 
perceived quality of the stimulus (Lang & Bradley, 2010; Noback et al., 2005). These spontaneous 
responses provide the basis for interaction with people and objects in the immediate environment 
(Niedenthal & Brauer, 2012) and thus have implications for social and cognitive experiences that may 
affect the risk of dementia and AD. 
2.6.2.2 Emotions and Psychosocial Experience 
The associations of positive valence emotions with approach behaviours, and negative emotions 
with avoidance behaviours, are consistent with the broaden-and-build theory (see section 2.6.1.5). Such 
tendencies to approach or withdraw affect the way in which individuals pursue social relationships, which 
may have implications for participation in recreational activities (e.g., Burger & Caldwell, 2000; Watson, 
Clark, McIntyre, & Hamaker, 1992). Participation in stimulating recreational activities, especially those 
with physical and social aspects, has been associated with a decreased risk of dementia, AD and VaD (see 
sections 2.5.2.3 to 2.5.2.5). Thus, behavioural tendencies that present opportunities for social interaction 
and recreation may contribute to enhanced cognitive function over the long term. Alternatively, 
withdrawal from social situations as a result of negative emotions limits the benefits gained through such 
interactions.  
In addition to presenting opportunities for stimulating social activities, approach behaviours 
consistent with positive emotions may enhance development of close relationships and social networks 
through friendship seeking. Individuals who experience positive moods (i.e., “happy people”) are more 
likely to exhibit pro-social behaviour including generosity, altruism and charity (Lyubomirsky, King, & 
Diener, 2005) and demonstrate increased social cooperativeness (Schwarz, 2000), which may lead to 
stronger friendships. Positive emotions are associated with a greater understanding of others as an 
extension of self and those who experience positive emotions tend to have greater satisfaction in their 
relationships (Waugh & Fredrickson, 2006; for meta-analysis, see Lyubomirsky et al., 2005). In turn, 
close social relationships provide support to cope with negative life events and may be associated with a 
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decreased risk of dementia and its subtypes. Alternatively, withdrawal from social situations resulting 
from negative emotions, and subsequent failure to develop close personal relationships, may lead to social 
isolation, loneliness, and elevated stress levels, all of which may contribute to the development of 
dementia and AD (Sections 2.5.2.4 & 2.6.4.1). 
 Physical Effects of Emotions 
2.6.3.1 The Autonomic Nervous System  
The physiological responses of emotions may also affect the risk of dementia, AD and VaD. 
Emotional processing in the brain leads to stimulation of the autonomic nervous system (ANS). The ANS 
controls subconscious, involuntary functions, such as respiration, cardiovascular function, digestion, 
perspiration, pupil dilation and sexual arousal (Purves, 2001). This effector system is regulated by the 
hypothalamus via the reticular formation and is therefore closely linked to the limbic system and 
emotional response. The ANS is comprised of two complementary divisions, called the sympathetic and 
parasympathetic systems, which are alternately employed.  
In the absence of intense stimuli, the parasympathetic division maintains homeostasis and energy 
metabolism (Purves, 2001). Emotional arousal stimulates the sympathetic division to prepare the body for 
appropriate action by stimulating highly precise physiological processes. Functions such as vascular, 
bronchial and pupillary dilation; increased heart rate and stroke volume; stimulation of glucose 
production; and secretion of sweat, hormones and neurotransmitters are variably activated based on the 
context of the situation (Purves, 2001). Other neuronal pathways within the sympathetic system inhibit 
functions that are not immediately required during activity (e.g., parasympathetic processes involved in 
digestion) so that all available energy can be diverted to the task at hand, if warranted (Purves, 2001). 
Repeated emotional arousal leading to chronic stimulation of the sympathetic ANS may contribute to 
dysfunction of these processes, leading to negative health outcomes associated with an increased risk of 
dementia, AD and VaD. 
2.6.3.2 Cardiovascular Effects of Emotions 
Most negative emotions stimulate ANS function, variably leading to accelerated heart rate, 
vasoconstriction and increased cardiac output. When experienced chronically, such cardiovascular 
reactivity may contribute to the development of cardiovascular conditions such as hypertension (Jonas, 
Franks, & Ingram, 1997), atherosclerosis (Stewart, Janicki, Muldoon, Sutton-Tyrrell, & Kamarck, 2007) 
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and coronary heart disease (Mauss & Gross, 2004). Several negative personality variables, such as 
impatience, anger, hostility, depression, and anxiety, are significantly associated with negative 
cardiovascular outcomes such as coronary heart disease, myocardial infarction, angina and cardiac death 
(for review, see Booth-Kewley & Friedman, 1987; Sirois & Burg, 2003). In addition, a prospective cohort 
study of older adults showed that depressive symptoms were associated with an increased risk of stroke 
even after adjusting for various comorbidities and lifestyle factors (Ostir, Markides, Peek, & Goodwin, 
2001). Cerebrovascular disease, atherosclerosis and hypertension accelerate the onset of dementia in AD 
and contribute to VaD pathology (see section 2.5.2.5). Thus, tendency toward negative emotions, which 
increase cardiovascular reactivity and the risk of adverse cardiovascular events, may also contribute to the 
development of AD and VaD.  
Alternatively, positive emotions serve to overcome the cardiovascular effects of negative emotions. 
Several studies have demonstrated that positive emotions have an undoing effect. The physiological 
effects caused by negative emotions return to baseline at a faster rate when positive, as compared to 
neutral, emotions are induced following a negative event (e.g., Fredrickson & Levenson, 1998; 
Fredrickson, Mancuso, Branigan, & Tugade, 2000). This phenomenon may explain the protective effects 
of positive emotions against health outcomes (Cohen & Pressman, 2006) and cardiovascular diseases in 
particular (Kubzansky, Sparrow, Vokonas, & Kawachi, 2001). Consistent with this idea, positive affect 
reduces the risk of stroke, which is highly involved in VaD (Ostir et al., 2001). As such, the combination 
of both positive and negative emotions acting together may affect the development of cardiovascular 
diseases that are associated with dementia outcomes. Over the long-term, the accumulation of positive 
and negative emotions and the tendency towards one valence or the other may differentially affect the 
development of diseases of dementia by increasing or decreasing the risk of underlying cardiovascular 
diseases. 
 Emotions, Stress and Emotion Regulation  
2.6.4.1 Stress as a Risk Factor for Dementia, AD and VaD 
Negative emotions, especially those of high arousal experienced over a prolonged period of time, 
are highly related to psychological stress. The stress response, which involves the release of corticotropin 
releasing hormone (CRH) and subsequent secretion of the hormone cortisol, is a recognized risk factor for 
dementia, AD and VaD (see section 2.5.2.4). Studies using animal models provide strong evidence of a 
molecular link between stress and the development of dementia and particularly AD. Stress leads to the 
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upregulation of the enzymes involved in the amyloidogenic pathway, causing an accumulation of Aβ 
plaques (Catania et al., 2009; Dong et al., 2012). In addition, CRH has been shown to affect neurogenesis; 
its overexpression in genetically modified mice is associated with significantly less dendritic arborization 
and fewer dendritic spines (Dong et al., 2012). Such findings indicate that stress may reduce the potential 
for neuroplasticity, thus restricting cognitive development. Chronically high levels of cortisol that are 
associated with the stress response increase hypertension and general cardiovascular risk (for review, see 
Whitworth, Williamson, Mangos, & Kelly, 2005). As such, stress may mediate the association of 
emotions with dementia, AD and VaD. Indeed, a Swedish cohort study with 38 years of follow-up found 
the association between neuroticism and clinically diagnosed AD was mediated by long-standing distress 
(Johansson et al., 2014). Alternatively, extraversion (i.e., the tendency to be sociable, assertive, 
enthusiastic and energetic), which was associated with low distress, did not affect the risk of AD 
(Johansson et al., 2014). 
2.6.4.2 Coping and Emotion Regulation  
The ability to cope with adverse situations, negative emotions and stress is important for optimal 
health and may have implications in the development of dementia and AD. Mature coping strategies such 
as positive reframing, creative exploration, humour and redirection of focus allow psychological growth 
even in the face of adversity (see meta-analysis by Lyubomirsky et al., 2005; Tugade, Fredrickson, & 
Barrett, 2004). Indeed, positive emotions mediate the ability to efficiently regulate negative emotions 
(Tugade & Fredrickson, 2004). Individuals who experience positive emotions on a daily basis are less 
reactive to stress and are better able to recover after a stressful event than individuals who do not 
experience daily positive emotions, an association that is especially true for highly resilient individuals 
(Ong, Bergeman, Bisconti, & Wallace, 2006). In a laboratory setting, individuals who had a tendency 
towards positive emotions had lower cortisol levels in response to a stress-inducing treatment and also 
displayed better cardiovascular recovery afterwards (Bostock, Hamer, Wawrzyniak, Mitchell, & Steptoe, 
2011). As such, while negative emotions contribute to stress and long-term poorer health outcomes, 
positive emotions may confer protective benefits by providing a coping mechanism and by enhancing 
resilience.  
Coping is a function of personality under a broader construct of emotion regulation. Emotion 
regulation is the dynamic process by which an individual controls, either consciously or unconsciously, 
which, when and how emotions are experienced and expressed (Gross, 1998). While coping focuses on 
decreasing negative emotion experiences, the goals of emotional regulation are much wider ranging such 
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that feelings and behaviours are adjusted to match situational context. Such strategies for reaching these 
goals include situation selection, situation modification, attentional deployment, cognitive change, and 
response modulation (Gross, 1998). These strategies require high-level cognitive manipulation involving 
bidirectional communication between emotion-generating limbic centers and emotion-regulating cortical 
centers of the brain (Gross, 1998). As such, capacity for emotional regulation may be demonstrative of 
cognitive ability and may have implications on the risk of dementia and AD. Indeed, similar to patterns 
found with coping, individuals who demonstrate high neurotic (negative) and low extraverted (positive) 
personality characteristics have an increased risk of AD over the long-term (Johansson et al., 2014). 
2.6.4.3 Suppression and Expression of Emotions 
Emotion regulation is generally viewed as a desirable ability, given the advantage it presents in 
controlling emotional responses to achieve specific goals. However, response modulation through 
suppression, as a strategy of emotion regulation, is thought to be less healthy than other strategies since it 
focuses on controlling behavioural responses after the emotion has been generated and thus results in 
unresolved emotions, depletion of cognitive resources and negative feelings about oneself (John & Gross, 
2004). As such, suppression of emotions is associated with negative health outcomes. Indeed, active 
suppression of an emotional experience heightens cardiovascular activation (Gross & Levenson, 1997) 
and is hypothesized to be associated with the development of cardiovascular diseases (Brosschot & 
Thayer, 1998; Pennebaker, 1992). Conversely, expression of emotions through verbal or written 
communication as a coping strategy has been associated with improved health outcomes in people with 
physical or psychiatric disorders (see meta-analysis by Frisina, Borod, & Lepore, 2004). In the short term, 
expressive writing of deep personal thoughts and emotions is found to decrease heart rate (Pennebaker, 
1997). Improvements in immune function, blood pressure, and lung and liver function have been found 
following interventions that asked participants to write about traumatic events over several weeks (Baikie 
& Wilhelm, 2005). Such findings suggest that coping with negative emotions through written or verbal 
expression may reduce the risk of cardiovascular diseases. 
In addition to serving as a regulatory mechanism, emotional expressivity also communicates the 
emotional state of an individual and thus is useful as a measurement of emotional experience. This is 
especially true for positive emotions, in which behavioural expression is closely correlated with habitual 
experience (Gross, John, & Richards, 2000). This same association is present, but weaker, for negative 
emotions, in which emotional disposition (i.e., high or low expressivity) interacts with experience to 
predict nonverbal emotional expression (Gross et al., 2000). Indeed, studies have found that emotional 
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expressivity may have predictive value for long-term health outcomes. Written emotional expressivity has 
been linked to several aspects of physical and psychological health (Pennebaker, 1997) and longevity 
(Danner et al., 2001). Similarly, emotional expression in single college yearbook photos was highly 
predictive of long-term outcomes (Harker & Keltner, 2001). As such, observation of emotional 
expressivity made at a single time-point may serve as a proxy measure of emotional experience in 
predicting long-term health outcomes, such as the development of dementia and AD.  
  Factors Affecting Emotional Expressivity 
The benefits of emotional expression through writing are consistent despite individual differences, 
such as age and sex (Pennebaker, 1997). However, these factors should be considered when measuring 
expressivity in written work given that expression may vary between individuals. Carstensen and 
colleagues (2003; 1999) posit that the perception of time, which tends to narrow with age, affects 
cognitive processing of emotional information so that older adults are more motivated by emotional, 
rather than knowledge-based, goals. As such, they experience a positivity bias compared to their younger 
counterparts (Charles, Mather, & Carstensen, 2003; Mather & Carstensen, 2005). Furthermore, men and 
women show fundamental differences in neural activation in emotion processing (Whittle, Yücel, Yap, & 
Allen, 2011) and women are more emotionally expressive than men (Kring & Gordon, 1998). Written 
language skills (i.e., idea density and grammatical complexity) may also affect the ability to communicate 
emotional experience through writing and have been considered in past investigations using scored 
autobiographies from the Nun Study (described in detail in section 4.2). Although idea density did not 
affect the association between positive emotional expressivity and longevity (Danner et al., 2001), 
correlations between idea density and both positive (r=0.26, p=0.01) and negative (r=0.19, p=0.07) 
emotion words (Snowdon et al., 1996a) suggest that idea density may confound the association between 
emotional expressivity and AD. Thus, individual differences in characteristics, such as age, sex and 
written language skills, may influence the association of emotional expressivity with dementia and AD.  
 
2.7 Summary 
The psychological, behavioural and physiological aspects of emotions present several possible 
mechanisms by which cognitive function and brain pathology in late life may be affected. Emotions guide 
perception and attention and are highly linked with learning, memory formation, decision-making and 
problem solving. Positive emotions tend to broaden the scope of attention and lead to more global thought 
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processes, while negative emotions narrow attention and lead to detail-oriented information retrieval. In 
addition to cognitive development, the behavioural effects of emotions affect the pursuit and development 
of close social relationships that increase opportunities for recreational activities and provide emotional 
support in the face of adversity. Emotional support is crucial for coping with negative life events, and thus 
may alleviate stress. Furthermore, the physiological characteristics of emotions may contribute to the risk 
of developing health concerns such as hypertension, atherosclerosis and various other cardiovascular 
diseases. The influence of emotions on these aspects of health and well-being is suggestive of a potential 
role in the development of dementia and associated neurodegenerative diseases.  
The aforementioned influences of emotions may affect the development of dementia, AD and VaD 
through one of two pathways: by a damaging, neuropathogenic effect or a beneficial, neuroprotective 
effect. In particular, the experience of negative emotions and the resulting psychological stress may 
contribute to the neuropathogenesis that is characteristic of AD and VaD by increasing underlying risk 
factors such as cardiovascular diseases and overexpression of the amyloidogenic pathway. Consistent 
with these ideas, affective disorders such as depression and posttraumatic stress disorder have been found 
to increase the risk of dementia and AD. Alternatively, positive affect reduces the cardiovascular effects 
of negative emotions and provides a source of resilience in stressful situations and thus may counteract 
the pathogenic effects of negative emotions.  
Beyond reversing the effects of negative emotions, positive emotions may have a neuroprotective 
effect against the development of dementia in the presence of brain pathology by helping to build 
cognitive resources and resist cognitive decline. Positive emotions also facilitate social networking that 
may further contribute to cognitive development by increasing the likelihood of mental stimulation 
through recreational activities. Such plausible mechanisms support the potential association between 
emotions and the development of dementia and AD. However, previous literature exploring this 
relationship is limited. Therefore, the objective of the current study is to establish the association of 
emotional expressivity with dementia and AD. Findings will provide a foundation on which future 
research can build to further explore the value of emotions in predicting these conditions. These efforts 
will also inform the development of preventative strategies to help reduce the expected burden of the 
diseases at both the individual and societal level. 
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Chapter 3 
Study Rationale 
3.1 Motivation 
 Gaps in Current Literature 
The current investigation builds upon previous findings from the same study (i.e., from the Nun 
Study described in section 4.2), which showed that emotional expressivity is predictive of longevity 
(Danner et al., 2001). In that study, individuals who expressed a high level of positive emotions were 
likely to live longer than those who expressed a low level of positive emotions. A possible explanation for 
this finding is that positive emotions are associated with higher quality of life and better health outcomes. 
Indeed, individuals with a positive mindset tend to have faster recovery times and better psychological 
well-being, immune function and general health outcomes than people who tend toward negative 
emotions (for review, see Naseem & Khalid, 2010). Such evidence points to a possible association 
between emotional expressivity in early adulthood and the development of dementia in late life. However, 
few studies have explored the relationship between emotions and the risk of dementia or its subtypes. 
Even fewer have taken a lifespan approach to investigate this relationship. Despite the limited availability 
of literature, several aspects of emotions experienced across the lifespan present potential mechanisms 
that may contribute to the risk of dementia and its subtypes. Emotions influence cognition and 
cardiovascular function, which have been shown to affect the risk of all-cause dementia and underlying 
pathology. In addition, psychosocial effects of emotions may have implications for cognitive decline and 
neurodegeneration. Given this evidence, the current study is intended as a novel investigation of the 
association between emotional expressivity in early adulthood and the development of dementia and the 
most prevalent subtype, AD, in late adulthood.  
Previous investigations of the association of emotional expressivity with dementia and its subtypes 
are limited and most of the literature has focused only on negative valence emotions. For example, 
perceived sadness has been associated with both MCI and an increased risk of converting from MCI to 
dementia when compared to individuals who did not report sadness (Caracciolo, Backman, Monastero, 
Winblad, & Fratiglioni, 2011). In addition, studies have found that neuroticism, depression, anxiety and 
loneliness are highly associated with dementia, and in particular, AD and VaD (see section 2.5.2.4). 
However, these studies have been relatively short-term and may not demonstrate a true causal 
relationship. Most had only five to eight years of follow-up even though evidence of AD pathology may 
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be present up to twenty years prior to disease diagnosis (see section 2.3.1). As such, the possibility that 
anxiety, depression and social withdrawal may be prodromal symptoms of the underlying neuropathology 
of dementia cannot be ruled out. Nevertheless, the observed effects of depression, anxiety and loneliness 
suggest a potential role of chronic emotional distress in the risk of dementia and its subtypes.  
The potential for novel research in this area is broad given the previous concentration on negative 
emotions, the relatively short follow-up periods in these studies, and the lack of literature on the effects of 
positive emotions on dementia. Danner and colleagues (2001) found that positive emotions predicted 
longevity, suggesting that positivity may confer benefits to general health. These benefits may extend to 
protecting against dementia and its subtypes because positive emotions broaden attention and perception 
and contribute to cognitive resources (Fredrickson, 2004). The present study is intended to further the 
understanding of the long-term effects of emotional expressivity of both positive and negative valence in 
predicting the development of dementia and AD. 
 Plausible Mechanisms 
Emotional expressivity may affect the risk of dementia and underlying neuropathology through two 
separate mechanisms. First, emotions are highly involved in cognitive processing and development and 
may confer neuroprotective benefits by contributing to cognitive reserve. Increased cognitive reserve 
allows an individual to maintain cognitive function even if neurodegeneration occurs (see section 2.5.2.3). 
Emotions guide perception and attention: negative emotions, in general, tend to narrow attention and lead 
to habitual thought-action repertoires whereas positive emotions increase the tendency to explore the 
environment, try novel experiences and interact with surrounding people and objects. Positive emotions 
arise from personally enriching experiences and contribute to further personal development through 
maximization of resources that may lead to enhanced cognitive ability (see section 2.6.1.5). Over the long 
term, a tendency toward either positive or negative emotions may have beneficial or detrimental effects, 
respectively, on cognitive development. Positivity, which broadens thoughts and enhances exploratory 
behaviour, is more likely to build cognitive reserve and protect against cognitive impairment associated 
with AD and related vascular pathology while negativity may limit such protective effects.  
The second mechanism by which emotional expressivity may affect the risk of dementia and its 
subtypes is through a neuropathogenic effect. In particular, negative emotions may increase the risk of 
AD pathology because they stimulate cardiovascular activity and are associated with psychological stress. 
Over the long term, chronic stress and cardiovascular over-stimulation can lead to atherosclerosis, 
hypertension and cardiovascular disease, which increase the risk of developing neuropathology associated 
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with AD as well as other subtypes of dementia, such as VaD (see section 2.5.2.5). Thus, in addition to 
limiting cognitive benefits associated with positive emotions, a tendency toward negative emotions may 
increase the risk of AD and resulting dementia by contributing to vascular pathology. However, positive 
and negative emotions interact to regulate cardiovascular function during emotional events. Positive 
emotions act as a coping mechanism to reverse the effects of negative emotions by efficiently returning 
cardiovascular function to baseline (see section 2.6.3.2) and may therefore protect against the adverse 
physiological effects associated with negativity. As such, the combined effects of positive and negative 
emotions may drive the association of emotional expressivity with dementia and AD.   
 
3.2 Objective 
To my knowledge, this is the first study of its kind to investigate the relationship between emotions 
in early adulthood and the development of dementia and AD in late life. Since this relationship has not 
previously been explored, the current research project is intended to, first and foremost, establish if an 
association exists. Data from the Nun Study, described elsewhere (section 4.2), will be used to explore 
this association. Low prevalence of vascular pathology in this study population prevented the 
investigation of the effects of emotions on VaD as an outcome, although this association is recommended 
as a focus for future study.  
Various measures of emotions expressed in single autobiographical accounts written in early 
adulthood by participants of the Nun Study will be compared to late-life outcomes of dementia and AD, 
diagnosed by cognitive assessments and post-mortem brain pathology. The validity of emotional 
expressivity in autobiographical documents as an indicator of broader emotional tendencies is supported 
by previous studies, which have linked written emotional expressivity to several aspects of physical and 
psychological health (Pennebaker, 1997). The data that will be used in the current investigation have been 
used previously to show that emotional expressivity affects longevity (Danner et al., 2001). Similarly, 
emotional expression in single college yearbook photos was highly predictive of long-term outcomes 
(Harker & Keltner, 2001). Such findings suggest that single, brief observations of emotional expressivity 
in early adulthood, such as those found in the Nun Study autobiographies, may be indicative of more 
stable temperament and personality traits and are useful for studying health outcomes in late adulthood.  
A secondary purpose of this project is to begin to understand the potential mechanisms by which 
emotions may affect the development of dementia and AD. All-cause dementia and AD specifically may 
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be differentially affected by overall expressivity, either emotional valence separately, or the interaction 
between positive and negative emotions. Analyses accounting for factors including age, education, 
APOE-ε4 status, cerebral infarcts and measures of linguistic ability, have been designed with the intention 
of investigating different aspects of emotional expressivity and hypotheses have been formed based on 
previous literature.  
First, overall emotional expressivity will be used to assess the effect of emotional expression in 
contrast to suppression or nondisclosure. Previous literature suggests that suppression of emotions may 
have long-term negative health effects (see section 2.6.4.3). Furthermore, written expression has been 
used as a therapeutic tool in helping to cope with emotional adversity. As such, overall emotional 
expressivity is expected to be associated with a decreased risk of dementia and its subtypes.  
Second, positive and negative emotional expressivity, measured individually, will provide insight 
into the effects of the tendency toward one or the other valence. Positive emotions have been found to 
increase exploratory behaviours and broaden thought-action repertoires, thereby enhancing cognition and 
potentially protecting against dementia and AD (see section 2.6.1.5). As such, positive emotions may be 
associated with a decreased risk of the outcomes of interest. Alternatively, negative emotions have 
deleterious cardiovascular effects and may increase the risk of dementia and AD by contributing to 
underlying brain pathology (see section 2.6.3.2). Considering these hypotheses, analyses featuring 
measures of positive and negative emotional expressivity separately may help to clarify the effects on 
cognitive and pathological outcomes of dementia and AD.  
Finally, the interaction between positive and negative emotions will be tested to determine whether 
emotions of different valence act together to affect the risk of dementia and AD. Positive emotions have 
been found to reverse the cardiovascular stimulation caused by negative emotions; thus, the risk of 
dementia, and more so AD given the significant vascular component, is expected to be highest when 
negative emotions are high and positive emotions are low (see section 2.6.3.2). Critical analysis of the 
results of this study will provide insights into the effects of emotional expressivity in early adulthood on 
development of dementia and AD in late life. However, definitive conclusions regarding the underlying 
mechanisms cannot be formed as this is beyond the scope of these data. 
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Chapter 4 
Methods 
4.1 Literature Search 
A systematic review of the literature was conducted in October 2013, and updated in September 
2014, to explore the current understanding of the effect of emotions across the lifespan on development of 
dementia and its two major subtypes, AD and VaD. Since this concept is relatively novel, a broad search 
of various terms synonymous to, and including, “emotions”, “Alzheimer’s disease”, “dementia” and 
“vascular dementia” were entered into the Medline database using the PubMed interface as well as into 
the PsycINFO database of the APA PsycNET. See appendix A for the full search construct. Publications 
were reviewed for relevance to the proposed topic and were included if they pertained to emotional 
experience or expression and development of dementia, AD or VaD. Inclusion was limited to English-
speaking, peer-reviewed articles. Date of publication was not limited.   
The purpose of the search was to review studies that had explored emotions as predictors of 
neurocognitive disorders. Thus, articles that investigated emotionality following onset of neurocognitive 
disorders were excluded. Study participants had to be at risk of dementia, AD and VaD at baseline (i.e., 
incident cases) to be considered for inclusion. Publications that discussed the temporal association 
between any aspect of emotions or a specific emotion and dementia outcomes were retained. In addition, 
the current investigation is concerned with non-disordered emotional expressivity so studies including 
major depression and anxiety disorder were excluded, although they were considered for inclusion in the 
background literature review. Likewise, studies on stress were also excluded from the core literature 
(Appendix A, Table 2); although stress is indicative of potential emotional state, it is not an emotion 
itself.  
In all, 2732 publications were identified: 2199 from Medline and 533 from PsycINFO. After 
duplicates were removed, 2595 remained. A review of titles narrowed the number to 56 publications for 
full review, and out of these, three were kept for incorporation into the current investigation. Concern for 
the low number of publications retrieved led to additional manual searches using dementia, AD or VaD 
terms and specific emotions. Reference lists of related articles were also scanned. Through these 
supplemental searches, two additional publications were obtained. In all, five publications were identified. 
The scarcity of literature on the topic supports the novelty and value of the current investigation. 
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4.2 Data Source: The Nun Study 
 Background 
The Nun Study is a longitudinal study on aging and Alzheimer’s disease (Snowdon et al., 1996b; 
Snowdon et al., 1997). In 1986, the principal investigator, Dr. David Snowdon, began a pilot study on a 
small group of religious sisters from the congregation of the School Sisters of Notre Dame (SSND) in 
Mankato, Minnesota, USA. This initial study led to the present Nun Study, which expanded the 
population to include members of the SSND congregation from seven religious provinces spanning 
midwestern, southern and eastern regions of the USA (Snowdon et al., 1997).  
The Nun Study provides a unique opportunity to investigate factors across the lifespan that 
contribute to late-life cognitive outcomes. Data, which will be described further in section 4.2.3, have 
been gathered from three main sources: archival documents from childhood onwards, annual assessments 
in older adulthood, and brain examinations at post-mortem autopsy.  
 Population 
Members of the SSND were eligible for the study if they were aged 75 or over at the time of 
recruitment in 1991. Agreement to full participation in all components of data collection, including post-
mortem brain donation, was required. Of the 1031 individuals who were eligible, 678 (66%) agreed to 
participate (Snowdon et al., 1996b) and written consent was obtained. Non-participants were similar to 
participants in age, country of birth, race and annual mortality rate (Snowdon et al., 1996b).  
At the time of recruitment, participants were aged 75 to 102, with a mean age of 83 (Danner et al., 
2001; Snowdon et al., 1997). The study population was highly educated, with 85% having obtained a 
bachelor’s degree or higher at the time of the first cognitive assessment (Tyas, Snowdon, Desrosiers, 
Riley, & Markesbery, 2007). The population is also unique because of the relatively homogeneous 
lifestyle of its members. That is, participants are similar in factors such as tobacco and alcohol use, 
marital status, reproductive history, housing, occupation and access to healthcare from adulthood to the 
end of life. 
 Data Collection 
Data in the Nun Study has three components, including annual cognitive and physical assessments, 
post-mortem brain autopsies and archival documents of personal history. These components provide 
valuable resources for study of lifespan factors contributing to health and cognitive function.  
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Annual cognitive assessments included the MMSE and the CERAD battery of neuropsychological 
tests (e.g., delayed word recall, verbal fluency, Boston Naming and constructional praxis; see section 
2.3.3). Physical function was measured as ability to perform basic and instrumental ADLs (Snowdon et 
al., 1996b). APOE status was determined using DNA obtained from buccal swabs and from brain tissue at 
the post-mortem autopsy according to standard techniques (Riley et al., 2000; Saunders et al., 1996).  
All participants agreed to post-mortem brain donation, which has provided a rich source of 
neuropathologic data. Brains underwent both gross and microscopic examinations to identify NFTs, Aβ 
plaques, infarcts, and various other lesions. Braak stage, brain weight and degree of atrophy were also 
documented (Riley et al., 2002). Neuropathological data collected at brain autopsy allow for a reliable 
diagnosis of AD and VaD. Evidence of vascular comorbidities, such as cerebral infarcts, was also 
assessed.  
Convent archives, which have been made available to the investigators, provide invaluable data on 
the participants from childhood and early adulthood. Academic report cards and autobiographies present 
measures of academic performance, intellectual ability and emotional expressivity. Various other 
documents offer insights into early-life experiences such as parental education, socioeconomic status, 
family environment and key life events. A more detailed description of information contained within the 
archives is provided elsewhere (Patzwald and Wildt, 2004).   
 
4.3 Study Design 
 Analytic Sample 
The sample for the present study was obtained based on availability of archival autobiographies. 
These autobiographies were written upon formal entry into the religious congregation, as instructed by the 
Mother Superior of the North American congregation of the SSND beginning in 1930 (Danner et al., 
2001). The instructions required that the individuals wrote an autobiographical sketch of key life details 
that did not exceed two to three hundred words and was written on a single sheet of paper (Danner et al., 
2001). This implies that the autobiographies were relatively consistent in length for the purpose of 
comparison in the current investigation. In order to ensure that the autobiographies were written 
personally and that English proficiency was consistent, autobiographies were selected for scoring if they 
had been handwritten and the participant was born and raised in the USA (Danner et al., 2001). The 
majority of autobiographies that met these criteria were found in two convents in Milwaukee, Wisconsin 
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and Baltimore, Maryland. In all, 180 autobiographies from these two locations fit the criteria for inclusion 
and were scored for emotional expressivity and written language skills, as described elsewhere (Danner et 
al., 2001; Snowdon, 1996b). Participants were eligible for inclusion in the current study if they had a 
scored autobiography as well as complete data on all other variables of interest.  
Cognitive assessments to determine the presence or absence of dementia were available for all 180 
individuals. Of these, 164 (91.1%) had full data on all covariates of interest. However, the availability of 
data on neuropathology greatly limited the number of individuals eligible for inclusion in the sample for 
the analysis of AD: only 95 (52.8%) of the 180 individuals at baseline had neuropathologic data. 
Individuals were missing these data because they were still alive or their post-mortem brain autopsy was 
not available. So as not to limit the number of participants included in the dementia analysis, a subset for 
the analyses of AD was defined. Of the 164 individuals who were included in the sample for the dementia 
analysis, 70 individuals had complete neuropathologic data, leaving 94 (52.2% of the original sample) 
who fulfilled all criteria for inclusion in the subset for the analysis of AD. However, multivariate logistic 
regression analysis using these initial samples yielded poorly fit models given the high impact, but low 
prevalence, of low education (see Appendix D). As a result, the samples were subsequently restricted by 
low education. After restriction, 149 participants were included in the final sample for the dementia 
analyses, and 85 remained in the final sample for the AD analyses (Figure 1).  
 Exposure Measures 
Measures of emotional expressivity as the exposure of interest were obtained from the handwritten 
autobiographies, described previously. Emotional content scores were derived from raw counts of words 
indicating positive or negative emotional experiences in the autobiographies. Two coders counted the 
emotion words independently and then a third coder verified each word for accuracy. A detailed 
description of the methods used to score emotional expressivity in the autobiographies is provided 
elsewhere (Danner et al., 2001). To meet the objective of the current study, emotions were measured as 
positive or negative in valence rather than as discrete emotions. Emotions of the same valence tend to 
show similar patterns of brain region activity and associated physiologic processes and thus likely have 
similar effects on cognitive, social and physical factors that potentially affect dementia outcomes (see 
Section 2.6).  
Measures of overall (i.e., the sum of positive and negative emotions), positive and negative 
emotional expressivity were included in the analyses. Each measure was categorized as “high” or “low” 
based on within-convent ranking of the respective raw word count: those that were in the top two 
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quartiles were categorized as high, while those who were in the bottom two quartiles were categorized as 
low. A second component of the analysis of dementia further separated the measures of expressivity into 
three categories, based on tertile rankings of the respective word counts (high, top tertile; moderate, 
middle tertile; and low, bottom tertile). Word counts were ranked within each convent separately to 
control for differences in distribution of expressivity and length of the autobiographies between the 
convents. 
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Figure 1. Flow chart illustrating the selection of samples for analyses of dementia and Alzheimer’s disease (AD) in association with emotional 
expressivity. The dashed arrows represent individuals who were excluded. The subset for analyses of AD was defined as individuals included in the 
dementia analyses who had available neuropathology data. The grey arrows represent an alternative derivation of this subset, based on missing 
neuropathologic criteria. 
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 Outcome Measures 
Two outcomes – dementia and AD – were assessed. VaD was also considered as an outcome given 
the relationship to AD (Section 2.5.1) and the strong vascular influence of emotions (Section 2.6.3); 
however, low prevalence of VaD prevented the performance of meaningful analysis. Dementia cases were 
defined as individuals who fulfilled the cognitive criteria for dementia at the time of the last cognitive 
assessment. AD cases were those who had dementia at the last cognitive assessment, and who fulfilled 
AD neuropathologic criteria at the postmortem autopsy. All cases were considered incident regardless of 
time of diagnosis, given the early age at which exposure data were collected (i.e., in young adulthood). 
Variables for dementia and AD were both dichotomous, defined as either presence (cases) or absence 
(non-cases) of the respective condition. For the analysis of AD, several combinations of case and non-
case definitions were analyzed to investigate the specific effects of emotional expressivity.  
The diagnosis of dementia in the Nun Study has been described previously and was based on 
normative data from the CERAD battery of functional tests (Riley et al., 2002). Criteria for a dementia 
diagnosis included impairment in memory and at least one other cognitive domain, impaired performance 
of ADLs and a decline from a previous level of function (see section 2.2.3). Specifically, 
neuropsychological tests indicated cognitive impairment if scores were <13 out of a possible 60 points on 
the Boston Naming test, <11 points (with no ceiling) on Verbal Fluency, <4 out of 10 for Delayed Word 
Recall, and <8 out of 11 for Constructional Praxis (Riley et al., 2002). These criteria had previously been 
compiled to derive a variable within the Nun Study dataset indicating if a dementia diagnosis was 
established at the last cognitive assessment. The referent group for the analysis of dementia was 
individuals who did not have a diagnosis of dementia at the last cognitive assessment.  
The case definition for AD required a diagnosis of dementia at the last cognitive assessment in 
addition to presence of AD neuropathology at post-mortem autopsy. Two different case definitions were 
analyzed, based on the fulfillment of neuropathologic criteria according to CERAD or NIA-RI guidelines 
(see section 2.3.3). The patterns of association of the two case definitions with emotional expressivity 
were compared. Two different non-case definitions were also analyzed to elucidate the potential effects of 
the cognitive and neuropathological components of an AD diagnosis. The two non-case definitions were 
(1) those who did not fit the case definition and who did not have dementia and (2) those who did not fit 
the case definition and who had neither dementia nor AD pathology. In all, four different samples for the 
analyses of AD were selected, based on the two case and two non-case definitions (Table 1).  
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Table 1. Case and non-case definitions: samples for AD analyses  
 Case Definition Non-Case Definition 
   
Analytic Sample    
NIA-RI/D - Dementia diagnosis  
- NIA-RI AD neuropathology 
- Not fulfilling case definition 
- No dementia diagnosis 
   
NIA-RI/DN - Dementia diagnosis 
- NIA-RI AD neuropathology 
- Not fulfilling case definition 
- No dementia diagnosis 
- No NIA-RI AD neuropathology 
   
CERAD/D - Dementia diagnosis 
- CERAD AD neuropathology 
- Not fulfilling case definition 
- No dementia diagnosis 
   
CERAD/DN - Dementia diagnosis 
- CERAD AD neuropathology 
- Not fulfilling case definition 
- No dementia diagnosis 
- No CERAD AD neuropathology 
   
Abbreviations: AD= Alzheimer’s disease; CERAD= Consortium to Establish a Registry for Alzheimer’s Disease; 
D= non-cases without dementia; DN= non-cases without dementia and AD neuropathology; NIA-RI= National 
Institute on Aging-Reagan Institute 
 
Diagnosis of VaD was based on NINDS-AIREN criteria for MID, a specific form of vascular 
dementia caused by multiple large infarcts (see section 2.4.2) that was diagnosed by researchers on the 
Nun Study. As such, the case definition for VaD in the current investigation required a dementia 
diagnosis at the last cognitive assessment and positive evidence of MID as determined by presence of 
multiple cerebral infarcts at postmortem autopsy. The sample for VaD analyses included the same 85 
individuals who were eligible for inclusion in the sample for AD analyses. Of these, only 1 (1.2%) was 
defined as a case so further analysis was not performed.  
 Covariates 
Associations between emotional expressivity in early adulthood and development of various 
dementia outcomes in late life were adjusted for age and highest level of education attained. The 
influence of cerebral infarcts, APOE-ε4, and measures of written language skills including idea density 
and grammatical complexity in the autobiographies was also evaluated.  
Age was measured as a continuous variable. All participants were aged 75 or older based on the 
age restrictions for participant recruitment. The age variable differed by model according to the case 
definition. In the dementia models, age was defined as the age at the last cognitive assessment. Age in the 
 48 
AD models was defined as the age at death, given that diagnoses rely on pathological evidence observed 
in a post-mortem autopsy. 
Education, APOE-ε4 and cerebral infarcts were each measured as dichotomous variables. After 
restriction on low education, which was defined as high school or less, the education variable was divided 
into two categories: bachelor’s degree, or master’s degree or higher. Participants were categorized as 
having at least one APOE-ε4 allele or having none. Likewise, individuals were classified as having either 
presence or absence of any cerebral infarct based on gross neuropathologic assessments that included 
visual inspection of both the intact brain and 1.5 centimeter-thick coronal sections (Snowdon et al., 1997). 
Several participants were missing data on cerebral infarcts (n=43); however, the presence of infarcts in 
the remaining sample (n=106) was determined to have no effect on the results so the sample was not 
restricted based on the availability of these data and the variable was not included in any further analyses. 
A full discussion and sensitivity analysis of the subset with complete data on cerebral infarcts are found in 
appendix B. 
In addition to being scored for emotional expressivity, the autobiographies were scored for idea 
density (Kintsch & Keenan, 1973; Turner & Greene, 1977) and grammatical complexity (Cheung & 
Kemper, 1992) as measures of written language skills. Idea density was measured as the average number 
of ideas expressed per ten words. Grammatical complexity was measured according to an established 
eight-level scale ranging from simple, one-clause sentences to complex, multi-clause sentences. Each 
score was ranked into quartiles within each convent separately. A detailed description of how these scores 
were obtained in the Nun Study autobiographies is described elsewhere (Snowdon, 1996b; Snowdon, 
2000). For the purpose of the current investigation, the top three quartiles of each variable were collapsed 
to obtain dichotomous variables classified as levels of  “higher” (i.e., those in the upper 3 quartiles) and 
“low” (i.e., those in the bottom quartile) idea density and grammatical complexity. The idea density and 
grammatical complexity measures were both collapsed in this way given the significant difference in 
prevalence of dementia in the lowest quartile compared to the top three quartiles. Among participants 
with scored autobiographies, 64% of individuals in the lowest quartile of idea density were diagnosed 
with dementia, compared to 23% in the top three quartiles (p<0.01). Likewise, 52% of individuals in the 
lowest quartile of grammatical complexity were diagnosed with dementia, compared to 28% with 
dementia in the top three quartiles (p<0.01). These dichotomous variables (bottom vs. top 3 quartiles) 
were used in all analyses. 
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4.4 Analytic Strategy 
 Descriptive Analysis 
Summary measures (e.g., mean, standard deviation) were used to describe variables that were 
included in the analyses. Associations between each exposure (i.e., three measures of emotional 
expressivity), outcome (i.e., dementia or AD), and covariates (i.e., age, education, APOE-ε4 status, idea 
density and grammatical complexity) were tested separately through bivariate analyses. Pearson chi-
square or Fisher’s exact tests were used to compare categorical variables. Associations where one variable 
was categorical and the other was continuous were measured using independent samples t-tests with 
Satterthwaite’s unequal variance correction, as appropriate.  
 Multivariate Analysis 
Multivariate logistic regression models were used to analyze the association of emotional 
expressivity with dementia and AD. First-order interactions between the covariates and the exposures 
were explored. A significant interaction was found between overall emotional expressivity and idea 
density with dementia as the outcome (p<0.05). Thus, further models of the sample for dementia analyses 
were stratified by idea density. Within the sample for the analyses of AD, none of the first-order 
interactions between the exposures of interest and the covariates were found to be significant. However, 
in order to maintain comparability with the dementia analysis, the sample used for the AD analyses was 
stratified by idea density as well. Sensitivity analyses without stratification were also performed for all 
models.   
After stratification by idea density, backwards elimination was performed to identify variables that 
significantly influenced the outcomes of interest. This method is preferable to the forward selection 
method because it is generally associated with a smaller mean squared error (Tyas et al., 2000). 
Backwards elimination started with the full model and nonsignificant variables were removed 
individually so only those variables that affected the outcome of interest were retained. Variables were 
eliminated if they exceeded a significance level of α=0.15 for main effects and α=0.05 for interaction 
terms (Tyas et al., 2000). Idea density and APOE-ε4 were consistently retained in the models. These 
results were taken into consideration when constructing subsequent models.  
The backwards elimination method was not sufficient to meet the objective of the study (i.e., to 
investigate the association of emotional expressivity with dementia and AD) because the emotional 
expressivity variable was rarely retained in the models. As such, crude, adjusted and full models were 
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generated manually to explore the effect of each covariate on the association between each emotional 
expressivity exposure and each outcome. All models were adjusted for age, education, APOE-ε4 status, 
and grammatical complexity in succession to obtain the most parsimonious model (Table 2). 
 
Table 2. Analytic strategy to investigate the association of emotional expressivity with dementia and 
AD, stratified by idea density1 
Variable Crude 1B 1C 1D Full Final3
       
Emotional Expressivity2 ✓ ✓ ✓ ✓ ✓ ✓ 
       
Age  ✓ ✓ ✓ ✓ ✓4
Education   ✓ ✓ ✓ ✓ 
APOE-ε4 Status    ✓ ✓ ✓ 
Grammatical Complexity     ✓ ✓ 
1 Analyses were repeated for low and higher idea density subgroups and for dementia and AD outcomes. 
2 Measures of overall, positive and negative emotional expressivity were analyzed separately.  
3 Variables that were significant in the model or affected the point estimate of emotional expressivity were included 
in the final model.  
4 The grey check marks indicate potential inclusion of covariates in the final model based on their effects in previous 
models. 
Abbreviations: AD= Alzheimer’s disease; APOE-ε4 = apolipoprotein E ε4 allele 
 
The sample size of the sample for dementia analyses was sufficient to perform further analyses to 
clarify the association between emotional expressivity and dementia. These analyses included the 
investigation of the effects of overall, positive, and negative expressivity when divided into tertiles (i.e., 
low, moderate and high categories), and the interaction between positive and negative emotional 
expressivity. This interaction was significant among individuals with higher idea density (p=0.036). As 
such, the sample was subsequently stratified by positive emotional expressivity (as well as by idea 
density) and models were generated to investigate the association between negative emotional 
expressivity and dementia within each strata of positive expressivity 
Assessment of all final models included the Hosmer-Lemeshow goodness of fit test (LACKFIT 
command in PROC LOGISTIC) to ensure observed values matched those expected based on the model. 
Models that had a p-value of less than 0.05 on the Hosmer-Lemeshow goodness of fit test were 
determined to have poor fit and were flagged for further investigation. Diagnostic tests, including C, 
CBAR and DFBETAS in PROC LOGISTIC, were used to identify influential outliers in all final models. 
C and CBAR indicate the influence of each observation on the confidence interval of the parameter 
estimate, and DFBETAS indicates the influence on the parameter estimate itself (SAS Institute Inc., 
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2009). C, CBAR and DFBETAS outside of ±1.96 (p=0.05) indicated a significant influence on the 
parameter estimate. Variance inflation factors (VIF command in PROC REG) were also generated; VIFs 
of 10 or greater indicate issues with multicollinearity (Belsley, Kuh, & Welsch, 1980). All analyses were 
carried out using SAS statistical software, version 9.4 (SAS Institute Inc., Cary, North Carolina). 
 
4.5 Ethics Approval 
All study participants provided written informed consent at the time of participant recruitment in 
1990 and again in 2006. Initial ethics approval for all aspects of data collection was obtained through the 
University of Kentucky. Since then, the study has moved to the University of Minnesota, where ethics 
approval and confidentiality practices are maintained. Hard copies of data sources, including archival 
material and clinical and neuropathological records, are kept in locked filing cabinets at the University of 
Minnesota. Access to these data is restricted. Data are also kept in electronic records by non-identifying 
participant ID numbers that were used in the current investigation. These electronic records are stored at 
the University of Waterloo on password-protected computers and are only available to authorized 
personnel. The Office of Research Ethics at the University of Waterloo has granted ethical clearance for 
this study (ORE#16551). Investigators have also signed confidentiality agreements pertaining to the 
ethics of this research. 
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Chapter 5 
Results 
The results of the analyses are described below. All univariate and bivariate statistics of the 
sample for dementia analyses (Section 5.1.1), followed by those of the AD analyses (Section 
5.1.2), are described first. Then the results of the main multivariate analyses of both dementia and 
AD as outcomes using the respective samples are presented together, but separated by low 
(Section 5.2.1) and higher (Section 5.2.2) idea density strata. Following the main results, the 
extended analyses of the sample used for dementia analyses (i.e., emotional expressivity 
categorized by tertiles and the modifying effects of positive expressivity on the association with 
negative emotional expressivity) are described (Section 5.2.3). Again, the results of the low and 
higher idea density subgroups are presented separately for each of these extended analyses. The 
model diagnostics are then reported (Section 5.2.4). Finally, sensitivity analyses of the findings, 
including investigation of the association between emotional expressivity and dementia using the 
smaller subset (Section 5.3.1), and reporting of the analyses without stratification by idea density 
(Section 5.3.2), are presented.  
 
5.1 Descriptive Statistics 
 Sample Selected for the Dementia Analyses 
Of 180 eligible individuals, 164 (91.1%) were initially included in the sample for dementia 
analyses (see Appendix C for a comparison to those who were excluded). However, given the 
strong influence of low education on dementia and AD, and the small number of participants with 
low education (i.e., a high school diploma or less; n=15), controlling potential confounding by 
education through adjustment in multivariate models was problematic. The multivariate logistic 
regression models including education as a significant covariate had a poor fit, which prevented 
meaningful conclusions from being made (Appendix D). As such, restriction was added as a 
strategy to control confounding. The analytic sample was restricted by education so that only 
participants with a university degree were included, and the education variable for the 
multivariate models was defined dichotomously as individuals with a Bachelor’s degree, or a 
Master’s degree or higher. After restriction, the new sample for dementia analyses had 149 
individuals (82.8% of the original 180 participants). Of those who were included, 47 (31.5%) 
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were classified as dementia cases, having been diagnosed with dementia at their last cognitive 
assessment.  
Cases (n=47) did not differ from individuals without dementia (n=102) in age or education; 
however, they did differ in APOE-ε4 status (p<0.01) and idea density (p<0.0001) (Table 3). 
Emotional expressivity, including raw emotion word counts, was similar between individuals 
with and without dementia (Table 4). Individuals with dementia expressed a mean of 9.8 (8.5 
positive and 1.3 negative) emotion words, whereas individuals without dementia expressed an 
average of 8.3 (7.1 positive and 1.2 negative) emotion words. However, the variation of 
expressivity was wide within each group: individuals with dementia ranged from zero to 29 (0-22 
positive and 0-7 negative) emotion words and those without dementia ranged from zero to 32 (0-
27 positive and 0-9 negative) emotion words. As such, no significant differences in raw emotional 
expressivity were detected between individuals with and without dementia, nor were significant 
differences found when emotional expressivity was ranked and assessed as quartiles or as a 
dichotomous variable. Furthermore, only seven individuals did not express any emotion words. 
These individuals were not different from the rest of the sample in the distribution of dementia 
(28.6% vs. 31.7%, p=0.86), age, education, APOE‐ε4 status, idea density or grammatical 
complexity. Furthermore, the overall patterns of association did not change in any of the models 
when these individuals were excluded, so they were retained in the sample. 
The distribution of dementia was significantly different between the two idea density strata 
(p<0.0001). Of the 29 participants with low idea density, 20 (69.0%) had dementia, whereas only 
27 (22.5%) of the 120 individuals with higher idea density had dementia (Table 5). Dementia 
status did not differ by age, education, APOE-ε4 status, or grammatical complexity (Table 5). 
Again, a wide range of emotional expressivity was found among individuals with and without 
dementia in both the low and higher idea density subgroups. As such, emotional expressivity, 
measured as raw counts, quartile rankings or dichotomous variables, did not differ by dementia 
status in either stratum (Table 6).  
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Table 3. Participant characteristics by dementia status: sample for dementia analyses 
(n=149) 
    
  Dementia1 
 All  
(n=149) 
No
(n=102) 
Yes  
(n=47) 
Characteristic    
Covariates    
Age2, Mean Years (SD) 88.1 (4.98)  88.2 (5.03)  88.0 (4.91)  
    
Level of Education,  %     
Bachelor’s Degree  42.3 42.2 42.6  
≥ Master’s Degree  57.7 57.8 57.4 
    
Presence of APOE‐ε4, %** 26.2 19.6 40.4  
    
Idea Density, %**    
Low  19.5 8.8 42.6 
Q2 24.8 27.4 19.2 
Q3 26.8 30.4 19.2 
High  26.9 33.3 19.2 
    
Grammatical Complexity, %    
Low 21.5 16.7 31.9 
Q2 23.5 25.5 19.2 
Q3 28.8 30.4 25.5 
High  26.2 27.4 23.4 
    
* p<0.05 
** p<0.01 
1 Based on diagnosis of dementia at the last cognitive assessment 
2 Age at last cognitive assessment 
Abbreviations:	APOE‐ε4=	apolipoprotein	E	ε4	allele;	Q=	quartile;	SD=	standard	deviation	
 
 
 
 
 
 
 
 
 
 
 55 
Table 4. Emotional expressivity by dementia status (n=149) 
    
  Dementia1 
 All  
(n=149) 
No
(n=102) 
Yes  
(n=47) 
Emotional Expressivity    
Raw Word Counts2, Mean (SD)    
Overall 8.8 (7.39) 8.3 (7.32) 9.8 (7.51) 
Positive 7.6 (6.30) 7.1 (6.23) 8.5 (6.41) 
Negative 1.2 (1.65) 1.2 (1.63) 1.3 (1.72) 
    
Raw Word Counts2, Median (Range)    
Overall 7.0 (0-32) 6.0 (0-32) 8.0 (0-29) 
Positive 6.0 (0-27) 5.0 (0-27) 7.0 (0-22) 
Negative 1.0 (0-9) 1.0 (0-9) 1.0 (0-7) 
    
Quartile Rankings, %    
Overall     
Low  22.1 23.5 19.2 
Q2 24.2 24.5 21.3 
Q3 30.2 27.5 36.2 
High  23.5 23.5 23.4 
 
Positive    
Low 24.8 25.5 23.4 
Q2 24.2 25.5 21.3 
Q3 24.8 23.5 27.7 
High 26.2 25.5 27.7 
    
Negative    
Low 12.1 10.8 14.9 
Q2 41.6 43.1 38.3 
Q3 29.5 28.4 31.9 
High 16.8 17.6 14.9 
    
1 Based on diagnosis of dementia at the last cognitive assessment 
2 Autobiographies were required to be no more than one page in length, providing an approximate 
standard length for comparison  
Abbreviations: Q= quartile; SD= standard deviation  
Note: Emotional expressivity did not significantly differ by dementia status. 
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Table 5. Participant characteristics by dementia and idea density: sample for dementia analyses (n=149)  
 
Note: Participant characteristics did not differ by dementia status in either idea density stratum. 
1 Low= lowest quartile of idea density; Higher= top three quartiles of idea density 
2 Based on diagnosis of dementia at the last cognitive assessment 
3 Age at last cognitive assessment 
Abbreviations: APOE‐ε4=	apolipoprotein	E	ε4	allele;	Q=	quartile;	SD=	standard	deviation 
 
 
 
 
  
 Idea density1
 Low Higher
  Dementia2  Dementia2
 All  
(n=29) 
No
(n=9) 
Yes
(n=20) 
All  
(n=120) 
No
(n=93) 
Yes
(n=27) 
Characteristic       
Covariates 
      
Age3, Mean Years (SD) 86.2 (5.29) 87.5 (6.38) 85.6 (4.81) 88.6 (4.81) 88.2 (4.92) 89.7 (4.29) 
       
Level of Education,  %        
Bachelor’s Degree  51.7 44.4 55.0 40.0 41.9 33.3 
≥ Master’s Degree  48.3 55.6 45.0 60.0 58.1 66.7 
       
Presence of APOE-ε4, % 48.3 33.3 55.5 20.8 18.3 29.6 
       
Grammatical Complexity, %       
Low 37.9 22.2 45.0 17.5 16.1 22.2 
Q2 24.1 33.3 20.0 23.3 24.7 18.5 
Q3 10.3 0.0 15.0 33.3 33.3 33.3 
High  27.6 44.4 20.0 25.8 25.8 25.9 
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Table 6. Emotional expressivity by dementia status and idea density: sample for dementia analyses (n=149) 
       
 Idea density1
 Low Higher 
  Dementia2  Dementia2
 All  
(n=29) 
No
(n=9) 
Yes  
(n=20) 
All  
(n=120) 
No  
(n=93) 
Yes 
(n=27) 
Emotional Expressivity       
Raw Word Counts3, Mean (SD)       
Overall 8.3 (7.07) 8.4 (7.91) 8.3 (6.88) 8.9 (7.49) 8.3 (7.31) 11.0 (7.87) 
Positive 7.3 (6.21) 7.6 (7.67) 7.2 (5.66) 7.6 (6.35) 7.1 (6.12) 9.5 (6.86) 
Negative 1.0 (1.54) 0.9 (0.93) 1.0 (1.76) 1.3 (1.68) 1.2 (1.68) 1.5 (1.70) 
       
Raw Word Counts3, Median (Range)       
Overall 5.0 (0-25)  5.0 (0-19) 7.0 (0-25) 7.0 (0-32) 6.0 (0-32) 8.0 (0-29) 
Positive 5.0 (0-19) 3.0 (0-18) 5.0 (0-19) 6.0 (0-27) 5.0 (0-27) 7.0 (0-22) 
Negative 0.0 (0-6) 1.0 (0-2) 1.0 (0-6) 1.0 (0-9) 1.0 (0-9) 1.0 (0-7) 
       
Quartile Rankings, %       
Overall        
Low  31.0 33.3 30.0 20.0 22.6 11.1 
Q2 17.2 0.0 25.0 25.8 28.0 18.5 
Q3 31.0 44.4 25.0 30.0 25.8 44.4 
High  20.7 22.2 20.0 24.2 23.6 25.9 
       
Positive       
Low 34.5 33.3 35.0 22.5 24.7 14.8 
Q2 17.2 22.2 15.0 25.8 25.8 25.9 
Q3 24.1 11.1 30.0 25.0 24.7 25.9 
High 24.1 33.3 20.0 26.7 24.7 33.3 
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 Idea density1
 Low Higher 
  Dementia2  Dementia2
 All  
(n=29) 
No
(n=9) 
Yes  
(n=20) 
All  
(n=120) 
No  
(n=93) 
Yes 
(n=27) 
Quartile Rankings (cont’d), %       
Negative       
Low 17.2 11.1 20.0 10.8 10.8 11.1 
Q2 48.3 44.4 50.0 40.0 43.0 29.6 
Q3 13.8 11.1 15.0 33.3 30.1 44.4 
High 20.7 33.3 15.0 15.8 16.1 14.8 
       
1 Low= lowest quartile of idea density; Higher= top three quartiles of idea density 
2 Based on diagnosis of dementia at the last cognitive assessment 
3 Autobiographies were required to be no more than one page in length, providing an approximate standard length for comparison  
Abbreviations: Q= quartile; SD= standard deviation  
Note: Emotional expressivity did not significantly differ by dementia status in either idea density stratum.   
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 Sample Selected for the AD Analyses 
Approximately 57% (n=85) of the 149 individuals from the sample for dementia analyses 
were included for analysis of AD. Four different analytic samples were created based on case and 
non-case definitions as described previously (see section 4.3.3). Final sample sizes varied 
according to these definitions. Twenty-five individuals were defined as cases according to NIA-
RI neuropathologic criteria and 24 were cases according to CERAD criteria. Of these individuals, 
20 fulfilled both CERAD and NIA-RI neuropathologic criteria while 5 fulfilled only NIA-RI 
neuropathologic criteria and 4 fulfilled only CERAD criteria. The number and proportion of non-
cases depended on the definition used (Table 7). The results obtained in the bivariate and 
multivariate analyses were similar, regardless of the analytic sample used; as such, the results 
from the NIA-RI/D sample will be presented and discussed. Results of the bivariate and 
multivariate analysis using CERAD/D sample for comparison are provided in Appendix F. 
 
Table 7. Sample sizes for the analyses of AD by idea density and case/non-case definitions  
   
 All  Idea Density1
  Low  Higher 
  Non-cases2 Cases3  Non-cases2 Cases3
Sample       
NIA-RI/D 794 6 13  48 12 
NIA-RI/DN 67 6 13  36 12 
CERAD/D 78 6 8  48 16 
CERAD/DN 52 4 8  24 16 
       
1 Low = lowest quartile of idea density; Higher = top three quartiles of idea density 
2 Non-cases do not have AD according to the corresponding criteria (i.e., CERAD or NIA-RI) and are 
dementia-free (D) or are dementia- and AD neuropathology-free (DN). 
3 Cases have been diagnosed with AD (i.e., clinical dementia at the last cognitive assessment and AD 
neuropathology at post-mortem autopsy). 
4 Individuals who were eligible for inclusion (n=85) were not necessarily included in the analytic samples, 
given the non-case definitions excluded individuals according to footnote 2.  
Abbreviations: AD= Alzheimer’s disease; CERAD= Consortium to Establish a Registry for Alzheimer’s 
Disease; D= non-cases without dementia; DN= non-cases without dementia or neuropathology;  
NIA-RI= National Institute on Aging – Reagan Institute 
 
In the NIA-RI/D sample, cases did not differ from non-cases on characteristics such as age 
at death or level of education (Table 8). Similar to the sample used for the analysis of dementia, 
emotional expressivity varied greatly in individuals both with and without AD, and no significant 
differences in emotional expressivity were found by AD status either (Table 9). However, 
diagnosis of AD was significantly associated with APOE-ε4 status (p<0.001) and idea density 
 60 
(p<0.0001). Similar to the sample used for the analyses of dementia, the proportion of cases was 
significantly different between the idea density strata: 13 of 19 (68.4%) individuals with low idea 
density were diagnosed with AD, whereas 12 of 60 (20.0%) in the high idea density subgroup had 
an AD diagnosis (p<0.0001; Table 10). Among individuals with low idea density, AD was 
significantly associated with grammatical complexity (p<0.05; Table 10), but was not associated 
with emotional expressivity (Table 11) or any other covariates in either idea density stratum.  
 
Table 8. Participant characteristics by AD status: NIA-RI/D analytic sample (n=79) 
    
  AD1 
 All  
(n=79) 
No
(n=54) 
Yes 
(n=25) 
Characteristic    
Covariates    
Age2, Mean Years (SD) 87.8 (3.83) 87.7 (3.93) 87.9 (3.69) 
    
Level of Education,  %     
Bachelor’s Degree  49.4 51.8 44.0 
≥ Master’s Degree  50.6 48.2 56.0 
    
Presence of APOE-ε4, %** 27.8 16.7 52.0 
    
Idea Density, %**    
Low  24.0 11.1 52.0 
Q2 21.5 27.8 8.0 
Q3 24.0 27.8 16.0 
High  30.4 33.3 24.0 
    
Grammatical Complexity, %    
Low 24.0 18.5 36.0 
Q2 22.8 27.8 12.0 
Q3 25.3 24.1 28.0 
High  27.8 29.6 24.0 
    
** p<0.01 
1 Based on diagnosis of AD according to NIA-RI criteria; non-cases are individuals who have not 
been diagnosed with AD and who did not have dementia at their last cognitive assessment 
2 Age at death 
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein E ε4 allele; NIA-RI= National 
Institute on Aging – Reagan Institute; Q= quartile; SD= standard deviation 
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Table 9. Emotional expressivity by AD status: NIA-RI/D analytic sample (n=79) 
1 Based on diagnosis of AD according to NIA-RI criteria; non-cases were individuals who have not 
been diagnosed with AD or dementia at their last cognitive assessment 
2 Autobiographies were required to be no more than one page in length, providing an approximate 
standard length for comparison  
Abbreviations: AD= Alzheimer’s disease; NIA-RI= National Institutes on Aging – Reagan Institute; 
Q= quartile; SD= standard deviation 
Note: Emotional expressivity did not significantly differ by AD status.  
    
  AD1 
 All  
(n=79)
No 
(n=54)
Yes 
(n=25) 
Emotional Expressivity    
Raw Word Counts2, Mean (SD)    
Overall 9.5 (8.00) 9.1 (8.01) 10.4 (8.03)
Positive 8.0 (6.72) 7.7 (6.68) 8.8 (6.89) 
Negative 1.4 (1.85) 1.4 (1.84) 1.5 (1.92) 
    
Raw Word Counts2, Median (Range)    
Overall 8.0 (0-32) 6.0 (1-32) 8.0 (0-29) 
Positive 6.0 (0-27) 5.0 (1-27) 6.0 (0-22) 
Negative 1.0 (0-9) 1.0 (0-9) 1.0 (0-7) 
    
Quartile Rankings, %    
Overall     
Low  19.0 16.7 24.0 
Q2 26.6 29.6 20.0 
Q3 29.1 29.6 28.0 
High  25.3 24.1 28.0 
    
Positive    
Low 22.8 20.4 28.0 
Q2 27.8 31.5 20.0 
Q3 22.8 24.1 20.0 
High 26.6 24.1 32.0 
    
Negative    
Low 12.7 9.3 20.0 
Q2 34.2 35.2 32.0 
Q3 34.2 37.0 28.0 
High 19.0 18.5 20.0 
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Table 10. Participant characteristics by AD and idea density: NIA-RI/D analytic sample (n=79)  
 
* p<0.05 
1 Low= lowest quartile of idea density; Higher= top three quartiles of idea density 
2 Based on diagnosis of AD according to NIA-RI criteria; non-cases are individuals who have not been diagnosed with AD and who 
did not have dementia at their last cognitive assessment 
3 Age at death 
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein E ε4 allele; NIA-RI= National Institute on Aging – Reagan 
Institute; SD= standard deviation 
 
 
 
 
  
 Idea density1
 Low Higher
  AD2  AD2
 All  
(n=19) 
No
(n=6) 
Yes
(n=13) 
All  
(n=60) 
No
(n=48) 
Yes
(n=12) 
Characteristic       
Covariates       
Age3, Mean Years (SD) 87.0 (4.32) 86.9 (4.29) 87.0 (4.51) 88.0 (3.67) 87.8 (3.92) 88.8 (2.38) 
       
Level of Education,  %        
Bachelor’s Degree  47.4 33.3 53.8 50.0 54.2 33.3 
≥ Master’s Degree  52.6 66.7 46.2 50.0 45.8 66.7 
       
Presence of APOE-ε4, % 47.4 16.7 61.5 21.7 16.7 41.7 
       
Grammatical Complexity, %       
Low 31.6 0.0* 46.2 21.7 20.8 25.0 
Q2 26.3 50.0 15.4 21.7 25.0 8.3 
Q3 15.8 0.0 23.1 28.3 27.1 33.3 
High  26.3 50.0 15.4 28.3 27.1 33.3 
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Table 11. Emotional expressivity by AD status and idea density: NIA-RI/D analytic sample (n=79) 
       
 Idea density1
 Low Higher 
  AD2  AD2
 All  
(n=19) 
No
(n=6) 
Yes 
(n=13) 
All  
(n=60) 
No 
(n=48) 
Yes
(n=12) 
Emotional Expressivity       
Raw Word Counts3, Mean (SD)       
Overall 9.3 (6.99) 9.3 (7.17) 9.3 (7.20) 9.5 (3.67) 9.0 (8.18) 11.5 (9.02) 
Positive 7.9 (5.96) 8.2 (7.19) 7.8 (5.63) 8.1 (6.99) 7.6 (5.68) 10.0 (4.83) 
Negative 1.4 (1.74) 1.2 (0.98) 1.5 (2.02) 1.4 (1.90) 1.4 (1.92) 1.5 (1.88) 
       
Raw Word Counts3, Median (Range)       
Overall 9.0 (0-25) 8.0 (1-19) 9.0 (0-25) 7.5 (0-32) 6.0 (1-32) 8.0 (0-29) 
Positive 5.0 (0-19) 6.5 (1-17) 5.0 (0-19) 6.0 (0-27) 5.0 (1-27) 7.0 (0-22) 
Negative 1.0 (0-6) 1.5 (0-2) 1.0 (0-6) 1.0 (0-9) 1.0 (0-9) 1.0 (0-7) 
       
Quartile Rankings, %       
Overall        
Low  21.0 16.7 23.1 18.3 16.7 25.0 
Q2 15.8 0.0 23.1 30.0 33.3 16.7 
Q3 36.8 50.0 30.8 26.7 27.1 25.0 
High  26.3 33.3 23.1 25.0 22.9 33.3 
       
Positive       
Low 26.3 16.7 30.8 21.7 20.8 25.0 
Q2 21.0 33.3 15.4 30.0 31.2 25.0 
Q3 26.3 16.7 30.8 21.7 25.0 8.3 
High 26.3 33.3 23.1 26.7 22.9 41.7 
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 Idea density1
 Low Higher 
  AD2  AD2
 All  
(n=19) 
No
(n=6) 
Yes 
(n=13) 
All  
(n=60) 
No 
(n=48) 
Yes
(n=12) 
Quartile Rankings (cont’d), %       
Negative       
Low 15.8 16.7 15.4 11.7 8.3 25.0 
Q2 36.8 16.7 46.2 33.3 37.5 16.7 
Q3 15.8 16.7 5.4 40.0 39.6 41.7 
High 31.6 50.0 23.1 15.0 14.6 16.7 
       
1 Low= lowest quartile of idea density; Higher= top three quartiles of idea density 
2 Based on diagnosis of AD according to NIA-RI criteria; non-cases are individuals who have not been diagnosed with AD and who did not have dementia 
at their last cognitive assessment 
3 Autobiographies were required to be no more than one page in length, providing an approximate standard length for comparison  
Abbreviations: AD= Alzheimer’s disease; NIA-RI= National Institute on Aging – Reagan Institute; Q= quartile; SD= standard deviation 
Note: Emotional expressivity did not significantly differ by AD status in either idea density strata.  
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  Sample Selected for the VaD Analyses 
The individuals who were eligible for inclusion in the sample for the analyses of AD also fit the 
criteria for inclusion in the sample for VaD analyses (n=85). Of the participants who had complete 
emotional expressivity and neuropathological data, only 1 (1.2%) was formally diagnosed with VaD. This 
individual had low idea density, a Bachelor’s degree, at least one APOE-ε4 allele and scored below the 
50th percentile for all measures of emotional expressivity. Given the low prevalence of cases in the 
sample, bivariate and regression analysis could not be performed.  
 
5.2 Multivariate Logistic Regression Models 
Multivariate logistic regression was performed to test the association of the three emotional 
expressivity measures (overall, positive and negative) with the presence of dementia and AD in late life, 
as described in section 4.4.2. For comparability across models, in addition to stratifying by idea density, 
all final models were adjusted for age and APOE-ε4 status. Inclusion of these two covariates with the 
emotional expressivity variables produced the most parsimonious results in the majority of the models. 
See Appendix E for the results of all the crude, adjusted and full models.    
The direction of association of emotional expressivity with dementia and AD varied across the 
idea density strata (Table 12). Compared to low expressivity, the odds of high overall and negative 
emotional expressivity were decreased in individuals with dementia and AD in the low idea density 
stratum, and increased in the high idea density stratum. In contrast, the odds of high positive emotional 
expressivity was approximately equal or increased among individuals with dementia or AD in both the 
high and low idea density subgroups. An interaction between positive and negative emotional 
expressivity clarified these patterns of association with dementia: negative expressivity was associated 
with increased odds of dementia only when positive expressivity was low. Otherwise, an inverse 
association was found between emotional expressivity and dementia.  
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Table 12. Direction of association of emotional expressivity with dementia and AD, stratified by idea 
density and adjusted for age at diagnosis and APOE-ε4 status 
    
 Dementia  AD1 
  Idea Density2   Idea Density2
 All3 Low Higher  All3 Low  Higher
Emotional 
Expressivity4 
	 	
 	      
Overall N/A5 Ð Ï*  Ï Ð Ï
  	    	 
Positive Ï	 Ï Ï  Ï Ï	 Ï
       
Negative Ï	 Ð Ï  Ï Ð Ï
Low Positive Ï	 Ð Ï*    
High Positive Ð	 Ð Ð    
	       
*p<0.05 
1 AD defined by NIA-RI criteria with non-cases defined as individuals without AD or dementia at the last cognitive 
assessment.  
2 Low= lowest quartile of idea density; Higher= top three quartiles of idea density 
3 Idea density was included as a covariate in unstratified models 
4 Top two quartiles vs. bottom two quartiles 
5 Not applicable given the significant interaction between overall emotional expressivity and idea density 
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein E ε4 allele; NIA-RI= National Institute on 
Aging – Reagan Institute 
 
 Lower Idea Density Subgroup 
Among individuals who displayed low idea density, emotional expressivity was not significantly 
associated with dementia and AD in any of the models (Table 13). Despite this lack of statistical 
significance, the results suggest that the odds of overall and negative emotional expressivity may be 
decreased in individuals with dementia and AD when idea density is low. Conversely, the odds of high 
positive emotional expressivity were slightly increased in individuals with dementia and AD. However, 
given the wide confidence intervals, the conclusions that can be drawn from these findings are limited.   
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Table 13. Association of emotional expressivity with dementia and AD among individuals with 
low idea density, adjusted for age at diagnosis and APOE-ε4 status 
    
 Dementia  
(n=29) 
 AD1  
(n=19) 
 OR 95% CI  OR 95% CI 
Emotional Expressivity2      
Overall  0.44 0.07, 2.30  0.40 0.02, 5.21 
      
Positive  1.37 0.27, 7.54  1.71 0.19, 19.44 
      
Negative 0.63 0.11, 3.56  0.24 0.02, 2.56 
      
1AD defined by NIA-RI criteria with non-cases defined as individuals without AD or dementia at the last 
cognitive assessment; See Appendix F for parameter estimates using alternate sample definitions. 
2 Top two quartiles vs. bottom two quartiles   
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein ε4; CI= confidence interval; NIA-RI= 
National Institute on Aging – Reagan Institute; OR= odds ratio 
Note: Full results of all models can be found in Appendix E.  
 
 
  Higher Idea Density Subgroup 
Among individuals with higher idea density, odds of high emotional expressivity was increased in 
individuals with dementia and AD.  This pattern was consistent for all measures of emotional expressivity 
and for both dementia and AD, although the majority of models did not reach significance (Table 14). 
Overall emotional expressivity was the exception: the association with dementia was significant 
(OR=2.60, 95% CI=1.04-7.11). 
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Table 14. Association of emotional expressivity with dementia and AD among individuals with 
high idea density, adjusted for age at diagnosis and APOE-ε4 status 
    
 Dementia  
(n=120) 
 AD1  
(n=60) 
 OR 95% CI  OR 95% CI 
Emotional Expressivity2      
Overall  2.60 1.04, 7.11  1.68 0.44, 7.14 
      
Positive  1.48 0.61, 3.66  1.14 0.30, 4.34 
      
Negative 1.99 0.81, 5.13  1.67 0.41, 7.91 
      
Bolded values are statistically significant. 
1 AD defined by NIA-RI criteria with non-cases defined as individuals without AD or dementia at the last 
cognitive assessment; See Appendix F for parameter estimates using alternate sample definitions.  
2 Top two quartiles vs. bottom two quartiles   
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein ε4 allele; CI= confidence interval; NIA-
RI= National Institute on Aging – Reagan Institute; OR= odds ratio 
Note: Full results of all models can be found in Appendix E. 
 
 Further Investigation using the Sample for Dementia Analyses 
Given the larger sample size, the sample for dementia analysis was subjected to further analyses 
that could not be performed on the samples selected for the analyses of AD. These analyses included 
ranking emotional expressivity measures in three categories (as opposed to two), and testing the 
interaction between positive and negative emotions. The analyses were intended to further clarify the 
association between emotional expressivity in early adulthood and dementia in late life. 
5.2.3.1 Emotional Expressivity Categorized by Tertiles 
5.2.3.1.1 Low Idea Density 
Categorization of emotional expressivity into three categories (high, moderate and low) presented 
further information on the association between expressivity and dementia. Again, overall and negative 
emotional expressivity were generally protective (i.e., OR<1) against dementia among individuals with 
low idea density (Table 15). Positive emotional expressivity differed from the previous analysis in that the 
odds of moderate positive expressivity, compared to low expressivity, was increased among individuals 
with dementia (OR=2.00, 95% CI=0.23-22.20), whereas the odds of high, compared to low, positive 
expressivity was decreased, although not significantly so, in individuals with dementia (OR=0.74, 95% 
CI=0.10-5.29).  
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Table 15. Association between emotional expressivity tertiles and dementia adjusted for age at 
diagnosis and APOE-ε4 status, stratified by idea density (n=149) 
   
 Idea Density1
 Low  
(n=29) 
 Higher  
(n=120) 
 OR 95% CI  OR 95% CI 
Emotional Expressivity2      
Overall3      
Moderate vs. Low 0.85 0.08, 10.05  1.70 0.54, 5.59 
High vs. Low 0.59 0.08, 3.89  1.74 0.59, 5.46 
      
Positive       
Moderate vs. Low 2.00 0.23, 22.20  1.48 0.47, 5.24 
High vs. Low 0.74 0.10, 5.29  1.98 0.62, 7.06 
      
Negative       
Moderate vs. Low 0.56 0.04, 14.72  3.59 1.13, 11.89 
High vs. Low 0.57 0.10, 3.42  1.34 0.46, 3.97 
      
Bolded values are statistically significant. 
1 Low= lowest quartile of idea density; Higher= top three quartiles of idea density  
2 Top two quartiles vs. bottom two quartiles   
3 Model adjusted for education, in addition to age and APOE-ε4 status. 
Abbreviations: APOE-ε4= apolipoprotein ε4 allele; CI= confidence interval; OR= odds ratio 
 
5.2.3.1.2 Higher Idea Density 
Among individuals with high idea density, all measures of emotional expressivity were consistently 
associated with increased odds of dementia (Table 15). The only significant association was found 
between moderate negative expressivity and dementia (OR=3.59, 95% CI=1.13-11.89). High negative 
emotional expressivity had a weaker (non-significant) association than moderate expressivity, when 
compared to low expressivity.  
All models were adjusted for age and APOE-ε4 status. However, the model of overall emotional 
expressivity and dementia had a poor fit (Hosmer-Lemeshow Goodness of Fit test, p=0.02) when adjusted 
for these two variables. As such, this model was adjusted for age, APOE-ε4 and education, which 
improved the fit. Neither moderate nor high overall expressivity was significantly associated with 
dementia.  
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5.2.3.2 The Association Between Negative Emotional Expressivity and Dementia, Modified by 
Positive Expressivity 
A significant interaction was found between positive and negative emotional expressivity among 
individuals with higher idea density (p=0.04). Thus, a fourth model was generated to test the association 
between negative emotional expressivity and dementia when stratified by both idea density and positive 
emotions. Among individuals with higher idea density, the odds of negative emotions was significantly 
increased in individuals with dementia only when positive emotions were low (OR=8.17, 95% CI=1.66-
58.96; Table 16).  
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Table 16. Association between negative emotional expressivity and dementia stratified by idea density and positive emotional 
expressivity (n=149)  
       
  Unadjusted  Adjusted for Age  Adjusted for Age and APOE-ε4 
  OR1 95% CI  OR1 95% CI  OR1 95% CI 
Idea 
Density2  
Positive Emotional 
Expressivity3  
               
Low  Low (n=15) 0.17 0.01, 2.34  0.12 0.003, 2.13  0.15 0.003, 3.55 
 High (n=14) 1.00 0.09, 11.32  0.77 0.04, 10.94  0.68 0.03, 10.64 
          
High  Low (n=58) 4.58 1.18, 20.05  5.62 1.34, 29.02  8.17 1.66, 58.96 
 High (n=62) 0.69 0.21, 2.24  0.70 0.22, 2.28  0.76 0.23, 2.57 
          
Bolded values are statistically significant.  
1 Top two quartiles vs. bottom two quartiles of negative emotional expressivity 
2 Low= lowest quartile; Higher= top three quartiles  
3 Low= bottom two quartiles; High= top two quartiles 
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; OR= odds ratio 
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 Model Diagnostics 
Diagnostic plots were generated for all final models of dementia and AD. In general, the plots were 
satisfactory and no issues with multicollinearity were detected. For all analyses using the sample for 
dementia analyses, one individual was repeatedly identified as an outlier compared to the rest of the 
sample. The participant had low idea density and low emotional expressivity, but was not diagnosed with 
dementia. She was 100.9 years old at her last cognitive assessment, did not have any APOE-ε4 alleles, 
was highly educated (Master’s degree or higher) and had high grammatical complexity. 
The displacement of the parameter and confidence intervals caused by this individual was not 
statistically significant, as determined by C, CBAR and DFBETAS diagnostic tests. The participant had a 
notable (non-significant) influence on the age parameter estimate but not on the estimate for overall 
emotional expressivity. Furthermore, the influence of this individual on the model was also tested by 
manual removal of the participant from the analytic sample. Neither the significance of the parameter 
estimates, nor the direction of associations between emotional expressivity and dementia, were changed 
when this individual was removed from the analysis, compared to when she was left in the sample. 
Eliminating this individual did not affect the results of the bivariate analyses: cases did not differ from 
non-cases on any of the variables of interest.  Given this individual only influenced the age parameter 
estimate and not the main exposure of interest, and that inclusion of the individual did not affect the 
statistical significance of any of the analyses, this individual was retained in the sample. However, her 
influence on the results leads to further discussion (see Section 6.1.1). 
 
5.3 Sensitivity Analysis 
 Dementia Analyses using the Subset Selected for the Analyses of AD 
In order to make a comparison between the association of emotional expressivity with dementia to 
that with AD, a sensitivity analysis of emotional expressivity and dementia was performed on the subset 
that was restricted based on the availability of neuropathologic data (n=85). The association between 
emotional expressivity and dementia was analyzed using the smaller subset to test how the results 
compared to those of the full sample for dementia analyses, and to the AD models. The sensitivity 
analysis was generally consistent when compared to the full sample. That is, the odds of overall and 
negative emotional expressivity was decreased among those with dementia while the odds of positive 
emotions was slightly increased in the low idea density stratum. Furthermore, the odds of high emotional 
expressivity, regardless of valence (i.e., overall, positive or negative), was increased in individuals with 
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dementia within the high idea density strata. However, the results of the sensitivity analysis using the 
smaller subset deviated from the full sample in that the association between overall expressivity and 
dementia was no longer significant (OR=2.27, 95% CI=0.72-7.94). See Appendix G for further results of 
the sensitivity analysis of the association between emotional expressivity and dementia using the subset 
selected for the AD analyses. 
 Analysis of Models Not Stratified by Idea Density 
The interaction between emotional expressivity and idea density was only significant in the model 
for overall emotional expressivity and dementia, and not in the models for positive or negative emotional 
expressivity with dementia, nor in any of the models for AD. For comparability, all models were stratified 
by idea density; however, a small number of participants had low idea density, so the parameter estimates 
had very wide confidence intervals. Thus, a sensitivity analysis was performed to investigate the 
association of emotional expressivity with dementia and AD without stratification. Instead, the models 
were adjusted for idea density, in addition to age at diagnosis and APOE-ε4 status. None of the 
associations of emotional expressivity with dementia and AD were significant (Table 17). The odds of 
high emotional expressivity was consistently increased in dementia and AD cases. The exception was 
when the analysis was stratified by positive emotional expressivity: the odds of negative emotional 
expressivity was decreased among cases when positive emotional expressivity was high. 
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Table 17. Sensitivity analysis of the association of emotional expressivity with dementia and 
AD without stratification by idea density 
    
 Dementia 
(n=149) 
 AD1 
(n=79) 
 OR 95% CI  OR 95% CI 
Emotional Expressivity2      
Overall N/A3  1.19 0.37, 4.00 
      
Positive 1.47 0.68, 3.24  1.24 0.40, 3.88 
      
Negative 1.49 0.68, 3.35  1.02 0.32, 3.42 
Low Positive 3.36 0.91, 14.07  2.62 0.43, 23.32 
High Positive 0.77 0.27, 2.23  0.49 0.08, 2.69 
      
1 AD defined by NIA-RI criteria with non-cases defined as individuals without AD or dementia at the last 
cognitive assessment; See Appendix F for parameter estimates using alternate sample definitions.  
2 Top two quartiles vs. bottom two quartiles 
3 Not applicable given the significant interaction between overall emotional expressivity and idea density 
Abbreviations: AD= Alzheimer’s disease; CI= confidence interval; NIA-RI= National Institute on Aging–
Reagan Institute; OR= odds ratio 
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Chapter 6 
Discussion 
6.1 Summary of Findings 
The results support an association between emotional expressivity in early adulthood and dementia 
in late life, modified by idea density in the written autobiographies. Significant associations were seen 
among individuals with higher idea density only (Tables 14 and 15). In this subgroup, odds of both high 
overall and moderate negative emotional expressivity were significantly greater in individuals with 
dementia. The increased odds of dementia associated with negative emotions was further clarified by an 
interaction between positive and negative emotions. This finding indicated that the odds of negative 
emotions was significantly higher in individuals with dementia when positive emotional expressivity was 
low (Table 16). 	
Most of the associations of emotional expressivity with dementia and AD were inverted across idea 
density strata: the odds of emotional expressivity was increased in individuals with dementia in the higher 
idea density subgroup, and decreased in the low idea density subgroup (Table 12). This suggests that the 
association varies based on written language skills, a previously identified risk factor for dementia and 
AD (Riley et al., 2005; Snowdon et al., 1996b). In all, the findings indicate that emotional expressivity in 
early adulthood is predictive of dementia in late life, as expected; however, the relationship is not 
straightforward.  
Emotional expressivity was not significantly associated with AD, regardless of emotional valence 
or sample selection criteria. A sensitivity analysis was performed to determine whether the association of 
emotional expressivity with dementia was consistent between the full analytic sample (n=149) and the 
subset retained for the analysis of AD (n=85). In the smaller sample, the association between emotional 
expressivity and dementia was no longer significant, suggesting that the sample size may have been 
insufficient to detect meaningful effects. This may have been true for the non-significant associations 
with AD as well. Indeed, the directions of association of emotional expressivity with both dementia and 
AD in the sub-sample were consistent with the results of the full sample used for the dementia analyses, 
despite the lack of significance. These similarities suggest that emotional expressivity may affect the risk 
of AD in the same way that it affects all-cause dementia; however, distinctions that may exist could not 
be identified given the non-significant results. Further studies are needed to clarify the association.  
Four main findings are highlighted in this investigation. First, the results were supported by 
cognitive reserve theory. Second, overall emotional expressivity was associated with increased odds of 
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dementia among individuals with higher idea density. Third, negative emotional expressivity increased 
the odds of dementia, an effect that was modified by positive emotional expressivity. Fourth, the effect of 
emotional expressivity on dementia and AD was modified by idea density, a measure of written language 
skills that is a known risk factor for dementia and AD. These four key points form the conclusions of this 
investigation and direct future studies. As such, the discussion will focus on these four findings.   
 Emotional Expressivity, Dementia and the Theory of Cognitive Reserve 
The association between emotional expressivity and dementia was only found among individuals 
with high idea density. This finding is consistent with the theory of cognitive reserve (Section 2.5.2.3). As 
found in previous studies, low idea density is likely indicative of a reduced ability to cope with 
neuropathological deterioration, thus signifying an increased risk of dementia compared to individuals 
with higher idea density (Riley et al., 2005; Snowdon et al., 1996b). As such, individuals who have a low 
level of cognitive resources likely begin to experience cognitive decline earlier when compared to 
individuals with a higher level of cognitive reserve (Figure 2). The findings of the current investigation 
indicate that overall emotional expressivity, and especially an imbalance of high negative and low 
positive expressivity, may be associated with an earlier decline in cognitive function among individuals 
with high idea density, as illustrated by the dashed line in Figure 2. 
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 Overall Emotional Expressivity and the Risk of Dementia 
Contrary to what was expected, overall emotional expressivity increased the odds of dementia. This 
increased odds was only found in low-risk individuals (i.e., individuals with higher idea density). 
Emotional writing has previously been shown to be therapeutic; expressive writing interventions have led 
to improvements in both short- (e.g., decreased heart rate) and long-term (e.g., lower blood pressure) 
health outcomes when participants were encouraged to disclose their emotions (see Section 2.6.4.3). This 
suggests that written expression of emotions may help to reduce the risk of cardiovascular issues over the 
long-term. However, the opposite was found in the current investigation: individuals who were highly 
expressive had higher odds of dementia than those who demonstrated low expressivity. Furthermore, a 
sensitivity analysis showed that individuals who did not express any emotion words did not differ in 
Figure 2. The effect of emotional expressivity on the risk of dementia according to the 
cognitive reserve theory. The theoretical trajectory of cognitive reserve indicates earlier onset of 
decline in individuals with low idea density (dashed line) compared to individuals with higher idea 
density (solid line). The dotted line represents the effects of overall emotional expressivity (or 
similarly, negative expressivity when positive expressivity is low) among individuals with higher 
idea density. High emotional expressivity may be associated with earlier, or steeper, decline among 
individuals with high idea density. The effect of emotional expressivity among individuals with low 
idea density was unclear, possibly because of the relatively old age of the Nun Study sample (75-
100+ years) and the earlier onset of symptoms within this group.  
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proportion of dementia diagnoses from the rest of the study sample, and excluding them did not change 
the overall results of the logistic regression analysis. As such, the absence of emotion words in the 
autobiographies may not have indicated emotional suppression as anticipated.  
The measure of overall emotional expressivity in the current investigation is likely not a 
representative measure of individual tendencies to express or suppress emotions, which may explain the 
inconsistency with existing literature. The previous studies included direct instructions for participants to 
either expressively write about their emotions (Baikie & Wilhelm, 2005; Pennebaker, 1997), or to 
suppress their emotions while watching emotionally charged film clips (Gross & Levenson, 1997). In 
contrast, participants in the Nun Study were not directed on the emotional content to be included in their 
autobiographies. As such, the emotional expressivity in the autobiographies is likely not a measure of the 
dichotomy between emotional expression and suppression. Rather, the combination of writing style and 
emotional expressivity better reflects the natural expressive tendencies of the participants and is thus more 
indicative of cognitive processing and personality than of emotional disclosure.  
A single outlier in the sample for dementia analyses illustrates how the emotional expressivity 
measure does not indicate the tendency to suppress or express emotions. The individual did not express 
any emotion words and was in the low idea density subgroup, but had high grammatical complexity. This 
combination of non-expressive, multi-clause sentences suggests that, rather than suppressing emotions, 
the individual had written with high complexity but lacking detailed content, emotional or otherwise. As 
such, the low emotional expressivity score does not necessarily suggest that she was suppressing her 
emotions. Although this is just one anecdotal example, it suggests that a low overall emotional 
expressivity score does not represent emotional suppression. Instead, another aspect of emotionality is 
captured by the variable, as suggested by the significant association between overall emotional 
expressivity and dementia. Further studies are necessary to clarify the meaning of the overall emotional 
expressivity measure.  
Although the meaning of the emotional expressivity measure is not yet well-understood, the 
findings support an effect of emotional expressivity on the development of dementia. Potential reasons for 
this effect are hypothesized. As discussed previously, emotions affect perceptive awareness and the way 
in which the environment is experienced (Section 2.6.1). Positive emotions function to broaden 
perception and exploration of the surroundings and thus, provide an apparent advantage in learning and 
development; however, a drawback could be an increase in distractibility, as described by Dreisbach and 
Goschke (2004), which may reduce efficient processing of new information for future use. This is 
consistent with the current findings that high overall emotional expressivity, potentially driven by the 
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high proportion of positive emotions, may distract from tasks at hand and thus may detract from focus 
and opportunities for cognitive development.  
Another explanation for the increased risk may be that the emotional expressivity in the 
autobiographies reflects more stable personality traits, such as neuroticism or extraversion, which are 
known to contribute to the risk of dementia and AD (Prina, Pender, Ferri, Mazzotti, & Albanese, 2014). 
Indeed, positive emotional expressivity measured in college yearbook photos was associated with 
personality traits across thirty years of follow-up, with some of these associations becoming stronger with 
age (Harker & Keltner, 2001). These findings support the possibility that emotional expressivity across 
the lifespan, as an indicator of more stable personality traits, may affect the development of dementia. 
Furthermore, the current finding that emotional expressivity is associated with the development of 
dementia may be based on competency in emotional regulation as a function of personality (Section 
2.6.4.2). As discussed in the following section, the odds of high negative emotional expressivity was 
increased among individuals with dementia only when positive emotions were low. This imbalance of 
high negative and low positive expressivity may be indicative of poor emotional regulation that may 
contribute to an increased risk of dementia. However, these explanations are speculative and further 
investigation is required to clarify the meaning of the association. 
 Negative Expressivity and the Modifying Effects of Positive Expressivity 
The association between negative emotional expressivity and dementia was complex. Negative 
emotions were expected to increase the risk of dementia given their effects on the cardiovascular system 
(Section 2.6.3.2) and the stress response (Section 2.6.4.1). The results partially supported this hypothesis, 
but the association was complicated by the expression of positive emotions. Intuitively, negative 
emotional expressivity may be expected to follow a dose-response relationship based on the reasoning 
that greater negativity may indicate more pronounced elevations in cardiovascular and stress responses. 
However, the results did not support this theory; individuals with moderate, but not high, negative 
emotional expressivity had significantly higher odds of dementia compared to the low emotional 
expressivity reference group. (As with overall emotional expressivity, this association was only found in 
the higher idea density subgroup).  
This deviation from an expected dose-response relationship may be partially explained by the fact 
that a large proportion of individuals with high negative emotional expressivity also had high positive 
expressivity. Previous studies have found that positive emotions reverse the acute effects of negative 
emotions (Fredrickson & Levenson, 1998; Fredrickson, Mancuso, Branigan, & Tugade, 2000), and 
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reduce the risk of stroke in individuals with depression (Ostir, Markides, Peek, & Goodwin, 2001). 
Indeed, positive emotional expressivity modified the effects of negative emotional expressivity: high 
negativity was only significantly associated with dementia when positive emotions were low. These 
findings support the hypothesis that the effects of positive and negative emotional expressivity are not 
independent, but rather interact to contribute to health outcomes. This is consistent with a previous study 
in which a combination of high neurotic and low extroverted personality traits was associated with an 
increased risk of AD an average of 29 years later (Johansson et al., 2014). Such findings suggest that an 
imbalance of negative emotional tendencies may contribute to an increased risk of dementia and AD, and 
that the ability to cope with such negative emotions may reduce the risk (see Section 2.6.4.2). However, 
given the small sample size (n=58) and wide confidence interval (OR=8.17, 95% CI=1.66-58.96), the 
findings from the current investigation are not definitive and conclusions should be drawn with 
reservations. Nonetheless, the expected interaction between positive and negative emotions is supported 
by the current results, and should be the focus of future research.    
 The Modifying Effect of Idea Density 
The direction of association of emotional expressivity with dementia and AD differed across the 
idea density strata; emotional expressivity was associated with increased odds of dementia and AD 
(OR>1.00) among individuals with higher idea density, and with decreased odds (OR<1.00) among those 
with low idea density (Table 12). This modifying effect found in the current investigation may be 
explained by the differing risk among individuals with high and low idea density, according to the 
cognitive reserve theory (Figure 2). That is, given the relatively advanced age (i.e., 75 years and older at 
baseline) of the current study population, the effects of emotional expressivity may be masked among 
individuals with low idea density because of the earlier onset of symptoms in this high-risk group.  
As described previously, the significant association found between emotional expressivity and 
dementia among individuals with higher idea density (Table 14) suggests that emotional expressivity, and 
particularly an imbalance of high negative expressivity, may detract from the cognitive advantage 
associated with superior written language skills. This same pattern of association was not found among 
individuals with low idea density. Rather, the odds ratio indicated decreased odds of high (compared to 
low) emotional expressivity with dementia, although none of the estimates were statistically significant 
(Table 13).  
This opposite, but non-significant, effect found in the low idea density subgroup has three possible 
explanations. First, emotional expressivity truly may not affect the development of dementia among high-
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risk individuals. Second, the point estimate may be accurate in that emotional expressivity is protective in 
this subgroup, but the small sample size and lack of survivors limited the statistical power so that the 
association did not reach significance. Third, emotional expressivity may have the same effect in 
individuals with low idea density as in those with high idea density but the effect could not be detected 
given the relatively old age of the study population. In all, the modifying effect of idea density indicates 
that the association of emotional expressivity with dementia and AD is not straightforward and is affected 
by other cognitive factors. Exploration of the association in a more diverse population, including 
individuals younger than 75 years, is recommended to gain further insight into the association.  
 
6.2 Strengths and Limitations 
 Limitations 
Limitations of the data and design used in the current investigation should be acknowledged. A 
major limitation lies in the exposure data; that is, the positive and negative word counts obtained from 
archived autobiographies. Emotional expressivity was obtained from a single time point and the 
implications of the measures are unclear, leading to questions of the meaning of the results.  
Furthermore, the situation in which the autobiographies were written may have affected the 
emotions that were expressed. For example, individuals may have been less likely to express negative 
emotions given that they were just entering the community and their superior would be reading what they 
had written. Indeed, the autobiographies contained significantly fewer negative emotion words, and the 
variability of negative expressivity was lower in comparison to positive emotion words (Table 4, 6, 9 and 
11). This limitation was addressed by collapsing the expressivity variables into ordinal categories to 
reflect relative expressivity. The data would be further strengthened by inclusion of other variables, such 
as emotional scores from a second autobiography written at a later time, or depression diagnoses to 
validate the measure. Regardless, the significant association found in this investigation and by others 
(Danner et al., 2001) suggests that emotional content does have predictive value and future studies should 
build upon these findings to clarify the effects of emotions across the lifespan on late-life cognitive 
outcomes.  
The conclusions drawn from the investigation were also limited by sample size, based on the 
availability of handwritten autobiographies. Of the original sample of 678 participants, 180 U.S.-born 
individuals had written their autobiographies by hand and were thus eligible for inclusion in the analysis. 
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The sample was further limited by missing data on the covariates of interest. Only 52% of individuals 
with a handwritten biography also had full data on neuropathologic data so the AD and VaD analyses 
were especially limited. Indeed, Table 12 demonstrates that the pattern of association between emotional 
expressivity and AD in the smaller analytic sample (n=79) was similar to that of emotional expressivity 
and dementia in the larger sample (n=149). However, none of the associations of emotional expressivity 
with AD reached significance, suggesting that the subset was too small to detect any meaningful 
differences that may exist. This was supported by the sensitivity analysis of emotional expressivity with 
dementia using the smaller subset, which did not reach significance either, suggesting that the sample size 
did not allow adequate statistical power. Furthermore, the analysis of VaD could not be performed given 
the low number of cases. As such, future studies should focus on obtaining more robust samples for the 
analysis of AD and VaD.  
Another limitation was the lack of data on comorbidities and health indicators. Information on 
health concerns, such as diabetes, cardiovascular diseases and depression, as well as measures such as 
blood pressure and heart rate, would have provided further insight into the mechanisms by which 
emotions may affect the development of dementia, AD and VaD. Inclusion of cerebral infarcts as a 
covariate in the analysis compensated for this limitation to some extent but further physical, and 
particularly vascular, indicators would help to confirm the conclusions.   
In addition, the generalizability of results is limited because of the characteristics of the study 
population. Participants in the study were highly educated women from a religious community and as a 
result had a relatively homogeneous lifestyle. Thus, they are not representative of the wider population in 
demographic characteristics or in potential confounders (e.g., socioeconomic status, tobacco/alcohol use). 
While these factors limit the applicability of the findings to the general population, the absence of such 
confounding factors allows for clearer etiologic conclusions to be made. 
Inclusion criteria required participants to be older than age 75 at the beginning of data collection. 
This may present survival bias because more severe, early-onset cases of the diseases of interest are not 
represented. As a result, the effects of emotions on dementia and AD may be underestimated or 
undetected. In addition, defining cases of dementia based on the last cognitive assessment limits potential 
analysis of the age at onset because onset of clinical symptoms is unspecified.  
 Strengths 
The homogeneity of the study population, which was mentioned as a limitation above, is also a key 
strength of the Nun Study data. Although the participants are not representative of the wider population, 
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their relatively uniform and conservative lifestyle free from many factors that contribute to disease risk 
naturally controls for many potential confounders. Furthermore, the etiology of dementia and AD likely 
does not differ in the Nun Study population compared to the wider population, so the results are an 
accurate reflection of the association without the noise of potential confounding lifestyle factors. As a 
result, stronger conclusions can be made regarding the contribution of emotional expressivity to the risk 
of dementia.  
Another strength of the study is the post-mortem brain autopsies, which provided neuropathological 
data for a definite diagnosis of AD and VaD. These data provided a strong measure of the outcome. The 
brain autopsy data also allowed analysis of cerebral infarcts as a potential confounding factor in the 
association of emotional expressivity with dementia and AD. Such detailed information on the condition 
of the brain at death also presents many opportunities for future studies to further evaluate the effects of 
emotional expressivity on neuropathologically defined conditions.  
Existing literature on the long-term effect of emotional experience on dementia and its subtypes is 
limited, raising the question of temporality (see Section 2.5.2.4). For example, many of the studies of the 
effects of depression, anxiety and loneliness on the development of AD had only five to eight years of 
follow-up. With such short follow-up periods, the possibility that depression and other affective disorders 
are a prodromal symptom of the disease cannot be ruled out given that evidence of AD neuropathology 
has been identified approximately twenty years prior to the appearance of clinical symptoms. The current 
investigation uses longitudinal data with over half a century of follow-up, which is substantially longer 
than any previous study. Such a long follow-up period allows temporal associations to be made with 
greater confidence. 
A major strength of the current investigation is the ability to control for written language skills 
using measurements from the same document as the emotional expressivity measures. This provides a 
unique opportunity to directly control for the effect of written language skills on emotional expressivity 
without relying on a proxy measure from another source. Indeed, the results indicate that idea density, as 
a measure of written language skills, is a key modifying factor in the association between emotional 
expressivity and the development of dementia. Without consideration of this unique variable, the main 
association of interest would not have been uncovered.  
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6.3 Implications 
The current investigation advances the understanding of emotional expressivity as a predictor of 
dementia. The findings are consistent with previous studies that suggest an integral role of emotions in 
affecting long-term health outcomes such as longevity (Danner et al., 2001), heart disease (Mauss & 
Gross, 2004), and mental health (Charles, Piazza, Mogle, Sliwinski, & Almeida, 2013). The results also 
support the positivity effect in older adults (Carstensen et al., 2003) by indicating that a balance of 
positive and negative emotions is advantageous across the lifespan and not only in late adulthood. Indeed, 
overall emotions, and a tendency toward negative emotional expressivity in particular, predicted the 
development of dementia over half a century later.   
Given the known effects of emotional experience on cognitive, psychosocial and physiological 
functions, the predictive nature of emotional expressivity on the risk of dementia is not surprising. The 
findings of the current investigation establish that an association across the lifespan may exist, but the 
underlying mechanisms are unclear. Establishing the relationship of emotions with these conditions is 
important because, although several lifestyle factors have been found to reduce the risk, AD and many 
other forms of dementia are irreversible. As such, the development of prevention strategies is key. 
Identification of further risk-reducing factors, such as the ability to regulate emotions and to cope with 
negative emotions, may help to lessen the burden of disease by providing opportunities for intervention. 
For example, increased focus on emotional coping skills in elementary education may be warranted. 
Awareness of the importance of emotions in affecting the development of dementia may also encourage 
the integration of emotional support into existing dementia interventions. Most importantly, the current 
findings support the theory that emotions in early adulthood contribute to the late-life development of 
dementia, and thus motivate further research to identify the underlying mechanisms of the association.  
 
6.4 Future Directions 
Given that this specific association between emotional expressivity in early adulthood and 
dementia in late life has not previously been explored, these novel findings provide a platform on which 
to base future studies. Further investigations are necessary to expand the understanding of the association. 
In particular, four key objectives are recommended for future studies to advance the current investigation. 
These recommended objectives are to: 1) replicate the study using other sample populations and measures 
of emotional experience to support the current findings; 2) develop an understanding of the emotional 
expressivity measure and what it reflects; 3) elucidate potential mechanisms by which emotions may 
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affect late-life development of dementia; and 4) expand the study population to clarify the association 
with AD and VaD.   
 Replicate the Study 
The novelty of this study calls for further investigation of the relationship between emotions and 
dementia. In order to establish the association, findings should be reproduced using a variety of study 
samples and measures of emotional experience. Consistency in future results would serve to support the 
findings of the current investigation that emotional expressivity has predictive value across the lifespan.  
Future investigations should replicate the current study using a more diverse, representative sample 
including men and women from the general population. In particular, assessment of the association of 
emotional expressivity with dementia and AD in men, in comparison to the current study of women, may 
help to clarify the mechanism underlying the association, given the recognized differences in emotional 
expressivity between genders. Also, different measures of emotional expressivity are recommended to 
broaden the understanding of the effects on cognitive decline and neurodegeneration. Beyond written 
autobiographies, potential sources for measuring emotional expressivity include yearbook photographs, 
videos and self or proxy reports. Primary sources (e.g., photographs, videos, autobiographies) are 
preferable for an accurate measure of emotional expressivity and are ideal for use in a prospective or 
retrospective cohort study design. However, recruitment and follow-up of a representative population of 
individuals with available yearbook photographs or autobiographies presents several logistic challenges. 
Alternatively, sample selection and data collection for a case-control study using self or proxy reports of 
emotional expressivity is more straightforward, but the exposure data are less reliable, especially given 
that dementia cases face cognitive challenges and may not be able to give an accurate estimation of 
emotional experience in a self-report. Selection of suitable proxies may also be difficult. In addition, 
conclusions of temporality are limited in case-control studies. These difficulties in designing a study to 
investigate the lifespan effect of emotions on dementia and related outcomes attest to the high value of the 
current investigation and the Nun Study in general.  
 Validate the Emotional Expressivity Measure 
The results of the current investigation indicate a significant association between emotional 
expressivity in autobiographies written in early adulthood and development of dementia in late life. 
However, the meaning of this association is unclear because the implications of the emotional 
expressivity measure are not well understood. Further clarification of the association is required to 
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understand the association on broader terms. For example, a second measure of emotional tendencies or 
personality at the time that the autobiographies were written would provide stronger evidence of how 
emotions, as part of a greater personality profile, may affect long-term cognitive outcomes. Furthermore, 
measurement of emotional expressivity later in life (e.g., from a second autobiography) would allow for 
the assessment of the stability of emotional expressivity over time to strengthen the argument that 
emotional expressivity across the lifespan influences the development of dementia. Further clarification 
of the meaning of the emotional expressivity measure would contribute to the understanding of the 
current association.  
 Clarify Mechanisms Underlying the Association Between Emotional Expressivity 
and Dementia 
Emotional expressivity was predictive of the development of dementia over half a century later, but 
the mechanism underlying this association is not clear. In the current investigation, presence of cerebral 
infarcts was included in the initial analysis but did not affect the association between emotional 
expressivity and development of dementia or its subtypes, suggesting that the mechanism may not be 
based on cerebrovascular pathology resulting from high emotionality and stress (see Appendix B). 
However, these conclusions are not definitive and further studies including the effects of various vascular 
lesions on the main association of interest are required to understand the underlying mechanism as it may 
relate to the physiological effects of emotions.  
Investigation of the association of emotional expressivity with time to onset of dementia, disease 
trajectory and discrepancies between cognitive decline and neurodegeneration would help to identify 
potential cognitive effects of emotional expressivity, as well as consistencies with the cognitive reserve 
theory. The effect of stress on the association between emotional expressivity and the development of 
dementia, AD and VaD could also be investigated. For example, future analysis could incorporate a 
measure of the experience of stress. Identification of the contribution of stress in the association between 
emotional expressivity and dementia would enhance understanding of the effects of emotions on long-
term outcomes and could guide strategies to reduce the risk of disease.   
 Expand the Analysis of AD and VaD 
The data available for analysis of the effects of emotional expressivity on the subtypes of dementia, 
AD and VaD, was limited in the current investigation and thus, is suggested as a focus for future research. 
Given the non-significant but similar results to the sample for dementia analyses, an association may exist 
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between emotional expressivity and AD; however, this could not be concluded due to non-significant 
results, likely because of the small sample size. As such, further investigation using a larger sample is 
warranted to confirm this suspected association between emotional expressivity and AD.  
The analysis could not be performed between emotional expressivity and VaD because of a very 
low number of cases. This is likely due to the nature of the lifestyle of the religious sisters in the study, 
which is relatively free of vascular risk factors. As such, a different study population with a higher 
prevalence of vascular risk factors and VaD is recommended for investigation of the association. 
Clarification of the effects of emotions on vascular outcomes, including VaD, may help in understanding 
the association of emotional expressivity with dementia by either confirming a vascular effect, or 
suggesting an alternative (e.g., cognitive) mechanism underlying the association, as suggested in Section 
3.1.2. Again, the difficulty in obtaining a robust sample with all necessary measures available poses a 
challenge.  
 
6.5 Conclusion 
As a novel study of the association of emotions in early adulthood with dementia, AD and VaD in 
late life, the aim of this research project was to establish whether the association exists. Consistent with 
related studies, the results support the potential contribution of emotional expressivity in early adulthood 
to long-term health outcomes, and in particular, the development of dementia, and possibly AD. Given 
limitations in the dataset, the effects of VaD could not be assessed and so conclusions on this association 
could not be made. The finding that emotional expressivity is associated with the development of 
dementia, modified by written language skills, lays the foundation for further research on the effect of 
emotional experience on dementia and underlying neurodegenerative diseases, as well as on other aspects 
of health across the lifespan. 
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Appendix A. Literature Search Construct and Article Summaries 
Table 1. Search terms and construct1 of literature search concerning emotions as predictors of dementia, AD and VaD. 
Emotional expressivity AD VaD Dementia 
Medline 
Expressed emotion [MeSH] OR 
positive emotion [tiab] OR 
positive emotions [tiab] OR 
emotions [MeSH] OR negative 
emotion [tiab] OR negative 
emotions [tiab]  
 
Alzheimer Disease [MeSH] OR 
Alzheimer's disease [tiab] OR 
Alzheimer disease [tiab] OR 
Alzheimer [tiab] OR Alzheimer’s 
[tiab] 
Dementia, Vascular [MeSH] OR 
Vascular dementia [tiab] OR 
dementia, multi-infarct [mesh] 
OR multi-infarct dementia [tiab] 
OR multiinfarct dementia [tiab] 
OR multi infarct dementia [tiab] 
Dementia [MeSH] OR dementia 
[tiab] 
PsycINFO 
Index Terms: {Affective 
Valence} OR {Emotional 
Content} OR {Emotional 
Responses} OR {Emotional 
States} OR {Emotionality 
(Personality)} OR Title: 
Emotional expressivity OR 
emotional expression OR 
emotion OR Any Field: 
Emotional expressivity OR 
emotional expression OR 
emotion 
Index Terms: {Alzheimer's 
Disease} OR Title: Alzheimer 
OR Abstract: Alzheimer 
 
Index Terms: {Vascular 
Dementia} OR Title: vascular 
dementia OR Abstract: vascular 
dementia OR Title: multi-infarct 
dementia OR Abstract: multi-
infarct dementia OR Title: multi 
infarct dementia OR Abstract: 
multi infarct dementia 
 
Index Terms: {Dementia} OR 
Title: dementia OR Abstract: 
dementia 
 
 
1Construct: (emotional expressivity) AND [(AD) OR (VaD) OR (dementia)] 
Abbreviations: AD= Alzheimer’s disease; MeSH= Medical Subject Headings; tiab= title/abstract; VaD= vascular dementia 
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Table 2. Summary of articles obtained from the literature search.  
Author Year Analytic sample N Independent variable Dependent 
variable 
Findings 
Caracciolo 
et al. 2010 
Cognitively intact, 
community-dwelling, 
elderly (75+), from 
Stockholm, Sweden 
764 
Low mood (perceived 
sadness on 
Comprehensive 
Psychopathological 
Rating Scale interview, 
0-6) 
MCI/CIND, 
clinical dementia  
All-MCI: HR=2.6 (95% CI=1.8-
3.7) with low mood at baseline; 
Conversion from amnestic MCI to 
dementia: HR=5.3 (95% CI=1.2-
23.3) 
Ellwardt et 
al. 2013 
Representative cohort of 
cognitively intact Dutch 
men and women mean 
age (63±6.65)  
488 
Emotional support; self-
reported loneliness as a 
mediating factor 
Cognitive function 
Emotional support was associated 
with less loneliness (βint=-0.35, 
p<0.001); Less loneliness was 
associated with better cognitive 
function (βint=-0.35, p<0.001) 
suggesting a mediating effect 
Holwerda 
et al. 2014 
Non-demented, 
community-dwelling 
older adults (65+) from 
the Netherlands 
2173 Social isolation; feelings of loneliness Dementia  
Feelings of loneliness: OR=1.64 
(95% CI=1.05-2.56); no significant 
association found for measures of 
social isolation 
Lavretsky 
et al. 2009 
Non-demented, middle 
aged (66.1±12.4), 
community-dwelling 
adults from USA 
43 
Depressive and anxiety 
symptoms (not 
diagnoses); stratified for 
MCI 
Brain mapping of 
Aβ plaques and 
NFTs through 
neuroimaging 
Correlation between depressive 
scores and medial temporal lobe 
Aβ /NFTs was significantly 
different (80%) between MCI/no 
MCI groups 
Wilson et 
al. 2007 
Non-demented older 
adults (80.7±7.1) from 
diverse settings in the 
Chicago area 
857 Loneliness and social isolation Incident AD 
Loneliness: RR=1.45 (95% 
CI=1.01-2.09) controlled for social 
activity and network size; Social 
activity: RR=0.52 (95% CI=0.34-
0.79) 
Abbreviations: Aβ = beta-amyloid; CI= confidence interval; CIND= cognitive impairment, no dementia; HR= hazard ratio; IQ= intelligence 
quotient; MCI= mild cognitive impairment; NFTs= neurofibrillary tangles; OR= odds ratio; RR= relative risk 
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Appendix B. Cerebral Infarct Sensitivity Analysis 
Emotions influence the development of cardiovascular disorders, such as atherosclerosis 
and hypertension (see section 2.6.3.2). Given that vascular diseases increase the risk of dementia, 
AD and VaD outcomes, emotional expressivity could potentially influence these outcomes 
through vascular involvement. As such, presence of cerebral infarcts, as an indicator of vascular 
assaults to brain tissue, was expected to mediate the effect of emotions on dementia and AD and 
was thus included in the analyses. However, in selecting the analytic sample, we found that the 
sample for dementia analyses was limited by missing infarct data: 43 (28.8%) of 149 who were 
otherwise eligible for inclusion did not have data on this covariate because they were still alive 
(n=27) or their post-mortem autopsy had not been processed (n=16). In an effort to maintain a 
robust sample size, those who did not have infarct data were retained for the main analysis; 
however, a sensitivity analysis excluding these individuals was also performed.  
Individuals who did not have cerebral infarct data were significantly different than the rest 
of the sample for dementia analyses on several measures. Those with missing infarct data were 
older at their last cognitive assessment (mean=91.8 years, SD=4.59, vs. mean=86.6, SD=4.32; 
p<0.01), and a greater proportion had a master’s degree or higher (76.7% vs. 50.0%; p<0.01) and 
better written language skills (p<0.01 for both idea density and grammatical complexity). They 
did not differ in the proportion that had dementia, at least one APOE-ε4 allele or in their 
expressivity of emotional words. Given that the majority of the excluded individuals were alive, 
the significant difference in age, education and written language skills may be due to survivor 
bias. The notion that they may have a lower prevalence of cerebral infarcts as well cannot be 
ruled out. The descriptive statistics of the subset with complete data on cerebral infarcts is found 
in below (Section B.1).  
The sensitivity analysis revealed that the presence of infarcts did not significantly affect the 
association between emotional expressivity and dementia; adjusting for cerebral infarcts did not 
greatly change the parameter estimate of the association between emotional expressivity and 
dementia (i.e., <10%), nor was the pattern of association different in the infarct subset compared 
to the main analytic sample (Table B5). The full results of the logistic regression analysis for the 
infarct subset are also found below (see tables in Section B.2). Notably, the association between 
overall emotional expressivity and dementia among individuals with high idea density was not 
significant in the final model, adjusted for age and APOE‐ε4,	in this subset (OR=2.68, 95% 
CI=0.89-8.96). However, the association was significant in the full model adjusted for all 
variables and most of the models bordered on significance with very wide confidence intervals 
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(Table 9). These findings suggested that the subset was too small to provide a robust analysis, and 
that cerebral infarcts did not mediate the association in this sample as expected. As such, 
available data on cerebral infarcts were not required for inclusion in the main analysis. 
 
Table B1. Participant characteristics by dementia status: analytic sample with 
cerebral infarcts data (n=106) 
 
 Dementia1 
 All  
(n=106) 
No
(n=68) 
Yes  
(n=38) 
Characteristic 
Covariates 
Age2, Mean Years (SD) 86.6 (4.32) 86.5 (4.30) 86.8 (4.41) 
 
Level of Education,  %  
Bachelor’s Degree  50.0 51.5 47.4 
≥ Master’s Degree  50.0 48.5 52.6 
 
Presence of APOE‐ε4, %* 29.2 22.1 42.1 
 
Presence of 1+ Cerebral Infarct, % 31.1 25.0 42.1 
 
Idea Density, %** 
Low  25.5 11.8 50.0 
Q2 20.8 25.0 13.2 
Q3 25.5 30.9 15.8 
High  28.3 32.4 21.0 
 
Grammatical Complexity, % 
Low 29.2 23.5 39.5 
Q2 21.7 25.0 15.8 
Q3 22.6 25.0 18.4 
High  26.4 26.5 26.3 
 
* p<0.05 
** p<0.01 
1 Based on diagnosis of dementia at the last cognitive assessment 
2 Age at last cognitive assessment 
Abbreviations:	APOE‐ε4=	apolipoprotein	E	ε4	allele;	Q=	quartile;	SD=	standard	deviation	
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Table B2. Emotional expressivity by dementia status: analytic sample with cerebral 
infarcts data (n=106) 
 
 Dementia1 
 All  
(n=106) 
No
(n=68) 
Yes  
(n=38) 
Emotional Expressivity 
Raw Word Counts2, Mean (SD) 
Overall 8.7 (7.74) 8.2 (7.72) 9.7 (7.79) 
Positive 7.5 (6.59) 7.0 (6.49) 8.5 (6.76) 
Negative 1.2 (1.68) 1.2 (1.70) 1.2 (1.68) 
 
Raw Word Counts2, Median (Range) 
Overall 6.0 (0-32) 5.0 (0-32) 8.0 (0-29) 
Positive 5.0 (0-27) 4.0 (0-27) 6.0 (0-22) 
Negative 1.0 (0-9) 1.0 (0-9) 1.0 (0-7) 
 
Quartile Rankings, % 
Overall  
Low  23.6 25.5 23.7 
Q2 24.5 27.9 18.4 
Q3 28.3 26.5 31.6 
High  23.6 22.1 26.3 
 
Positive 
Low 26.4 26.5 26.3 
Q2 25.5 27.9 21.0 
Q3 21.7 22.1 21.0 
High 26.4 23.5 31.6 
 
Negative 
Low 12.3 10.3 15.8 
Q2 40.6 41.2 39.5 
Q3 33.0 33.8 31.6 
High 14.2 14.7 13.2 
 
1 Based on diagnosis of dementia at the last cognitive assessment 
2 Autobiographies were required to be no more than one page in length, providing an approximate 
standard length for comparison 
Abbreviations: Q= quartile; SD= standard deviation  
Note: Emotional expressivity did not significantly differ by dementia status. 
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Table B3. Participant characteristics by dementia and idea density: analytic sample with cerebral infarcts data (n=106) 
 
Note: Participant characteristics did not differ by dementia status in either idea density stratum. 
1 Low= lowest quartile of idea density; Higher= top three quartiles of idea density 
2 Based on diagnosis of dementia at the last cognitive assessment 
3 Age at last cognitive assessment 
Abbreviations: APOE‐ε4=	apolipoprotein	E	ε4	allele;	Q=	quartile;	SD=	standard	deviation 
 
  
 Idea density1
 Low Higher
 Dementia2 Dementia2
 All  
(n=27) 
No
(n=8) 
Yes 
(n=19) 
All  
(n=79) 
No
(n=60) 
Yes
(n=19) 
Characteristic 
Covariates 
Age3, Mean Years (SD) 85.4 (4.44) 85.8 (4.16) 85.3 (4.65) 87.0 (4.23) 86.6 (4.35) 88.3 (3.69) 
 
Level of Education,  %  
Bachelor’s Degree  55.6 50.0 57.9 48.1 51.7 36.8 
≥ Master’s Degree  44.4 50.0 42.1 51.9 48.3 63.2 
 
Presence of APOE-ε4, % 51.8 37.5 57.9 21.5 20.0 26.3 
 
Presence of 1+ Cerebral Infarct, % 40.7 25.0 47.4 27.8 25.0 36.8 
 
Grammatical Complexity, % 
Low 40.7 25.0 47.4 25.3 23.3 31.6 
Q2 25.9 37.5 21.0 20.2 23.3 10.5 
Q3 11.1 0.0 15.8 26.6 28.3 21.0 
High  22.2 37.5 15.8 27.8 25.0 36.8 
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Table B4. Emotional expressivity by dementia status and idea density: analytic sample with cerebral infarcts data (n=106) 
       
 Idea density1
 Low Higher 
  Dementia2  Dementia2
 All  
(n=27) 
No
(n=8) 
Yes  
(n=19) 
All  
(n=79) 
No  
(n=60) 
Yes 
(n=19) 
Emotional Expressivity       
Raw Word Counts3, Mean (SD)       
Overall 8.6 (7.13) 9.5 (7.75) 8.2 (7.04) 8.8 (7.98) 8.0 (7.76) 11.2 (8.38) 
Positive 7.5 (6.24) 8.5 (7.62) 7.0 (5.75) 7.6 (6.74) 6.8 (6.37) 9.9 (7.52) 
Negative 1.1 (1.57) 1.0 (0.92) 1.1 (1.79) 1.2 (1.73) 1.2 (1.78) 1.3 (1.60) 
       
Raw Word Counts3, Median (Range)       
Overall 5.0 (0-25) 8.0 (1-19) 5.0 (0-25) 6.0 (0-32) 5.0(0-32) 8.0 (0-29) 
Positive 5.0 (0-19) 6.5 (1-18) 5.0 (0-19) 5.0 (0-27) 4.5 (0-27) 7.0 (0-22) 
Negative 0.0 (0-6) 1.0 (0-2) 0.0 (0-6) 1.0 (0-9) 1.0 (0-9) 1.0 (0-7) 
       
Quartile Rankings, %       
Overall        
Low  29.6 25.0 31.6 21.5 23.3 15.8 
Q2 14.8 0.0 21.0 27.8 31.7 15.8 
Q3 33.3 50.0 26.3 26.6 23.3 36.8 
High  22.2 25.0 21.0 24.0 21.7 31.6 
       
Positive       
Low 33.3 25.0 36.8 24.0 26.7 15.8 
Q2 18.5 25.0 15.8 27.8 28.3 26.3 
Q3 22.2 12.5 26.3 21.5 23.3 15.8 
High 25.9 37.5 21.0 26.6 21.7 42.1 
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 Idea density1
 Low Higher 
  Dementia2  Dementia2
 All  
(n=27) 
No
(n=8) 
Yes  
(n=19) 
All  
(n=79) 
No  
(n=60) 
Yes 
(n=19) 
Negative       
Low 14.8 12.5 15.8 11.4 10.0 15.8 
Q2 48.2 37.5 52.6 38.0 41.7 26.3 
Q3 14.8 12.5 15.8 39.2 36.7 47.4 
High 22.2 37.5 15.8 11.4 11.7 10.5 
       
1 Low= lowest quartile of idea density; Higher= top three quartiles of idea density 
2 Based on diagnosis of dementia at the last cognitive assessment 
3 Autobiographies were required to be no more than one page in length, providing an approximate standard length for comparison 
Abbreviations: Q= quartile; SD= standard deviation  
Note: Emotional expressivity did not significantly differ by dementia status in either idea density strata. 
 
 
 
 
 
 
 
 
 
 122 
B.2 Multivariate Logistic Regression Sensitivity Analysis Using the Cerebral Infarcts Subset 
 
Table B5. Sensitivity analysis of the effect of cerebral infarcts on the association between emotional expressivity and dementia, OR 
(95% CI)  
    
  Infarcts Subset1 
(n=106) 
 Main Analytic Sample 
(n=149) 
  Crude Adjusted2 Final3  Final3
Idea Density4  Emotional Expressivity5    
Low  Overall 0.30 
(0.04-1.70) 
0.33 
(0.04-1.97) 
0.34 
(0.04-2.20) 
 0.44 
(0.07-2.30) 
      
 Positive 0.90 
(0.17-4.86) 
0.94 
(0.17-5.28) 
1.00 
(0.18-5.69) 
 1.37 
(0.27-7.54) 
      
 Negative 0.46 
(0.08-2.55) 
0.45 
(0.07-2.58) 
0.51 
(0.07-3.46) 
 0.63 
(0.11-3.56) 
       
Higher  Overall 2.65 
(0.92-8.41) 
2.55 
(0.87-8.13) 
2.68 
(0.89-8.96) 
 2.60 
(1.04-7.11) 
      
 Positive 1.68 
(0.60-4.91) 
1.72 
(0.61-5.10) 
1.67 
(0.58-4.96) 
 1.48 
(0.61-3.66) 
      
 Negative 1.47 
(0.52-4.29) 
1.44 
(0.51-4.23) 
1.52 
(0.50-4.84) 
 1.99 
(0.81-5.13) 
     
Bolded values are statistically significant. 
1 Subset selected from main analytic sample based on availability of cerebral infarct data 
2 Adjusted for presence of cerebral infarcts 
3 Adjusted	for	age	at	last	cognitive	assessment	and	APOE‐ε4	
4	Low=	lowest	quartile	of	idea	density;	Higher=	top	three	quartile	of	idea	density	
5	Top	two	quartiles	vs.	bottom	two	quartiles	
Abbreviations:	CI=	confidence	interval;	OR=	odds	ratio 
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B.2.1 Full Models of Infarct Sensitivity Analysis: Low Idea Density  
 
Table B6. Results of multivariate logistic regression analyses of the association between overall emotional expressivity and dementia among individuals 
with low idea density, using the analytic sample with cerebral infarcts data, OR (95% CI), n=27 
 Crude1 1B Education 1C APOE-ε4  1D Infarcts 1E Grammatical 
Complexity 
Full Final  
Variable            
High Overall EE 0.30 
(0.04-1.70) 
0.30 
(0.04-1.77) 
0.28 
(0.03-1.63) 
0.28 
(0.03-1.74) 
0.34 
(0.04-2.10) 
0.34 
(0.04-2.25) 
0.33 
(0.04-1.97) 
0.37 
(0.04-2.49) 
0.33 
(0.04-1.97) 
0.36 
(0.04-2.43) 
0.34 
(0.04-2.20) 
            
Age  1.01 
(0.82-1.24) 
 1.00 
(0.81-1.23) 
 0.99 
(0.80-1.23) 
 1.00 
(0.79-1.25) 
 1.02 
(0.80-1.30) 
1.00 
(0.82-1.24) 
           
Education 
(Master’s vs. 
Bachelor’s) 
  0.63 
(0.10-3.60) 
0.62 
(0.10-3.66) 
 0.60 
(0.09-3.59) 
 0.75 
(0.11-4.96) 
 0.75 
(0.11-5.06) 
 
           
APOE-ε4 Status     1.81 
(0.31-11.66) 
1.88 
(0.31-12.77) 
 2.00 
(0.32-
14.09) 
 1.63 
(0.22-
12.68) 
1.81 
(0.30-11.68) 
           
Cerebral Infarcts       2.36 
(0.39-19.75) 
2.33 
(0.34-
21.53) 
 2.10 
(0.28-
20.02) 
 
            
Grammatical 
Complexity 
        0.42 
(0.05-2.59) 
0.52 
(0.05-4.08) 
 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio 
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Table B7. Results of multivariate logistic regression analyses of the association between positive emotional expressivity and dementia among individuals 
with low idea density, using the analytic sample with cerebral infarcts data, OR (95% CI), n=27 
 Crude1 1B Education 1C APOE-ε4  1D Infarcts 1E2 Grammatical 
Complexity 
Full2 Final  
Variable            
High Positive 
EE 
0.90 
(0.17-4.86) 
0.92 
(0.17-5.09) 
0.91 
(0.17-4.95) 
0.95 
(0.17-5.40) 
0.98 
(0.18-5.61) 
1.08 
(0.19-6.72) 
0.94 
(0.17-5.28) 
1.00 
(0.17-6.17) 
0.94 
(0.17-5.28) 
0.97 
(0.16-5.99) 
1.00 
(0.18-5.69) 
            
Age  0.98 
(0.80-1.18) 
 0.96 
(0.79-1.18) 
 0.96 
(0.78-1.18) 
 0.96 
(0.77-1.19) 
 0.98 
(0.78-1.25) 
0.98 
(0.80-1.19) 
            
Education 
(Master’s vs. 
Bachelor’s ) 
  0.73 
(0.13-3.95) 
0.68 
(0.12-3.84) 
 0.58 
(0.08-3.53) 
 0.77 
(0.10-5.21) 
 0.80 
(0.11-5.42) 
 
            
APOE-ε4 
Status 
    2.29 
(0.43-14.13) 
2.48 
(0.45-16.62) 
 2.40 
(0.42-16.31) 
 2.03 
(0.32-14.90) 
2.28 
(0.42-14.05) 
            
Cerebral 
Infarcts 
      2.69 
(0.47-21.76) 
2.53 
(0.39-23.08) 
 2.32 
(0.34-21.62) 
 
            
Grammatical 
Complexity 
        0.37 
(0.05-2.11) 
0.55 
(0.05-4.19) 
 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
2 Hosmer-Lemeshow Goodness of Fit test, p<0.01 
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio 
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Table B8. Results of multivariate logistic regression analyses of the association between negative emotional expressivity and dementia among individuals 
with low idea density, using the analytic sample with cerebral infarcts data, OR (95% CI), n=27 
 Crude1 1B Education 1C APOE-ε4  1D Infarcts 1E Grammatical 
Complexity 
Full2 Final  
Variable           
High 
Negative EE 
0.46 
(0.08-2.55) 
0.45 
(0.07-2.87) 
0.45 
(0.08-2.49) 
0.45 
(0.06-2.91) 
0.52 
(0.09-3.02) 
0.50 
(0.07-3.44) 
0.45 
(0.07-2.58) 
0.46 
(0.05-3.62) 
0.52 
(0.09-3.03) 
0.46 
(0.06-3.53) 
0.51 
(0.07-3.46) 
            
Age  1.01 
(0.81-1.25) 
 1.00 
(0.80-1.24) 
 0.99 
(0.79-1.23) 
 1.01 
(0.79-1.29) 
 1.02 
(0.80-1.33) 
1.00 
(0.81-1.24) 
            
Education 
(Master’s vs. 
Bachelor’s) 
  0.68 
(0.12-3.78) 
0.68 
(0.11-3.91) 
 0.58 
(0.09-3.52) 
 0.76 
(0.10-5.20) 
 0.77 
(0.10-5.27) 
 
            
APOE-ε4 
Status 
    2.07 
(0.37-12.93) 
2.27 
(0.40-15.21) 
 2.19 
(0.36-15.48) 
 1.84 
(0.26-14.09) 
2.07 
(0.37-12.93) 
            
Cerebral 
Infarcts 
      2.76 
(0.47-22.95) 
2.64 
(0.40-25.08) 
 2.38 
(0.34-23.25) 
 
            
Grammatical 
Complexity 
        0.41 
(0.05-2.41) 
0.54 
(0.05-4.17) 
 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
2 Hosmer-Lemeshow Goodness of Fit test, p<0.01 
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio 
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B.2.2 Full Models of Infarct Sensitivity Analysis: High Idea Density 
 
Table B9. Results of multivariate logistic regression analyses of the association between overall emotional expressivity and dementia among individuals 
with high idea density, using the analytic sample with cerebral infarcts data, OR (95% CI), n=79 
 Crude1 1B Education 1C APOE-ε4  1D Infarcts 1E Grammatical 
Complexity 
Full Final  
Variable            
High Overall 
EE 
2.65 
(0.92-8.41) 
2.46 
(0.84-7.89) 
2.89 
(0.98-9.41) 
2.80 
(0.93-9.40) 
2.92 
(0.98-9.66) 
3.05 
(0.98-10.61) 
2.55 
(0.87-8.13) 
2.95 
(0.94-10.32) 
2.76 
(0.95-8.89) 
3.28 
(1.03-11.88) 
2.68 
(0.89-8.96) 
            
Age  1.10 
(0.96-1.27) 
 1.11 
(0.97-1.31) 
 1.11 
(0.96-1.31) 
 1.11 
(0.96-1.30) 
 1.13 
(0.97-1.34) 
1.09 
(0.95-1.27) 
            
Education 
(Master’s vs. 
Bachelor’s) 
  2.07 
(0.71-6.51) 
2.34 
(0.77-7.77) 
 2.34 
(0.77-7.86) 
 2.26 
(0.73-7.66) 
 2.40 
(0.76-8.35) 
 
            
APOE-ε4 
Status 
    1.81 
(0.48-6.40) 
1.70 
(0.44-6.17) 
 1.73 
(0.45-6.34) 
 1.96 
(0.49-7.54) 
1.72 
(0.45-6.18) 
           
Cerebral 
Infarcts 
      1.60 
(0.50-4.89) 
1.47 
(0.44-4.68) 
 1.48 
(0.44-4.77) 
 
            
Grammatical 
Complexity 
        0.69 
(0.19-2.02) 
0.47 
(0.13-1.69) 
 
Bolded values are statistically significant. 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio 
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Table B10. Results of multivariate logistic regression analyses of the association between positive emotional expressivity and dementia among individuals 
with high idea density, using the analytic sample with cerebral infarcts data, OR (95% CI), n=79 
 Crude1 1B Education 1C APOE-ε4  1D Infarcts 1E Grammatical 
Complexity 
Full Final  
Variable            
High Positive 
EE 
1.68 
(0.60-4.91) 
1.66 
(0.58-4.92) 
1.87 
(0.65-5.65) 
1.91 
(0.65-5.96) 
1.69 
(0.60-4.96) 
1.94 
(0.66-6.08) 
1.72 
(0.61-5.10) 
1.96 
(0.66-6.17) 
1.76 
(0.62-5.23) 
2.16 
(0.71-7.05) 
1.67 
(0.58-4.96) 
            
Age  1.11 
(0.97-1.28) 
 1.12 
(0.98-1.31) 
 1.12 
(0.98-1.31) 
 1.12 
(0.98-1.31) 
 1.13 
(0.98-1.34) 
1.10 
(0.97-1.28) 
            
Education 
(Master’s vs. 
Bachelor’s) 
  2.02 
(0.70-6.27) 
2.24 
(0.75-7.28) 
 2.24 
(0.75-7.34) 
 2.14 
(0.70-7.09) 
 2.30 
(0.74-7.83) 
 
            
APOE-ε4 Status     1.45 
(0.40-4.71) 
1.39 
(0.38-4.66) 
 1.43 
(0.38-4.86) 
 1.58 
(0.42-5.60) 
1.41 
(0.38-4.67) 
            
Cerebral 
Infarcts 
      1.80 
(0.58-5.44) 
1.66 
(0.51-5.22) 
 1.68 
(0.51-5.37) 
 
            
Grammatical 
Complexity 
        0.62 
(0.20-2.05) 
0.50 
(0.14-1.77) 
 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio 
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Table B11. Results of multivariate logistic regression analyses of the association between negative emotional expressivity and dementia among individuals 
with high idea density, using the analytic sample with cerebral infarcts data, OR (95% CI), n=27 
 Crude1 1B Education 1C APOE-ε4  1D Infarcts 1E Grammatical 
Complexity 
Full Final  
Variable          
High 
Negative EE 
1.47 
(0.52-4.29) 
1.35 
(0.47-4.00) 
1.57 
(0.55-4.66) 
1.51 
(0.52-4.63) 
1.69 
(0.57-5.38) 
1.76 
(0.56-5.99) 
1.44 
(0.51-4.23) 
1.73 
(0.55-5.94) 
1.48 
(0.52-4.33) 
1.82 
(0.57-6.37) 
1.52 
(0.50-4.84) 
            
Age  1.10 
(0.97-1.27) 
 1.12 
(0.97-1.30) 
 1.11 
(0.97-1.30) 
 1.11 
(0.97-1.30) 
 1.12 
(0.97-1.32) 
1.10 
(0.96-1.27) 
            
Education 
(Master’s vs. 
Bachelor’s) 
  1.92 
(0.67-5.86) 
2.12 
(0.72-6.83) 
 2.18 
(0.72-7.20) 
 2.09 
(0.68-7.01) 
 2.24 
(0.72-7.85) 
 
            
APOE-ε4 
Status 
    1.73 
(0.46-6.19) 
1.67 
(0.43-6.20) 
 1.70 
(0.43-6.39) 
 1.87 
(0.47-7.21) 
1.60 
(0.42-5.80) 
            
Cerebral 
Infarcts 
      1.72 
(0.55-5.15) 
1.60 
(0.49-4.96) 
 1.59 
(0.49-4.98) 
 
            
Grammatical 
Complexity 
        0.66 
(0.21-2.16) 
0.54 
(0.16-1.89) 
 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio 
 129 
Appendix C. Assessment of Non-Response 
Various subsets of the total Nun Study population were identified based on “non-response” 
(i.e., missing data or ineligibility because of restriction). The descriptive statistics of these subsets 
were compared to assess generalizability of the final analytic sample and to identify potential 
sources of bias. In total, 678 individuals were included in the Nun Study population; however, 
emotions data from scored autobiographies was only available for 180 individuals, which made 
up the baseline population of individuals who were eligible for inclusion in the analysis (Figure 
1). As such, individuals who did (n=180) and did not have emotions data (n=498) were compared 
(Table C1).  
Of the 180 individuals who had data on emotions, 164 had complete data on all covariates 
of interest and were therefore included in the initial sample for the analyses of dementia. Non-
response analysis was performed on those who were included in the initial sample (n=164) 
compared to those who were not included from the baseline sample population (n=16; Table C2).  
The multivariate regression analysis of the initial sample for dementia analyses yielded 
models with poor fit because of the large influence of low education and the relatively low 
number of individuals with low education. As a result, the sample was further restricted on low 
education, so that 149 individuals remained in the final analytic sample. Individuals who were 
included in the final sample (n=149) were compared to those who were excluded from the 
baseline sample population (n=31; Table C3) and to those who were excluded from the initial 
sample selected for the analysis of dementia (n=15; Table C4).  
Of the 149 individuals who were retained in the final sample for dementia analyses, 85 had 
complete neuropathologic data and were therefore included in the final sample for AD analyses. 
The descriptive statistics of the individuals included in this sample (n=85) were compared to 
those of individuals who were excluded from the baseline sample population (n=95; Table C5) 
and to those of individuals who were excluded from the final sample used for the analyses of 
dementia (n=64; Table C6).  
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Table C1. Descriptive statistics of sample who had emotions data compared to those without 
emotions data  
     
  Total Emotions Data No Emotions 
Data 
Age at Last Cognitive 
Assessment, Years**   
n 678 180 498 
Mean (SD) 89.5 (5.71) 87.5 (5.26) 90.2 (5.70) 
     
Age at Death, Years**  n 606 151 455 
Mean (SD) 90.4 (5.37) 87.9 (4.46) 91.2 (5.39) 
     
Dementia**  n 678 180 498 
%  43.8 33.3 47.6 
     
Education**  n 678 180 498 
      ≤High School  
      Bachelor’s Degree 
      Master’s Degree 
% 15.5 
39.8 
44.7 
8.9 
38.3 
52.8 
17.9 
40.4 
41.8 
     
Presence of At Least One 
APOE-ε4 Allele 
n 619 164 455 
%  22.8 26.8 21.3 
     
Presence of At Least One 
Cerebral Infarct  
n 521 122 399 
% 35.1 32.0 36.1 
     
** p<0.01 
Abbreviations: APOE-ε4= apolipoprotein E ε4; SD= standard deviation 
Note: Individuals who had emotions data and were therefore eligible for inclusion in the sample were 
compared to those who did not have emotions data; significant differences in descriptive statistics of the 
two subsets are indicated with asterisks. 
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Table C2. Descriptive statistics of initial sample for dementia analyses compared to those with emotions 
data who were excluded because of missing data on one or more covariates of interest  
     
  Total Initial Dementia 
Subset 
Excluded1
Age at Last Cognitive 
Assessment, Years**   
n 180 164 16 
Mean (SD) 87.5 (5.26) 88.0 (4.95) 81.7 (4.93) 
     
Age at Death, Years n 151 137 14 
Mean (SD) 87.9 (4.46) 88.0 (4.46) 86.37 (4.33) 
     
Dementia*  n 180 164 16 
%  33.3 36.0 6.2 
     
Education n 180 164 16 
      ≤High School  
Bachelor’s Degree 
Master’s Degree   
% 8.9 
38.3 
52.8 
9.2 
38.4 
52.4 
6.2 
37.4 
56.9 
     
Presence of At Least One 
APOE-ε4 allele 
n 164 164 0 
%  26.8 26.8 0.0 
     
Presence of At Least One 
Cerebral Infarct2  
n 122 120 2 
%  32.0 31.7 50.0 
     
* p<0.05 
**p<0.01 
1 n=16 excluded due to missing data on APOE-ε4 status 
Abbreviations: APOE-ε4= apolipoprotein ε4; SD= standard deviation 
Note: Individuals who had all covariates of interest and who were therefore included in the initial sample for 
dementia analyses were compared to those who were excluded from the baseline sample; significant differences 
in descriptive statistics of the two subsets are indicated with asterisks. 
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Table C3. Descriptive statistics of the final sample for dementia analyses compared to those from the 
baseline sample who were excluded because of missing data or who were restricted on education  
     
  Total Final Dementia 
Subset 
Excluded1
Age at Last Cognitive 
Assessment, Years ** 
n 180 149 31 
Mean (SD) 87.5 (5.26) 88.1 (4.98) 84.5 (5.62) 
     
Age at Death, Years n 151 122 29 
Mean (SD) 87.9 (4.46) 88.0 (4.44) 87.2 (4.58) 
     
Dementia  n 180 149 31 
%  33.3 31.5 41.9 
     
Education** n 180 149 31 
      ≤High School  
Bachelor’s Degree 
Master’s Degree   
% 8.9 
38.3 
52.8 
0.0 
42.3 
57.7 
51.6 
19.4 
20.0 
     
Presence of At Least One 
APOE-ε4 allele 
n 164 149 15 
%  26.8 26.2 33.3 
     
Presence of At Least One 
Cerebral Infarct  
n 122 106 16 
%  32.0 31.1 37.5 
         
**p<0.01 
1n=16 excluded due to missing data on APOE-ε4 status; n=15 restricted due to low education 
Abbreviations: APOE-ε4= apolipoprotein ε4; SD= standard deviation 
Note: Individuals from the final sample for dementia analyses were compared to those individuals from the 
eligible baseline sample who were excluded because of missing data on one or more covariates of interest or 
who were restricted on low education; significant differences in descriptive statistics of the two subsets are 
indicated with asterisks. 
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Table C4. Descriptive statistics of final sample for dementia analyses compared to those from the initial 
sample who were restricted on low education  
     
  Total Final Dementia 
Subset 
Restricted on 
Education 
Age at Last Cognitive 
Assessment, Years  
n 164 149 15 
Mean (SD) 88.0 (4.95) 88.1 (4.98) 87.4 (4.84) 
     
Age at Death, Years n 137 122 15 
Mean (SD) 88.0 (4.46) 88.0 (4.44) 88.0 (4.82) 
     
Dementia** n 164 149 15 
% 36.0 31.5 80.0 
     
Education** n 164 149 15 
      ≤High School  
Bachelor’s Degree 
Master’s Degree   
% 9.2 
38.4 
52.4 
0.0 
42.3 
57.7 
100.0 
0.0 
0.0 
     
Presence of At Least One 
APOE-ε4 allele 
n 164 149 15 
%  26.8 26.2 33.3 
     
Presence of At Least One 
Cerebral Infarct  
n 120 106 14 
%  31.7 31.1 35.7 
     
**p<0.01 
Abbreviations: APOE-ε4= apolipoprotein ε4; SD= standard deviation 
Note: Individuals from the final sample for dementia analyses were compared to those individuals from the initial 
sample who were restricted on low education; significant differences in descriptive statistics of the two subsets 
are indicated with asterisks. 
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Table C5. Descriptive statistics of the final sample for AD analyses compared to those from the baseline 
sample who were excluded because of missing data or who were restricted on education  
     
  Total AD Subset Excluded1
Age at Last Cognitive 
Assessment, Years  
n 180 85 95 
Mean (SD) 87.5 (5.26) 87.8 (3.91) 87.2 (6.23) 
     
Age at Death, Years n 151 85 66 
Mean (SD) 87.9 (4.46) 88.5 (3.74) 87.0 (5.16) 
     
Dementia  n 180 85 95 
%  33.3 36.5 30.5 
     
Education** n 180 85 95 
      ≤High School  
Bachelor’s Degree 
Master’s Degree   
% 8.9 
38.3 
52.8 
0.0 
49.4 
50.6 
16.8 
28.4 
54.7 
     
Presence of At Least One 
APOE-ε4 allele 
n 164 85 79 
% 26.8 25.9 27.8 
     
Presence of At Least One 
Cerebral Infarct  
n 122 85 37 
% 32.0 28.2 40.5 
     
**p<0.01 
1n=16 excluded due to missing data on APOE-ε4 status; n=70 excluded due to missing neuropathology data; 
n=9 restricted due to low education 
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein ε4; SD= standard deviation 
Note: Individuals from the final sample for AD analyses were compared to those individuals from the eligible 
baseline sample who were excluded because of missing data on any covariates of interest or on 
neuropathology, or who were restricted on low education; significant differences in descriptive statistics of the 
two subsets are indicated with asterisks. 
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Table C6. Descriptive statistics of the final Sample for AD analyses compared to those from the final 
sample for dementia analyses who were missing neuropathology data  
     
  Total AD Subset Excluded1
Age at Last Cognitive 
Assessment, Years  
n 149 85 64 
Mean (SD) 88.1 (4.98) 87.8 (3.91) 88.5 (6.12) 
     
Age at Death, Years n 122 85 37 
Mean (SD) 88.0 (4.44) 88.5 (3.74) 86.9 (5.64) 
     
Dementia  n 149 85 64 
%  31.5 36.5 25.0 
     
Education* n 149 85 64 
      ≤High School  
Bachelor’s Degree 
Master’s Degree   
% 0.00 
42.3 
57.7 
0.00 
49.4 
50.6 
0.00 
32.8 
67.2 
     
Presence of At Least One 
APOE-ε4 allele 
n 149 85 64 
%  26.2 25.9 26.6 
     
Presence of At Least One 
Cerebral Infarct  
n 106 85 21 
% 31.1 28.2 42.9 
     
*p<0.05 
1n= 64 excluded due to missing neuropathology data 
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein ε4; SD= standard deviation 
Note: Individuals from the final sample for the AD analyses were compared to those individuals from the final 
sample for dementia analyses who were excluded because of missing data on neuropathology; significant 
differences in descriptive statistics of the two subsets are indicated with asterisks. 
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Appendix D. Analysis of the Association Between Emotional 
Expressivity and Dementia Without Restriction by Education  
Initially, 164 individuals were included in the analysis of the association between emotional 
expressivity and dementia. These individuals were eligible for inclusion because they had complete data 
on all variables of interest, including emotional expressivity and scores of written language skills in 
autobiographies written by hand in early adulthood; cognitive assessments to determine presence of 
dementia in late adulthood; and data on age, education and APOE-ε4 status. Of those who were included, 
59 (36.0%) were diagnosed with dementia. Individuals with dementia did not differ from those without 
dementia (n=105) in age or emotional expressivity; however, they had significantly lower levels of 
education (p<0.001) and written language skills (i.e., idea density, p<0.0001; grammatical complexity, 
p<0.01), and were more likely to have at least one APOE-ε4 allele (p<0.01).  
Distribution of cases and non-cases was significantly different between the two idea density strata 
(p<0.0001). Of those with low idea density, 28 (75.7%) had dementia. These individuals did not differ 
from those who did not have dementia in age, education, or APOE-ε4 status. Among those with higher 
idea density, 31 (24.4%) had dementia. In this subgroup, cases had lower education (p<0.05), higher 
overall emotional expressivity (p<0.05), and were more likely to have moderate (vs. low) negative 
expressivity (p<0.05) than individuals without dementia.  
Multivariate logistic regression analysis of the association between emotional expressivity (overall, 
positive and negative) and dementia, stratified by idea density, was performed on this sample. Age and 
APOE-ε4 status influenced the parameter estimates of emotional expressivity in many of the models so 
their inclusion in the final models was necessary. Furthermore, although it did not change the emotional 
expressivity parameter estimates, education was statistically significant in many of the models so it also 
had to be included in the final models. However, when all three covariates (i.e., age, education and 
APOE-ε4 status) were included in the final models with emotional expressivity, several of the models did 
not converge or had a poor fit, in particular among individuals with low idea density (Tables D1-D6). 
The poor fit was likely due to the large influence that low education has on the risk of dementia, 
and the low prevalence of individuals with a high school diploma or less in the Nun Study population. As 
such, individuals with less than a university education (n=15) were restricted from the sample for the final 
analysis; 3 individuals without dementia and 12 with dementia were removed based on this restriction 
criterion. Restriction resolved all of the differences between individuals with and without dementia after 
stratification by idea density (Section 5.1.1). Furthermore, this method controlled for the confounding 
effects of low education to allow for a more interpretable estimation of the association of emotional 
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expressivity with dementia and AD. Indeed, restricting by education yielded better-fit models. However, a 
drawback of this restriction was that the generalizability of the results was further limited.   
 
Table D1. Multivariate logistic regression analyses of the association between overall emotional 
expressivity and dementia among individuals with low idea density before restriction on education 
(n=37), OR (95% CI) 
 Crude1 1B 1C 1D2 Full2
Variable      
High Overall EE 0.38 
(0.07-1.73) 
0.39 
(0.07-1.82) 
0.41 
(0.07-2.06) 
0.44 
(0.07-2.30) 
0.44 
(0.07-2.34) 
      
Age  0.96 
(0.82-1.13) 
0.93 
(0.79-1.09) 
0.94 
(0.80-1.10) 
0.96 
(0.80-1.14) 
      
Education (>High School)   <0.001 
(<0.001-0.66) 
<0.001 
(<0.001-0.61) 
<0.001 
(<0.001-0.95) 
      
APOE-ε4 Status3    2.04 
(0.38-12.43) 
1.70 
(0.28-11.16) 
      
Grammatical Complexity     0.52 
(0.06-3.82) 
Bolded values are significant.  
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
2 Model did not converge: quasi-complete separation of data points detected.  
3 Presence of at least APOE-ε4 allele 
Abbreviations: APOE-ε4= apolipoprotein E ε4; CI= confidence interval; EE= emotional expressivity; OR= odds ratio 
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Table D2. Multivariate logistic regression analyses of the association between positive emotional 
expressivity and dementia among individuals with low idea density before restriction on education 
(n=37), OR (95% CI) 
 Crude1 1B 1C2 1D Full
Variable      
High Positive EE 0.94 
(0.20-4.50) 
0.98 
(0.21-4.81) 
1.29 
(0.26-6.79) 
1.37 
(0.27-7.54) 
1.37 
(0.26-7.61) 
      
Age  0.95 
(0.82-1.11) 
0.93 
(0.79-1.09) 
0.95 
(0.80-1.11) 
0.96 
(0.81-1.14) 
     
Education (>High school)   <0.001 
(<0.001-0.61) 
<0.001 
(<0.001-0.55) 
<0.001 
(<0.001-0.89) 
     
APOE-ε4 status3    2.30 
(0.44-14.01) 
1.90 
(0.33-12.49) 
     
Grammatical Complexity     0.51 
(0.05-3.67) 
Bolded values are significant.  
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
2 Model did not converge: quasi-complete separation of data points detected.  
3 Presence of at least APOE-ε4 allele 
Abbreviations: APOE-ε4= apolipoprotein E ε4; CI= confidence interval; EE= emotional expressivity; OR= odds ratio 
 
 
Table D3. Multivariate logistic regression analyses of the association between negative emotional 
expressivity and dementia among individuals with low idea density before restriction on education 
(n=37), OR (95% CI) 
 Crude1 1B 1C2 1D2 Full2
Variable      
High Negative EE 0.69 
(0.15-3.36) 
0.78 
(0.16-3.99) 
0.60 
(0.11-3.31) 
0.63 
(0.11-3.56) 
0.63 
(0.11-3.59) 
      
Age  0.96 
(0.82-1.12) 
0.94 
(0.80-1.10) 
0.95 
(0.81-1.12) 
0.97 
(0.81-1.15) 
     
Education (>High school)   <0.001 
(<0.001-0.58) 
<0.001 
(<0.001-0.55) 
<0.001 
(<0.001-0.86) 
     
APOE-ε4 status3    2.17 
(0.42-13.05) 
1.79 
(0.30-11.66) 
     
Grammatical Complexity     0.51 
(0.06-3.73) 
Bolded values are significant.  
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
2 Model did not converge: quasi-complete separation of data points detected.  
3 Presence of at least APOE-ε4 allele 
Abbreviations: APOE-ε4= apolipoprotein E ε4; CI= confidence interval; EE= emotional expressivity; OR= odds ratio 
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Table D4. Multivariate logistic regression analyses of the association between overall emotional 
expressivity and dementia among individuals with high idea density before restriction on education 
(n=127), OR (95% CI) 
 Crude1 1B 1C2 1D Full
Variable      
High Overall EE 2.55 
(1.09-6.36) 
2.47 
(1.05-6.22) 
2.51 
(1.05-6.47) 
2.79 
(1.14-7.39) 
2.90 
(1.18-7.78) 
      
Age  1.08 
(0.98-1.19) 
1.09 
(0.99-1.20) 
1.09 
(1.00-1.21) 
1.11 
(1.00-1.23) 
     
Education (>High school)   0.18 
(0.03-0.91) 
0.18 
(0.03-0.92) 
0.20 
(0.03-1.06) 
     
APOE-ε4 status3    2.19 
(0.78-6.04) 
2.40 
(0.84-6.78) 
     
Grammatical Complexity     0.55 
(0.18-1.78) 
Bolded values are significant.  
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
2 Model did not converge: quasi-complete separation of data points detected.  
3 Presence of at least APOE-ε4 allele 
Abbreviations: APOE-ε4= apolipoprotein E ε4; CI= confidence interval; EE= emotional expressivity; OR= odds ratio 
 
 
Table D5. Multivariate logistic regression analyses of the association between positive emotional 
expressivity and dementia among individuals with high idea density before restriction on education 
(n=127), OR (95% CI) 
 Crude1 1B2 1C2 1D Full2
Variable      
High Positive EE 1.72 
(0.76-4.02) 
1.65 
(0.72-3.88) 
1.75 
(0.75-4.22) 
1.80 
(0.77-4.40) 
1.90 
(0.80-4.70) 
      
Age  1.08 
(0.99-1.18) 
1.09 
(0.99-1.20) 
1.09 
(1.00-1.21) 
1.10 
(1.00-1.23) 
     
Education (>High school)   0.17 
(0.03-0.86) 
0.17 
(0.03-0.88) 
0.19 
(0.03-0.99) 
     
APOE-ε4 status3    1.91 
(0.70-5.04) 
2.07 
(0.75-5.60) 
     
Grammatical Complexity     0.57 
(0.19-1.80) 
Bolded values are significant.  
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
2 Model did not converge: quasi-complete separation of data points detected.  
3 Presence of at least APOE-ε4 allele 
Abbreviations: APOE-ε4= apolipoprotein E ε4; CI= confidence interval; EE= emotional expressivity; OR= odds ratio 
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Table D6. Multivariate logistic regression analyses of the association between negative emotional 
expressivity and dementia among individuals with high idea density before restriction on education 
(n=127), OR (95% CI) 
 Crude1 1B 1C 1D Full
Variable      
High Negative EE 1.79 
(0.79-4.19) 
1.84 
(0.80-4.36) 
1.71 
(0.74-4.13) 
1.97 
(0.82-4.94) 
1.99 
(0.83-4.99) 
      
Age  1.08 
(0.99-1.19) 
1.10 
(1.00-1.21) 
1.10 
(1.00-1.22) 
1.11 
(1.01-1.23) 
     
Education (>High school)   0.20 
(0.03-1.00) 
0.21 
(0.04-1.08) 
0.23 
(0.40-1.21) 
     
APOE-ε4 status2    2.16 
(0.78-5.91) 
2.32 
(0.82-6.48) 
     
Grammatical Complexity     0.62 
(0.21-1.93) 
Bolded values are significant.  
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
2 Presence of at least APOE-ε4 allele 
Abbreviations: APOE-ε4= apolipoprotein E ε4; CI= confidence interval; EE= emotional expressivity; OR= odds ratio 
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Appendix E. All Multivariate Logistic Regression Models 
As described in the methods (Section 4.4.2), the association of emotional expressivity with 
dementia and AD was assessed through multivariate logistic regression analysis. Tables presented in the 
following sections provide the complete results, including all crude, adjusted, full and final models, 
beginning with the main analysis of the association of emotional expressivity with both dementia and AD, 
stratified by idea density (Section E.1). Models were generated for each emotional expressivity measure 
(i.e., overall, positive, negative) with each outcome (i.e., dementia, AD), and adjusted for each covariate 
(i.e., age, education, APOE-ε4, grammatical complexity) separately and in succession as outlined in the 
analytic strategy (Table 2).  
Analysis using emotional expressivity tertiles was performed to further investigate the association 
with dementia, also stratified by idea density (Section E.2). In addition, a significant interaction was 
found between positive and negative emotional expressivity in association with dementia among 
individuals with high idea density. As such, models of the association between negative emotional 
expressivity and dementia, stratified both by idea density and by positive emotional expressivity, were 
generated (Section E.3). 
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E.1 Main Analysis of Emotional Expressivity with Dementia and AD 
 
E.1.1 Main Analysis: Low Idea Density  
 
Table E1. Results of multivariate logistic regression analyses of the association between overall emotional expressivity and dementia among individuals 
with low idea density, OR (95% CI), n=29 
 Crude1 1B Education 1C APOE-ε4  1D Grammatical 
Complexity
Full Final  
Variable       
High Overall EE 0.41  
(0.07-2.02) 
0.41 
(0.07-2.06) 
0.36 
(0.06-1.86) 
0.36 
(0.06-1.90) 
0.46 
(0.08-2.37 
0.40 
(0.06-2.15)
0.43 
(0.07-2.22)
0.39 
(0.06-2.18)
0.44 
(0.07-2.30) 
       
Age  0.93 
(0.79-1.09) 
 0.94 
(0.79-1.09) 
 0.94 
(0.80-1.10)
0.96 
(0.80-1.14)
0.94 
(0.80-1.10) 
   
Education (Master’s vs. 
Bachelor’s Degree) 
  0.54 
(0.09-2.78) 
0.54 
(0.09-2.84) 
 0.54 
(0.09-2.89)
0.55 
(0.09-2.98)
 
   
APOE-ε4 Status     2.19 
(0.42-13.15) 
2.04 
(0.37-12.73)
1.70 
(0.28-11.49)
2.04 
(0.38-12.43) 
   
Grammatical Complexity      0.37 
(0.05-2.06)
0.52 
(0.06-3.96)
 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio 
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Table E2. Results of multivariate logistic regression analyses of the association between overall emotional expressivity and AD1 among individuals with 
low idea density, OR (95% CI), n=19 
 Crude2 1B Education 1C APOE-ε4 1D Grammatical 
Complexity3 
Full3 Final  
Variable          
High Overall EE 0.23 
(0.01-2.02) 
0.22 
(0.01-2.02) 
0.20 
(0.01-1.87) 
0.22 
(0.01-2.09) 
0.40 
(0.02-5.11) 
0.45 
(0.02-7.06) 
0.27 
(0.01-3.07) 
0.21  
(0.004-4.01) 
0.40 
(0.02-5.21) 
          
Age  1.03 
(0.79-1.33) 
 0.97 
(0.71-1.29) 
 0.84 
(0.51-1.20) 
 0.92 
(0.50-1.61) 
0.98 
(0.74-1.30) 
          
Education (Master’s vs. 
Bachelor’s Degree) 
  0.36 
(0.03-2.80) 
0.32 
(0.02-3.15) 
 0.11 
(0.001-2.08) 
 0.10 
(0.001-2.22) 
 
          
APOE‐ε4 Status     6.22 
(0.63-145.93) 
16.00 
(0.89->999.9) 
 8.70 
(0.47->999.9) 
6.37 
(0.62-152.88) 
          
Grammatical Complexity       <0.001 
(<0.001-0.64) 
<0.001 
(<0.001-0.62) 
 
Bolded values are statistically significant. 
1 Based on diagnosis of AD according to NIA-RI criteria; non-cases defined as those without AD or dementia at their last cognitive assessment 
2 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
3 Model did not converge: quasi-complete separation of data detected 
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; NIA-RI= National Institute on Aging – 
Reagan Institute; OR= odds ratio 
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Table E3. Results of multivariate logistic regression analyses of the association between positive emotional expressivity and dementia among individuals 
with low idea density, OR (95% CI), n=29 
 Crude1 1B Education 1C APOE-ε4 1D Grammatical 
Complexity 
Full Final
Variable        
High Positive EE 1.25 
(0.26-6.41) 
1.29 
(0.26-6.79) 
1.27 
(0.26-6.60) 
1.33 
(0.26-7.23) 
1.39 
(0.28-7.64) 
1.48 
(0.28-8.74) 
1.32 
(0.26-7.13) 
1.46 
(0.27-8.56)
1.37 
(0.27-7.54)
        
Age  0.93 
(0.79-1.09) 
 0.93 
(0.79-1.09) 
 0.95 
(0.80-1.10) 
 0.96 
(0.80-1.14)
0.95 
(0.80-1.11)
   
Education (Master’s vs. 
Bachelor’s Degree) 
  0.65 
(0.12-3.18) 
0.64 
(0.12-3.20) 
 0.59 
(0.10-3.07) 
 0.61 
(0.10-3.24)
   
APOE-ε4 Status     2.54 
(0.51-15.28) 
2.42 
(0.46-15.45) 
 2.00 
(0.34-13.93)
2.30 
(0.44-14.01)
   
Grammatical Complexity       0.34 
(0.04-1.87) 
0.53 
(0.06-3.91)
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio  
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Table E4. Results of multivariate logistic regression analyses of the association between positive emotional expressivity and AD1 among individuals with 
low idea density, OR (95% CI), n=19 
 Crude2 1B Education 1C APOE-ε4 1D Grammatical 
Complexity3 
Full3 Final 
Variable          
High Positive EE 1.17 
(0.16-8.59) 
1.17 
(0.16-8.71) 
1.35 
(0.18-11.16) 
1.56 
(0.19-15.22) 
1.74 
(0.19-19.24) 
5.20 
(0.36-217.98) 
1.33 
(0.14-12.95) 
2.52 
(0.15-113.93) 
1.71 
(0.19-19.44) 
          
Age  0.99 
(0.77-1.25) 
 0.92 
(0.68-1.20) 
 0.77 
(0.46-1.12) 
 0.90 
(0.50-1.59) 
0.98 
(0.74-1.28) 
          
Education (Master’s vs. 
Bachelor’s Degree) 
  0.41 
(0.04-2.98) 
0.28 
(0.02-2.89) 
 0.03 
(<0.001-1.23) 
 0.08 
(<0.001-2.35) 
 
          
APOE-ε4 Status     8.98 
(0.98-216.49) 
38.61 
(1.82->999.9) 
 11.05 
(0.54->999.9) 
8.95 
(0.98-214.98) 
          
Grammatical Complexity       <0.001 
(<0.001-0.55) 
<0.001 
(<0.001-1.27) 
 
Bolded values are statistically significant. 
1 Based on diagnosis of AD according to NIA-RI criteria; non-cases defined as those without AD or dementia at their last cognitive assessment 
2 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
3 Model did not converge: quasi-complete separation of data detected 
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; NIA-RI= National Institute on Aging – 
Reagan Institute; OR= odds ratio 
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Table E5. Results of multivariate logistic regression analyses of the association between negative emotional expressivity and dementia among individuals 
with low idea density, OR (95% CI), n=29 
 Crude1 1B Education 1C APOE-ε4 1D2 Grammatical 
Complexity 
Full Final
Variable        
High Negative EE 0.54 
(0.10-2.82) 
0.60 
(0.11-3.31) 
0.50 
(0.09-2.67) 
0.55 
(0.10-3.12) 
0.58 
(0.11-3.20) 
0.56 
(0.09-3.27) 
0.59 
(0.11-3.23) 
0.56 
(0.09-3.29)
0.63 
(0.11-3.56)
        
Age  0.94 
(0.80-1.10) 
 0.94 
(0.80-1.10) 
 0.96 
(0.81-1.12) 
 0.97 
(0.82-1.15)
0.95 
(0.81-1.12)
   
Education (Master’s vs. 
Bachelor’s Degree) 
  0.60 
(0.11-2.99) 
0.60 
(0.11-3.06) 
 0.56 
(0.09-2.96) 
 0.57 
(0.09-3.08)
   
APOE-ε4 Status     2.32 
(0.46-13.75) 
2.28 
(0.43-14.31) 
 1.88 
(0.31-12.86)
2.17 
(0.42-13.05)
   
Grammatical Complexity       0.37 
(0.05-2.04) 
0.52 
(0.06-3.88)
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2)  
2 Hosmer-Lemeshow goodness of fit test, p<0.05 
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio  
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Table E6. Results of multivariate logistic regression analyses of the association between negative emotional expressivity and AD1 among individuals with 
low idea density, OR (95% CI), n=19 
 Crude2 1B Education 1C APOE-ε4 1D3 Grammatical 
Complexity3 
Full3 Final 
Variable          
High Negative EE 0.31 
(0.03-2.24) 
0.28 
(0.02-2.23) 
0.24 
(0.02-1.91) 
0.25 
(0.02-2.19) 
0.27 
(0.02-2.41) 
<0.001 
(<0.001-1.19) 
0.20 
(0.02-1.90) 
<0.001 
(<0.001-0.17) 
0.24 
(0.02-2.56) 
          
Age  1.04 
(0.80-1.37) 
 0.98 
(0.72-1.32) 
 0.90 
(0.54-1.22) 
 1.88 
(0.68-9.29) 
1.04 
(0.77-1.37) 
          
Education (Master’s vs. 
Bachelor’s Degree) 
  0.31 
(0.03-2.52) 
0.29 
(0.02-2.94) 
 <0.001 
(<0.001-0.84) 
 <0.001 
(<0.001-0.33) 
 
          
APOE-ε4 Status     8.74 
(0.93-214.56) 
>999.9 
(2.43->999.9) 
 >999.9 
(0.48>999.9) 
8.85 
(0.92-225.83) 
          
Grammatical Complexity       <0.001 
(<0.001-0.46) 
<0.001 
(<0.001-0.12) 
 
Bolded values are statistically significant. 
1 Based on diagnosis of AD according to NIA-RI criteria; non-cases defined as those without AD or dementia at their last cognitive assessment 
2 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
3 Model did not converge: quasi-complete separation of data detected 
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; NIA-RI= National Institute on Aging – 
Reagan Institute; OR= odds ratio 
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E.1.2 Main Analysis: High Idea Density  
 
Table E7. Results of multivariate logistic regression analyses of the association between overall emotional expressivity and dementia among individuals 
with high idea density, OR (95% CI), n=120 
 Crude1 1B Education 1C APOE‐ε4  1D Grammatical 
Complexity 
Full Final
Variable        
High Overall EE 2.43 
(0.99-6.39) 
2.34 
(0.95-6.20) 
2.38 
(0.97-6.30) 
2.31 
(0.94-6.13) 
2.67 
(1.07-7.22) 
2.58 
(1.02-7.06) 
2.50 
(1.02-6.64) 
2.76 
(1.08-7.74)
2.60 
(1.04-7.11)
        
Age  1.07 
(0.97-1.18) 
 1.06 
(0.97-1.18) 
 1.07 
(0.97-1.19) 
 1.09 
(0.98-1.22)
1.07 
(0.97-1.19)
   
Education (Master’s vs. 
Bachelor’s Degree) 
  1.38 
(0.56-3.55) 
1.33 
(0.54-3.45) 
 1.28 
(0.51-3.36) 
 1.34 
(0.53-3.58)
   
APOE‐ε4 Status     2.29 
(0.77-6.06) 
2.26 
(0.78-6.35) 
 2.49 
(0.85-7.22)
2.30 
(0.80-6.45)
   
Grammatical Complexity       0.62 
(0.21-1.94) 
0.44 
(0.14-1.47)
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2)  
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio  
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Table E8. Results of multivariate logistic regression analyses of the association between overall emotional expressivity and AD1 among individuals with 
high idea density, OR (95% CI), n=60 
 Crude2 1B Education 1C APOE‐ε4  1D3 Grammatical 
Complexity 
Full Final
Variable        
High Overall EE 1.40 
(0.39-5.32) 
1.36 
(0.38-5.19) 
1.55 
(0.42-6.09) 
1.57 
(0.42-6.32) 
1.75 
(0.46-7.40) 
1.97 
(0.50-8.89) 
1.42 
(0.40-5.42) 
2.11 
(0.52-9.74)
1.68 
(0.44-7.14)
        
Age  1.08 
(0.90-1.35) 
 1.11 
(0.90-1.42) 
 1.09 
(0.87-1.41) 
 1.12  
(0.88-1.48)
1.06 
(0.86-1.33)
   
Education (Master’s vs. 
Bachelor’s Degree) 
  2.84 
(0.68-10.52) 
2.68 
(0.71-12.01) 
 2.84 
(0.71-13.82) 
 3.21 
(0.77-16.82)
   
APOE-ε4 Status     4.00 
(0.95-17.27) 
3.88 
(0.88-17.68) 
 4.18 
(0.93-20.05)
3.75 
(0.88-16.48)
   
Grammatical Complexity       0.77 
(0.18-3.96) 
0.48 
(0.08-2.87)
1 Based on diagnosis of AD according to NIA-RI criteria; non-cases defined as those without AD or dementia at their last cognitive assessment 
2 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
3 Model did not converge: quasi-complete separation of data detected 
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; NIA-RI= National Institute on Aging – 
Reagan Institute; OR= odds ratio 
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Table E9. Results of multivariate logistic regression analyses of the association between positive emotional expressivity and dementia among individuals 
with high idea density, OR (95% CI), n=120 
 Crude1 1B Education 1C APOE-ε4 1D Grammatical 
Complexity 
Full Final
Variable        
High Positive EE 1.49 
(0.63-3.62) 
1.42 
(0.56-3.50) 
1.49 
(0.63-3.65) 
1.43 
(0.60-3.52) 
1.53 
(0.64-3.76) 
1.49 
(0.62-3.71) 
1.53 
(0.64-3.77) 
1.58 
(0.65-4.00)
1.48 
(0.61-3.66)
        
Age  1.07 
(0.97-1.18) 
 1.07 
(0.97-1.18) 
 1.07 
(0.97-1.18) 
 1.08 
(0.98-1.21)
1.07 
(0.98-1.19)
   
Education (Master’s vs. 
Bachelor’s Degree) 
  1.45 
(0.60-3.72) 
1.39 
(0.57-3.57) 
 1.35 
(0.55-3.50) 
 1.42 
(0.57-3.74)
   
APOE-ε4 Status     1.93 
(0.70-5.10) 
1.98 
(0.70-5.32) 
 2.14 
(0.75-5.89)
2.01 
(0.72-5.40)
   
Grammatical Complexity       0.64 
(0.23-1.99) 
0.48 
(0.15-1.55)
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2)  
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio  
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Table E10. Results of multivariate logistic regression analyses of the association between positive emotional expressivity and AD1 among individuals with 
high idea density, OR (95% CI), n=60 
 Crude2 1B Education 1C APOE-ε4 1D Grammatical 
Complexity 
Full Final
Variable        
High Positive EE 1.09 
(0.30-3.94) 
1.12 
(0.31-4.12) 
1.19 
(0.32-4.45) 
1.28 
(0.34-5.01) 
1.13 
(0.30-4.27) 
1.36 
(0.34-5.59) 
1.09 
(0.30-3.97) 
1.43 
(0.36-6.08)
1.14 
(0.30-4.34)
        
Age  1.08 
(0.90-1.35) 
 1.11 
(0.90-1.42) 
 1.10 
(0.88-1.42) 
 1.12 
(0.89-1.48)
1.06 
(0.87-1.34)
   
Education (Master’s vs. 
Bachelor’s Degree) 
  2.41 
(0.66-10.12) 
2.60 
(0.69-11.48) 
 2.69 
(0.68-12.84) 
 3.01 
(0.73-15.38)
   
APOE-ε4 Status     3.59 
(0.88-14.45) 
3.42 
(0.81-14.41) 
 3.65 
(0.85-16.02)
3.38 
(0.82-13.76)
   
Grammatical Complexity       0.79 
(0.19-4.04) 
0.52 
(0.10-2.96)
1 Based on diagnosis of AD according to NIA-RI criteria; non-cases defined as those without AD or dementia at their last cognitive assessment 
2 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; NIA-RI= National Institute on Aging – 
Reagan Institute; OR= odds ratio 
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Table E11. Results of multivariate logistic regression analyses of the association between negative emotional expressivity and dementia among individuals 
with high idea density, OR (95% CI), n=120 
 Crude1 1B Education 1C APOE-ε4  1D2 Grammatical 
Complexity 
Full2 Final
Variable        
High Negative EE 1.69 
(0.72-4.12) 
1.72 
(0.72-4.24) 
1.68 
(0.71-4.11) 
1.73 
(0.72-4.28) 
1.94 
(0.80-4.95) 
2.01 
(0.82-5.22) 
1.68 
(0.71-4.10) 
2.03 
(0.82-5.32)
1.99 
(0.81-5.13)
        
Age  1.07 
(0.98-1.19) 
 1.07 
(0.98-1.19) 
 1.08 
(0.98-1.20) 
 1.09 
(0.99-1.22)
1.08 
(0.98-1.20)
   
Education (Master’s vs. 
Bachelor’s Degree) 
  1.44 
(0.59-3.68) 
1.39 
(0.57-3.59) 
 1.36 
(0.55-3.56) 
 1.45 
(0.58-3.86)
   
APOE -ε4 Status     2.21 
(0.78-6.11) 
2.28 
(0.79-6.46) 
 2.45 
(0.84-7.06)
2.31 
(0.80-6.53)
   
Grammatical Complexity       0.68 
(0.24-2.12) 
0.50 
(0.16-1.63)
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2)  
2 Hosmer-Lemeshow goodness of fit test, p<0.05 
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio  
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Table E12. Results of multivariate logistic regression analyses of the association between negative emotional expressivity and AD1 among individuals with 
high idea density, OR (95% CI), n=60 
 Crude2 1B Education 1C APOE-ε4  1D Grammatical 
Complexity 
Full Final 
Variable          
High Negative EE 1.18 
(0.33-4.50) 
1.13 
(0.31-4.34) 
1.30 
(0.36-5.10) 
1.31 
(0.35-5.29) 
1.78 
(0.45-8.27) 
2.30 
(0.52-13.22) 
1.19 
(0.33-4.52) 
1.49 
(0.55-14.77) 
1.67 
(0.41-7.91) 
          
Age  1.08 
(0.90-1.34) 
 1.10 
(0.90-1.41) 
 1.09 
(0.86-1.42) 
 1.12 
(0.87-1.50) 
1.05 
(0.85-1.33) 
          
Education (Master’s vs. 
Bachelor’s Degree) 
  2.43 
(0.66-10.24) 
2.62 
(0.69-11.65) 
 3.17 
(0.75-17.49) 
 3.75 
(0.83-24.28) 
 
          
APOE-ε4 Status     4.35 
(0.98-20.63) 
4.74 
(0.98-25.85) 
 5.16 
(1.05-28.98) 
4.04 
(0.90-19.68) 
          
Grammatical Complexity       0.79 
(0.19-4.04) 
0.47 
(0.08-2.81) 
 
Bolded values are statistically significant. 
1 Based on diagnosis of AD according to NIA-RI criteria; non-cases defined as those without AD or dementia at their last cognitive assessment 
2 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; NIA-RI= National Institute on Aging – 
Reagan Institute; OR= odds ratio 
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E.2 Analysis of the Association of Emotional Expressivity Tertiles with Dementia 
 
E.2.1 Analysis with Emotional Expressivity Tertiles: Low Idea Density  
 
Table E13. Results of multivariate logistic regression analyses of the association between overall emotional expressivity tertiles and dementia among 
individuals with low idea density, OR (95% CI), n=29 
 Crude1 1B Education 1C APOE-ε4  1D Grammatical 
Complexity 
Full Final 
Variable          
Overall EE          
Low 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Moderate  0.67 
(0.08-6.59) 
0.70 
(0.08-7.14) 
0.63 
(0.07-6.36) 
0.68 
(0.07-7.00) 
0.81 
(0.09-8.66) 
0.85 
(0.08-10.05) 
0.71 
(0.08-7.36) 
0.86 
(0.08-10.75) 
0.84 
(0.09-9.24) 
High 0.58 
(0.09-3.51) 
0.62 
(0.09-3.87) 
0.51 
(0.07-3.22) 
0.55 
(0.08-3.58) 
0.64 
(0.09-4.06) 
0.59 
(0.08-3.89) 
0.60 
(0.09-3.77) 
0.57 
(0.08-3.78) 
0.65 
(0.09-4.17) 
          
Age  0.94 
(0.80-1.10) 
 0.94 
(0.80-1.10) 
 0.95 
(0.80-1.11) 
 0.96 
(0.81-1.14) 
0.95 
(0.80-1.11) 
          
Education (Master’s vs. 
Bachelor’s Degree) 
  0.58 
(0.10-2.95) 
0.59 
(0.10-3.04) 
 0.57 
(0.10-3.02) 
 0.58 
(0.10-3.14) 
 
          
APOE-ε4 status     2.36 
(0.46-14.17) 
2.26 
(0.42-14.48) 
 1.88 
(0.30-12.94) 
2.20 
(0.42-13.44) 
          
Grammatical Complexity       0.36 
(0.04-1.94) 
0.51 
(0.05-3.70) 
 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2)  
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio  
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Table E14. Results of multivariate logistic regression analyses of the association between positive emotional expressivity tertiles and dementia among 
individuals with low idea density, OR (95% CI), n=29 
 Crude1 1B Education 1C APOE-ε4  1D Grammatical 
Complexity 
Full Final 
Variable          
Positive EE          
Low 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Moderate  1.50 
(0.19-14.24) 
1.80 
(0.22-18.39) 
1.27 
(0.13-13.74) 
1.57 
(0.16-18.02) 
1.76 
(0.21-17.98) 
1.77 
(0.18-21.17) 
2.10 
(0.24-22.35) 
2.16 
(0.20-28.33) 
2.00 
(0.23-22.20) 
High 0.64 
(0.09-4.10) 
0.66 
(0.09-4.48) 
0.60 
(0.08-3.95) 
0.63 
(0.08-4.35) 
0.76 
(0.10-5.31) 
0.71 
(0.09-5.13) 
0.70 
(0.09-4.94) 
0.71 
(0.09-5.41) 
0.74 
(0.10-5.29) 
          
Age  0.92 
(0.78-1.08) 
 0.93 
(0.78-1.08) 
 0.94 
(0.78-1.10) 
 0.95 
(0.79-1.13) 
0.93 
(0.78-1.09) 
          
Education (Master’s vs. 
Bachelor’s) 
  0.71 
(0.12-3.98) 
0.74 
(0.12-4.28) 
 0.72 
(0.12-4.14) 
 0.79 
(0.13-4.84) 
 
          
APOE-ε4 status     2.47 
(0.48-15.18) 
2.29 
(0.42-14.58) 
 1.85 
(0.31-12.51) 
2.26 
(0.42-14.03) 
          
Grammatical Complexity       0.29 
(0.03-1.69) 
0.43 
(0.04-3.23) 
 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2)  
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio  
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Table E15. Results of multivariate logistic regression analyses of the association between negative emotional expressivity tertiles and dementia among 
individuals with low idea density, OR (95% CI), n=29 
 Crude1 1B Education 1C APOE-ε4  1D Grammatical 
Complexity 
Full Final 
Variable          
Negative EE          
Low 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Moderate  0.67 
(0.05-16.61) 
0.65 
(0.05-16.33) 
0.58 
(0.04-14.89) 
0.57 
(0.04-14.88) 
0.56 
(0.04-14.62) 
0.49 
(0.02-13.91) 
0.47 
(0.03-12.66) 
0.42 
(0.02-12.87) 
0.56 
(0.04-14.72) 
High 0.50 
(0.09-2.78) 
0.56 
(0.09-3.25) 
0.45 
(0.07-2.59) 
0.50 
(0.08-3.02) 
0.53 
(0.09-3.08) 
0.50 
(0.08-3.09) 
0.52 
(0.09-3.04) 
0.49 
(0.07-3.06) 
0.57 
(0.10-3.42) 
          
Age  0.94 
(0.80-1.10) 
 0.94 
(0.80-1.10) 
 0.96 
(0.81-1.12) 
 0.97 
(0.82-1.15) 
0.95 
(0.80-1.12) 
          
Education (Master’s vs. 
Bachelor’s Degree) 
  0.57 
(0.10-2.91) 
0.57 
(0.10-2.98) 
 0.53 
(0.09-2.87) 
 0.55 
(0.09-3.02) 
 
          
APOE-ε4 status     2.42 
(0.47-14.77) 
2.37 
(0.44-15.21) 
 1.90 
(0.31-13.36) 
2.26 
(0.42-14.00) 
          
Grammatical Complexity       0.33 
(0.04-1.93) 
0.48 
(0.05-3.72) 
 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2)  
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio  
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E.2.2 Analysis with Emotional Expressivity Tertiles: High Idea Density  
 
Table E16. Results of multivariate logistic regression analyses of the association between overall emotional expressivity tertiles and dementia among 
individuals with high idea density, OR (95% CI), n=120 
 Crude1 1B1 Education 1C APOE-ε4  1D Grammatical 
Complexity 
Full Final2  
Variable          
Overall EE          
Low 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Moderate  1.46 
(0.48-4.57) 
1.47 
(0.48-4.64) 
1.51 
(0.50-4.73) 
1.52 
(0.50-4.84) 
1.58 
(0.52-5.02) 
1.70 
(0.54-5.59) 
1.40 
(0.46-4.14) 
1.60 
(0.50-5.35) 
1.62 
(0.52-5.26) 
High 1.67 
(0.58-5.06) 
1.64 
(0.56-5.00) 
1.68 
(0.58-5.10) 
1.65 
(0.57-5.06) 
1.73 
(0.60-5.31) 
1.74 
(0.59-5.46) 
1.65 
(0.57-5.00) 
1.72 
(0.58-5.42) 
1.72 
(0.58-5.34) 
          
Age  1.07 
(0.98-1.19) 
 1.07 
(0.97-1.18) 
 1.08 
(0.98-1.19) 
 1.09 
(0.98-1.21) 
1.08 
(0.98-1.19) 
          
Education (Master’s vs. 
Bachelor’s Degree) 
  1.46 
(0.60-3.75) 
1.41 
(0.57-3.64) 
 1.38 
(0.56-3.62) 
 1.44 
(0.58-3.82) 
 
          
APOE-ε4 status     1.96 
(0.70-5.23) 
2.04 
(0.72-5.57) 
 2.17 
(0.76-6.01) 
2.07 
(0.73-5.62) 
          
Grammatical Complexity       0.69 
(0.24-2.16) 
0.52 
(0.17-1.71) 
 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2)  
2 Hosmer-Lemeshow goodness of fit test, p<0.05 
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio  
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Table E17. Results of multivariate logistic regression analyses of the association between positive emotional expressivity tertiles and dementia among 
individuals with high idea density, OR (95% CI), n=120 
 Crude1 1B Education 1C APOE-ε4  1D Grammatical 
Complexity 
Full Final 
Variable          
Positive EE          
Low 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
Moderate  1.66 
(0.54-5.79) 
1.56 
(0.50-5.47) 
1.68 
(0.54-5.86) 
1.58 
(0.50-5.54) 
1.59 
(0.51-5.56) 
1.51 
(0.48-5.35) 
1.63 
(0.52-5.67) 
1.44 
(0.45-5.12) 
1.48 
(0.47-5.24) 
High 2.20 
(0.70-7.75) 
2.07 
(0.65-7.36) 
2.20 
(0.70-7.77) 
2.08 
(0.65-7.39) 
2.11 
(0.67-7.46) 
2.00 
(0.62-7.15) 
2.20 
(0.70-7.78) 
1.97 
(0.61-7.08) 
1.98 
(0.62-7.06) 
          
Age  1.07 
(0.97-1.18) 
 1.06 
(0.97-1.18) 
 1.07 
(0.97-1.18) 
 1.08 
(0.98-1.20) 
1.07 
(0.97-1.19) 
          
Education (Master’s vs. 
Bachelor’s Degree) 
  1.45 
(0.60-3.72) 
1.39 
(0.56-3.58) 
 1.35 
(0.54-3.51) 
 1.41 
(0.56-3.71) 
 
          
APOE-ε4 status     1.80 
(0.65-4.76) 
1.84 
(0.66-4.96) 
 1.98 
(0.69-5.41) 
1.88 
(0.67-5.06) 
          
Grammatical Complexity       0.67 
(0.24-2.09) 
0.51 
(0.17-1.67) 
 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2)  
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio  
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Table E18. Results of multivariate logistic regression analyses of the association between negative emotional expressivity tertiles and dementia among 
individuals with high idea density, OR (95% CI), n=120 
 Crude1 1B Education 1C APOE-ε4  1D Grammatical 
Complexity 
Full Final
Variable        
Negative EE        
Low 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Moderate  3.00 
(0.99-9.23) 
2.97 
(0.97-9.25) 
3.40 
(1.10-10.91) 
3.34 
(1.06-10.86) 
3.58 
(1.14-11.70) 
4.06 
(1.24-14.14) 
2.90 
(0.95-9.00) 
3.93 
(1.18-13.87)
3.59 
(1.13-11.89)
High 1.14 
(0.40-3.20) 
1.15 
(0.40-3.27) 
1.12 
(0.40-3.18) 
1.14 
(0.40-3.27) 
1.30 
(0.45-3.81) 
1.35 
(0.46-4.05) 
1.12 
(0.40-3.17) 
1.35 
(0.46-4.06)
1.34 
(0.46-3.97)
        
Age  1.07 
(0.97-1.18) 
 1.06 
(0.97-1.18) 
 1.07 
(0.97-1.19) 
 1.08 
(0.98-1.20)
1.07 
(0.98-1.19)
   
Education (Master’s vs. 
Bachelor’s Degree) 
  1.77 
(0.70-4.79) 
1.68 
(0.66-4.59) 
 1.66 
(0.64-4.57) 
 1.76 
(0.67-5.00)
   
APOE-ε4 status     2.29 
(0.79-6.46) 
2.37 
(0.81-6.83) 
 2.50 
(0.84-7.35)
2.40 
(0.82-6.88)
   
Grammatical Complexity       0.76 
(0.26-2.42) 
0.56 
(0.18-1.88)
Bolded values are statistically significant. 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2)  
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio  
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E.3 Analysis of the Association Between Negative Emotional Expressivity and Dementia, Stratified by Idea Density and Positive 
Emotional Expressivity 
 
 
Table E19. Results of multivariate logistic regression analyses of the association between negative emotional expressivity and dementia among individuals 
with low idea density and low positive emotional expressivity, OR (95% CI), n=15 
 Crude1 1B Education 1C APOE-ε4  1D2 Grammatical 
Complexity 
Full2 Final 
Variable          
High Negative EE 0.17 
(0.01-2.34) 
0.12 
(0.003-2.13) 
0.17 
(0.01-2.48) 
0.12 
(0.003-2.18) 
0.19 
(0.005-3.70) 
0.15 
(0.003-3.31) 
0.15 
(0.004-2.48) 
0.15 
(0.003-3.29) 
0.15 
(0.003-3.55) 
          
Age  0.85 
(0.65-1.04) 
 0.85 
(0.62-1.05) 
 0.90 
(0.65-1.15) 
 0.90 
(0.60-1.17) 
0.91 
(0.68-1.14) 
          
Education (Master’s vs. 
Bachelor’s Degree) 
  1.26 
(0.11-14.90) 
0.89 
(0.05-12.89) 
 0.53 
(0.02-9.41) 
 0.51 
(0.01-9.36) 
 
          
APOE-ε4 Status     8.68 
(0.74-254.38) 
6.56 
(0.31-389.07) 
 7.09 
(0.27-655.90) 
5.19 
(0.28-175.62) 
          
Grammatical Complexity       0.23 
(0.01-2.75) 
1.24 
(0.02-73.35) 
 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2)  
2 Hosmer-Lemeshow goodness of fit test, p<0.05 
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio  
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Table E20. Results of multivariate logistic regression analyses of the association between negative emotional expressivity and dementia among individuals 
with low idea density and high positive emotional expressivity, OR (95% CI), n=14 
 Crude1 1B Education 1C APOE-ε4  1D Grammatical 
Complexity 
Full Final 
Variable          
High Negative EE 1.00 
(0.09-11.32) 
0.77 
(0.04-10.94) 
0.80 
(0.06-10.12) 
0.44 
(0.02-7.71) 
1.00 
(0.09-11.44) 
0.32 
(0.002-11.53) 
0.10 
(0.09-13.42) 
0.10 
(<0.001-12.11) 
0.68 
(0.03-10.64) 
          
Age  1.07 
(0.81-1.46) 
 1.14 
(0.85-1.58) 
 1.33 
(0.90-3.03) 
 2.60 
(1.05-37.47) 
1.09 
(0.81-1.56) 
          
Education (Master’s vs. 
Bachelor’s Degree) 
  0.21 
(0.01-2.46) 
0.15 
(0.004-2.00) 
 0.04 
(<0.001-1.17) 
 <0.001 
(<0.001-0.38) 
 
          
APOE-ε4 Status     0.68 
(0.06-7.55) 
0.09 
(<0.001-2.96) 
 <0.001 
(<0.001-0.62) 
0.56 
(0.03-6.85) 
          
Grammatical Complexity       0.49 
(0.02-5.84) 
0.01 
(<0.001-1.41) 
 
Bolded values are statistically significant. 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2)  
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio  
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Table E21. Results of multivariate logistic regression analyses of the association between negative emotional expressivity and dementia among individuals 
with high idea density and low positive emotional expressivity, OR (95% CI), n=58 
 Crude1 1B Education 1C APOE-ε4  1D Grammatical 
Complexity 
Full Final 
Variable          
High Negative EE 4.58 
(1.18-20.05) 
5.62 
(1.34-29.02) 
4.73 
(1.21-21.18) 
6.90 
(1.51-43.45) 
5.80 
(1.37-30.90) 
10.34 
(1.86-97.16) 
4.49 
(1.16-19.73) 
11.23 
(1.93-114.65) 
8.17 
(1.66-58.96) 
          
Age  1.17 
(0.99-1.45) 
 1.19 
(1.00-1.49) 
 1.21 
(1.01-1.54) 
 1.24 
(1.03-1.60) 
1.19 
(1.00-1.49) 
          
Education (Master’s vs. 
Bachelor’s Degree) 
  2.12 
(0.50-11.32) 
2.71 
(0.59-16.40) 
 2.61 
(0.53-16.74) 
 3.45 
(0.63-27.30) 
 
          
APOE-ε4 Status     2.49 
(0.42-14.88) 
2.80 
(0.42-19.78) 
 3.08 
(0.45-24.09) 
3.01 
(0.47-20.58) 
          
Grammatical Complexity       0.70 
(0.15-3.96) 
0.37 
(0.06-2.48) 
 
Bolded values are statistically significant. 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2)  
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio  
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Table E22. Results of multivariate logistic regression analyses of the association between negative emotional expressivity and dementia among individuals 
with high idea density and high positive emotional expressivity, OR (95% CI), n=62 
 Crude1 1B Education 1C APOE-ε4  1D Grammatical 
Complexity 
Full Final 
Variable          
High Negative EE 0.69 
(0.21-2.24) 
0.70 
(0.22-2.28) 
0.68 
(0.21-2.22) 
0.69 
(0.21-2.26) 
0.75 
(0.23-2.55) 
0.76 
(0.23-2.57) 
0.68 
(0.21-2.22) 
0.75 
(0.23-2.57) 
0.76 
(0.23-2.58) 
          
Age  1.02 
(0.90-1.18) 
 1.02 
(0.90-1.17) 
 1.03 
(0.90-1.19) 
 1.05 
(0.91-1.22) 
1.04 
(0.91-1.19) 
          
Education (Master’s vs. 
Bachelor’s Degree) 
  1.20 
(0.38-4.07) 
1.17 
(0.36-4.01) 
 1.27 
(0.38-4.94) 
 1.28 
(0.38-4.54) 
 
          
APOE-ε4 Status     2.43 
(0.61-9.32) 
2.62 
(0.64-10.43) 
 2.85 
(0.68-11.84) 
2.55 
(0.63-9.97) 
          
Grammatical Complexity       0.64 
(0.14-3.36) 
0.49 
(0.10-2.81) 
 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2)  
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio  
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Appendix F. Full Analysis of Alzheimer’s Disease Using Alternative 
Samples 
Four samples were selected for the analyses of AD based on NIA-RI and CERAD diagnostic 
criteria, and on two different non-case definitions (i.e., D= individuals who were dementia-free; DN= 
individuals who were both dementia- and AD neuropathology-free). Analyses were repeated for each 
of the samples to identify potential differences; however, the results were very similar for all samples 
so only those of the NIA-RI/D sample, as the most robust sample, were presented in the main 
document. The full results, including descriptive statistics (Section F.1.1) and all multivariate logistic 
regression models (Section F.1.2) of the CERAD/D sample are presented here, as supplementary 
information. The NIA-RI/DN and CERAD/DN samples did not contribute any further insight into the 
association between emotional expressivity and AD, so full models are not presented. Instead, the 
parameter estimates of all analyses, stratified by idea density are presented in Section F.2 for 
comparison. A summary of the sensitivity analysis without stratification by idea density is also 
presented for all three of the alternative samples (Section F.3). 
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F.1 Analysis Using the CERAD/D Sample 
 
F.1.1 Descriptive Statistics 
 
Table F1. Participant characteristics by AD status: CERAD analytic sample (n=78) 
    
  AD1 
 All  
(n=78) 
No
(n=54) 
Yes 
(n=24) 
Characteristic    
Covariates    
Age2, Mean Years (SD) 88.7 (3.48) 88.4 (3.73) 89.4 (2.81) 
    
Level of Education,  %     
Bachelor’s Degree  48.7 51.8 41.7 
≥ Master’s Degree  51.3 48.2 58.3 
    
Presence of APOE-ε4, %** 26.9 16.7 50.0 
    
Idea Density, %    
Low  18.0 11.1 33.3 
Q2 23.1 27.8 12.5 
Q3 26.9 27.8 25.0 
High  32.0 33.3 29.2 
    
Grammatical Complexity, %    
Low 24.4 18.5 37.5 
Q2 23.1 27.8 12.5 
Q3 23.1 24.1 20.8 
High  29.5 29.6 29.2 
    
** p<0.01 
1 Based on diagnosis of AD according to CERAD criteria; non-cases are individuals who have not 
been diagnosed with AD and who did not have dementia at their last cognitive assessment 
2 Age at death 
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein E ε4 allele; CERAD= 
Consortium to Establish a Registry for Alzheimer’s Disease; Q= quartile; SD= standard deviation 
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Table F2. Emotional expressivity by AD status: CERAD analytic sample (n=78) 
1 Based on diagnosis of AD according to CERAD criteria; non-cases were individuals who have not 
been diagnosed with AD or dementia at their last cognitive assessment 
2 Autobiographies were required to be no more than one page in length, providing an approximate 
standard length for comparison 
Abbreviations: AD= Alzheimer’s disease; CERAD= Consortium to Establish a Registry for 
Alzheimer’s Disease; Q= quartile; SD= standard deviation 
Note: Emotional expressivity did not significantly differ by AD status.  
    
  AD1 
 All  
(n=78)
No 
(n=54)
Yes 
(n=24) 
Emotional Expressivity    
Raw Word Counts2, Mean (SD)    
Overall 9.4 (8.01) 9.1 (8.01) 10.1 (8.12)
Positive 8.0 (6.73) 7.7 (6.68) 8.8 (6.95) 
Negative 1.4 (1.83) 1.4 (1.84) 1.4 (1.86) 
    
Raw Word Counts2, Median (Range)    
Overall 6.5 (0-29) 6.0 (1-32) 8.0 (0-29) 
Positive 6.0 (0-27) 5.0 (1-27) 6.0 (0-22) 
Negative 1.0 (0-9) 1.0 (0-9) 1.0 (0-7) 
    
Quartile Rankings, %    
Overall     
Low  18.0 16.7 20.8 
Q2 26.9 29.6 20.8 
Q3 29.5 29.6 29.2 
High  25.6 24.1 29.2 
    
Positive    
Low 20.5 20.4 20.8 
Q2 30.8 31.5 29.2 
Q3 20.5 24.1 12.5 
High 28.2 24.1 37.5 
    
Negative    
Low 12.8 9.3 20.8 
Q2 33.3 35.2 29.2 
Q3 35.9 37.0 33.3 
High 18.0 18.5 16.7 
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Table F3. Participant characteristics by AD and idea density: CERAD analytic sample (n=78)  
 
* p<0.05 
1 Low= lowest quartile of idea density; Higher= top three quartiles of idea density 
2 Based on diagnosis of AD according to CERAD criteria; non-cases are individuals who have not been diagnosed with AD and who 
did not have dementia at their last cognitive assessment 
3 Age at death 
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein E ε4 allele; CERAD= Consortium to Establish a Registry for 
Alzheimer’s Disease; SD= standard deviation 
 
 
 
  
 Idea density1
 Low Higher
  AD2  AD2
 All  
(n=14) 
No
(n=6) 
Yes
(n=8) 
All  
(n=64) 
No
(n=48) 
Yes
(n=16) 
Characteristic       
Covariates       
Age3, Mean Years (SD) 88.4 (3.24) 87.8 (4.07) 88.8 (2.70) 88.8 (3.55) 88.5 (3.72) 89.7 (2.90) 
       
Level of Education,  %        
Bachelor’s Degree  50.0 33.3 62.5 48.4 54.2 31.2 
≥ Master’s Degree  50.0 66.7 37.5 51.6 45.8 68.8 
       
Presence of APOE-ε4, % 57.1 16.7* 87.5 20.3 16.7 31.2 
       
Grammatical Complexity, %       
Low 21.4 0.0 37.5 25.0 20.8 37.5 
Q2 35.7 50.0 25.0 20.3 25.0 6.2 
Q3 7.1 0.0 12.5 26.6 27.1 25.0 
High  35.7 50.0 25.0 28.1 27.1 31.2 
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Table F4. Emotional expressivity by AD status and idea density: CERAD analytic sample (n=78) 
       
 Idea density1
 Low Higher 
  AD2  AD2
 All  
(n=14) 
No
(n=6) 
Yes 
(n=8) 
All  
(n=64) 
No 
(n=48) 
Yes
(n=16) 
Emotional Expressivity       
Raw Word Counts3, Mean (SD)       
Overall 9.4 (7.16) 9.3 (7.17) 7.65 (2.70) 9.4 (8.23) 9.0 (8.18) 10.5 (8.56) 
Positive 8.0 (6.06) 8.2 (7.19) 7.9 (5.59) 8.0 (6.92) 7.6 (6.69) 9.2 (7.67) 
Negative 1.4 (1.78) 1.2 (0.98) 1.5 (2.27) 1.4 (1.86) 1.4 (1.92) 1.3 (1.70) 
       
Raw Word Counts3, Median (Range)       
Overall 7.0 (1-25) 8.0 (1-19) 7.0 (2-25) 6.5 (0-32) 6.0 (1-32) 8.0 (0-29) 
Positive 6.5 (1-19) 6.5 (1-17) 6.5 (2-19) 6.0 (0-27) 5.0 (1-27) 6.0 (0-22) 
Negative 1.0 (0-6) 1.5 (0-2) 0.5 (0-6) 1.0 (0-9) 1.0 (0-9) 1.0 (0-7) 
       
Quartile Rankings, %       
Overall        
Low  21.4 16.7 25.0 17.2 16.7 18.8 
Q2 14.3 0.0 25.0 29.7 33.3 18.8 
Q3 28.6 50.0 12.5 29.7 27.1 37.5 
High  35.7 33.3 37.5 23.4 22.9 25.0 
       
Positive       
Low 21.4 16.7 25.0 20.3 20.8 18.8 
Q2 28.6 33.3 25.0 31.2 31.2 31.2 
Q3 14.3 16.7 12.5 21.9 25.0 12.5 
High 35.7 33.3 37.5 26.6 22.9 37.5 
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 Idea density1
 Low Higher 
  AD2  AD2
 All  
(n=14) 
No
(n=6) 
Yes 
(n=8) 
All  
(n=64) 
No 
(n=48) 
Yes
(n=16) 
Negative       
Low 21.4 16.7 25.0 10.9 8.3 18.8 
Q2 28.6 16.7 37.5 34.4 37.5 25.0 
Q3 14.3 16.7 12.5 40.6 39.6 43.8 
High 35.7 50.0 25.0 14.1 14.6 12.5 
       
1 Low= lowest quartile of idea density; Higher= top three quartiles of idea density 
2 Based on diagnosis of AD according to CERAD criteria; non-cases are individuals who have not been diagnosed with AD and who did not have 
dementia at their last cognitive assessment 
3 Autobiographies were required to be no more than one page in length, providing an approximate standard length for comparisonAbbreviations: AD= 
Alzheimer’s disease; CERAD= Consortium to Establish a Registry for Alzheimer’s Disease; Q= quartile; SD= standard deviation 
Note: Emotional expressivity did not significantly differ by AD status in either idea density strata.  
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F.1.2 Multivariate Logistic Regression Models 
 
F.1.2.1 Main Analysis: Low Idea Density 
 
Table F5. Results of multivariate logistic regression analyses of the association between overall emotional expressivity and AD1 among individuals with 
low idea density, OR (95% CI), n=14 
 Crude2 1B Education 1C APOE-ε4 1D3 Grammatical 
Complexity3 
Full3 Final
Variable          
High Overall EE 0.20 
(0.01-2.08) 
0.12 
(0.003-1.59) 
0.11 
(0.003-1.56) 
0.05 
(<0.001-1.19) 
0.38 
(0.01-13.69) 
0.01 
(<0.001->999.9) 
0.30 
(0.01-4.53) 
<0.001 
(<0.001->999.9) 
0.46 
(0.01-21.81) 
          
Age  1.24 
(0.84-2.13) 
 1.27 
(0.78-2.85) 
 0.46 
(<0.001-4.31) 
 0.48 
(<0.001-4.42) 
0.94 
(0.50-1.77) 
          
Education (Master’s vs. 
Bachelor’s) 
  0.17 
(0.01-1.92) 
0.16 
(0.001-2.21) 
 <0.001 
(<0.001-0.60) 
 <0.001 
(<0.001-0.24) 
 
          
APOE-ε4 Status     28.91 
(1.96->999.9) 
>999.0 
(5.46->999.9) 
 >999.9 
(2.52->999.9) 
35.65 
(1.60->999.9) 
          
Grammatical Complexity       <0.001 
(<0.001-1.52) 
<0.001 
(<0.001-2.68) 
 
Bolded values are statistically significant. 
1 Based on diagnosis of AD according to CERAD criteria; non-cases defined as those without AD or dementia at their last cognitive assessment 
2 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
3 Model did not converge: quasi-complete separation of data detected 
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein E ε4 allele; CERAD= Consortium to Establish a Registry for Alzheimer’s Disease; CI= confidence interval; 
EE= emotional expressivity; OR= odds ratio 
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Table F6. Results of multivariate logistic regression analyses of the association between positive emotional expressivity and AD1 among individuals with 
low idea density, OR (95% CI), n=14 
 Crude2 1B Education 1C APOE-ε4 1D3 Grammatical 
Complexity3 
Full3 Final
Variable          
High Positive EE 1.00 
(0.11-8.76) 
0.94 
(0.10-8.40) 
1.20 
(0.12-13.25) 
1.15 
(0.11-13.12) 
1.00 
(0.03-29.59) 
>999.9 
(<0.001->999.9) 
1.50 
(0.13-19.11) 
>999.9 
(0.83->999.9) 
1.05 
(0.03-32.74) 
          
Age  1.10 
(0.78-1.62) 
 1.04 
(0.71-1.55) 
 0.004 
(<0.001-0.79) 
 0.005 
(<0.001-0.68) 
0.89 
(0.49-1.52) 
          
Education (Master’s vs. 
Bachelor’s) 
  0.29 
(0.02-2.57) 
0.32 
(0.02-3.16) 
 <0.001 
(<0.001-0.02) 
 <0.001 
(<0.001-0.005) 
 
          
APOE-ε4 Status     35.00 
(2.57->999.9) 
>999.9 
(286.38->999.9) 
 >999.9 
(326.39->999.9) 
47.62 
(2.67->999.9) 
          
Grammatical Complexity       <0.001 
(<0.001-0.91) 
<0.001 
(<0.001->999.9) 
 
Bolded values are statistically significant. 
1 Based on diagnosis of AD according to CERAD criteria; non-cases defined as those without AD or dementia at their last cognitive assessment 
2 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
3 Model did not converge: quasi-complete separation of data detected 
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein E ε4 allele; CERAD= Consortium to Establish a Registry for Alzheimer’s Disease; CI= confidence interval; 
EE= emotional expressivity; OR= odds ratio 
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Table F7. Results of multivariate logistic regression analyses of the association between negative emotional expressivity and AD1 among individuals with 
low idea density, OR (95% CI), n=14 
 Crude2 1B Education 1C APOE-ε4 1D3 Grammatical 
Complexity3 
Full3 Final
Variable          
High Negative EE 0.30 
(0.03-2.58) 
0.02 
(<0.001-0.86) 
0.19 
(0.01-2.06) 
0.001 
(<0.001-0.50) 
0.49 
(0.02-14.72) 
0.01 
(<0.001->999.9) 
0.33 
(0.02-3.72) 
<0.001 
(<0.001->999.9) 
0.64 
(0.001-92.66) 
          
Age  1.73 
(0.97-4.17) 
 2.27 
(0.99-13.20) 
 0.46 
(0.001-4.30) 
 0.48 
(0.002-4.42) 
0.95 
(0.39-2.67) 
          
Education (Master’s vs. 
Bachelor’s) 
  0.19 
(0.01-2.06) 
0.07 
(<0.001-2.07) 
 <0.001 
(<0.001-0.55) 
 <0.001 
(<0.001-0.21) 
 
          
APOE-ε4 Status     30.91 
(2.16->999.9) 
>999.9 
(4.05->999.9) 
 >999.9 
(2.08->999.9) 
37.23 
(0.81->999.9) 
          
Grammatical Complexity       <0.001 
(<0.001-1.12) 
<0.001 
(<0.001-2.68) 
 
Bolded values are statistically significant. 
1 Based on diagnosis of AD according to CERAD criteria; non-cases defined as those without AD or dementia at their last cognitive assessment 
2 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
3 Model did not converge: quasi-complete separation of data detected 
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein E ε4 allele; CERAD= Consortium to Establish a Registry for Alzheimer’s Disease; CI= confidence interval; 
EE= emotional expressivity; OR= odds ratio 
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F.1.2.2 Main Analysis: High Idea Density 
 
Table F8. Results of multivariate logistic regression analyses of the association between overall emotional expressivity and AD1 among individuals with 
high idea density, OR (95% CI), n=64 
 Crude2 1B Education 1C APOE-ε4 1D Grammatical 
Complexity 
Full Final
Variable          
High Overall EE 1.67 
(0.53-5.58) 
1.66 
(0.52-5.63) 
1.88 
(0.58-6.59) 
2.04 
(0.61-7.63) 
1.94 
(0.60-6.92) 
2.39 
(0.68-9.48) 
1.74 
(0.55-5.98) 
3.09 
(0.82-14.09) 
1.88 
(0.58-6.76) 
          
Age 1.11 
(0.94-1.35) 
 1.15 
(0.95-1.44) 
 1.15 
(0.94-1.44) 
 1.20 
(0.96-1.56) 
1.10 
(0.92-1.35) 
          
Education (Master’s vs. 
Bachelor’s) 
  2.81 
(0.86-10.32) 
3.25 
(0.95-13.08) 
 3.45 
(0.98-14.59) 
 4.69 
(1.20-23.11) 
 
          
APOE-ε4 Status     2.62 
(0.66-10.17) 
2.60 
(0.62-10.90) 
 3.60 
(0.78-17.97) 
2.42 
(0.60-5.60) 
          
Grammatical Complexity       0.42 
(0.12-1.51 
0.23 
(0.05-0.99) 
 
Bolded values are statistically significant. 
1 Based on diagnosis of AD according to CERAD criteria; non-cases defined as those without AD or dementia at their last cognitive assessment 
2 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein E ε4 allele; CERAD= Consortium to Establish a Registry for Alzheimer’s Disease; CI= confidence interval; 
EE= emotional expressivity; OR= odds ratio 
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Table F9. Results of multivariate logistic regression analyses of the association between positive emotional expressivity and AD1 among individuals with 
high idea density, OR (95% CI), n=64 
 Crude2 1B Education 1C APOE-ε4 1D Grammatical 
Complexity 
Full Final
Variable          
High Positive EE 1.09 
(0.35‐3.42) 
1.13 
(0.35‐3.61) 
1.23 
(0.38‐4.05) 
1.36 
(0.41‐4.71) 
1.11 
(0.35‐3.54) 
1.41 
(0.42‐4.99) 
1.14 
(0.36‐3.66) 
1.72 
(0.48‐6.75) 
1.14 
(0.35‐3.69) 
          
Age  1.11 
(0.94‐1.35) 
 1.14 
(0.95‐1.43) 
 1.14 
(0.94‐1.43) 
 1.17 
(0.95‐1.51) 
1.10 
(0.93‐1.35) 
         
Education (Master’s vs. 
Bachelor’s) 
  2.67 
(0.83‐9.72) 
2.99 
(0.89‐11.63) 
 3.09 
(0.90‐12.44) 
 4.10 
(1.08‐19.31) 
 
          
APOE-ε4 Status     2.28 
(0.59‐8.36) 
2.20 
(0.55‐8.52) 
 2.84 
(0.66‐12.43) 
2.13 
(0.54‐7.88) 
          
Grammatical 
Complexity 
      0.44 
(0.13‐1.54) 
0.27 
(0.06‐1.09) 
 
Bolded values are statistically significant. 
1 Based on diagnosis of AD according to CERAD criteria; non-cases defined as those without AD or dementia at their last cognitive assessment 
2 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein E ε4 allele; CERAD= Consortium to Establish a Registry for Alzheimer’s Disease; CI= confidence interval; 
EE= emotional expressivity; OR= odds ratio 
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Table F10. Results of multivariate logistic regression analyses of the association between negative emotional expressivity and AD1 among individuals with 
high idea density, OR (95% CI), n=64 
 Crude2 1B Education 1C APOE-ε4 1D Grammatical 
Complexity 
Full Final
Variable          
High Negative EE 1.09 
(0.35-3.50) 
1.06 
(0.33-3.45) 
1.24 
(0.39-4.16) 
1.32 
(0.40-4.70) 
1.34 
(0.41-4.72) 
1.76 
(0.48-7.37) 
1.08 
(0.34-3.51) 
2.15 
(0.55-10.20) 
1.27 
(0.38-4.48) 
          
Age  1.11 
(0.94-1.34) 
 1.14 
(0.95-1.42) 
 1.14 
(0.94-1.43) 
 1.18 
(0.95-1.53) 
1.10 
(0.92-1.34) 
          
Education (Master’s vs. 
Bachelor’s) 
  2.68 
(0.83-9.74) 
3.00 
(0.89-11.88) 
 3.38 
(0.94-14.86) 
 4.69 
(1.16-25.71) 
 
          
APOE-ε4 Status     2.49 
(0.61-9.87) 
2.66 
(0.62-11.54) 
 3.57 
(0.77-17.77) 
2.28 
(0.56-9.13) 
          
Grammatical 
Complexity 
      0.44 
(0.13-1.55) 
0.26 
(0.06-1.08) 
 
Bolded values are statistically significant. 
1 Based on diagnosis of AD according to CERAD criteria; non-cases defined as those without AD or dementia at their last cognitive assessment 
2 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
3 Model did not converge: quasi-complete separation of data detected 
Abbreviations: AD= Alzheimer’s disease; APOE-ε4= apolipoprotein E ε4 allele; CERAD= Consortium to Establish a Registry for Alzheimer’s Disease; CI= confidence interval; 
EE= emotional expressivity; OR= odds ratio 
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F.2 Measures of the Association of Emotional Expressivity with AD Using Alternative Samples 
 
F.2.1 Main Analysis: Low Idea Density 
 
Table F11. Association of emotional expressivity with AD among individuals with low idea 
density, adjusted for age at diagnosis and APOE-ε4 status, in the analytic samples where the 
non-cases are defined as those with neither dementia nor AD neuropathology 
     
 CERAD/DN (n=12)  NIA-RI/DN (n=19) 
 OR 95% CI  OR 95% CI 
Emotional Expressivity      
      
Overall 2.00 0.02, 357.96  0.40 0.02, 5.21 
      
Positive 6.26 0.12, 957.04  1.71 0.19, 19.44 
      
Negative 1.70 0.003, 366.95  0.24 0.02, 2.56 
      
Abbreviations: AD = Alzheimer’s disease; APOE-ε4= apolipoprotein ε4; CERAD= Consortium to Establish a 
Registry for Alzheimer’s Disease; CI= confidence interval; /DN= non-cases without dementia or 
neuropathology; NIA-RI= National Institute on Aging – Reagan Institute; OR= odds ratio 
 
 
F.2.2 Main Analysis: High Idea Density 
 
 
Table F12. Association of emotional expressivity with AD among individuals with high idea 
density, adjusted for age at diagnosis and APOE-ε4 status, in the analytic samples where the 
non-cases are defined as those with neither dementia nor AD neuropathology 
     
 CERAD/DN (n=40)  NIA-RI/DN (n=48) 
 OR 95% CI  OR 95% CI 
Emotional Expressivity      
      
Overall 2.51 0.61, 12.13  1.60 0.39, 7.38 
      
Positive 1.55 0.39, 6.50  1.19 0.29, 5.02 
      
Negative 1.26 0.30, 6.09  1.82 0.42, 9.73 
      
Abbreviations: AD = Alzheimer’s disease; APOE-ε4= apolipoprotein ε4; CERAD= Consortium to Establish a 
Registry for Alzheimer’s Disease; CI= confidence interval; /DN= non-cases without dementia or 
neuropathology; NIA-RI= National Institute on Aging – Reagan Institute; OR= odds ratio 
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F.3 Sensitivity Analysis of Non-Stratified Models Using Alternative Samples 
 
Table F13. Sensitivity analysis of the association of emotional expressivity with AD without stratification by idea density, in the analytic 
samples where the non-cases are defined as those with neither dementia nor AD neuropathology 
      
 CERAD/D (n=78)  CERAD/DN (n=52)  NIA-RI/DN (n=67)
 OR 95% CI  OR 95% CI  OR 95% CI 
Emotional Expressivity         
         
Overall 1.57 0.54, 4.85  1.75 0.50, 6.70  1.44 0.46, 4.80 
         
Positive 1.11 0.39, 3.14  1.56 0.45, 5.58  1.42 0.47, 4.47 
         
Negative 1.10 0.37, 3.45  0.95 0.25, 3.75  1.01 0.33, 3.26 
Low Positive 2.23 0.40, 17.50  2.25 0.35, 20.12  2.43 0.42, 20.38 
High Positive  0.59 0.12, 2.98  0.17 0.01, 1.70  0.28 0.09, 2.49 
         
Abbreviations: AD = Alzheimer’s disease; APOE-ε4= apolipoprotein ε4; CERAD= Consortium to Establish a Registry for Alzheimer’s Disease; CI= confidence 
interval; /D= non-cases without dementia; /DN= non-cases without dementia or neuropathology; NIA-RI= National Institute on Aging – Reagan Institute;  
OR= odds ratio
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Appendix G. Sensitivity Analysis of the Association of Emotional 
Expressivity with Dementia using the Subset for the Analyses of 
AD   
 
A sensitivity analyses was performed to investigate the association between emotional 
expressivity and dementia using the subset for the analyses of AD (n=85), which was limited by the 
availability of AD neuropathologic data. The purpose of this analysis was to allow a true comparison 
of the association of emotional expressivity with dementia to the association with AD. The full 
models generated in this sensitivity analysis, stratified by idea density, are found below (Tables G1-
G6). In all, the association was very similar with dementia as it was with AD in this subset.  
 
G.1 Sensitivity Analysis using the Subset Selected for the Analyses of AD: Low Idea Density 
Table G1. Results of multivariate logistic regression analyses of the association between overall emotional 
expressivity and dementia among individuals with low idea density (n=19), OR (95% CI) 
 Crude1 1B 1C 1D Full2  Final 
Variables       
High Overall EE 0.23 
(0.01-2.02) 
0.21 
(0.01-1.95)
0.20 
(0.01-2.02)
0.46 
(0.02-7.10)
0.20 
(0.003-3.97) 
0.40 
(0.02-5.20)
       
Age  1.05 
(0.81-1.37)
1.00 
(0.74-1.33)
0.87 
(0.56-1.23)
0.97 
(0.55-1.71) 
1.00 
(0.75-1.32)
       
Education 
(Master’s vs. 
Bachelor’s) 
  0.35 
(0.03-3.44) 
0.14 
(0.002-2.35) 
0.12 
(0.002-2.53) 
 
       
APOE-ε4 Status    13.86 
(0.82->999.9)
7.71 
(0.40-971.86) 
6.23 
(0.59-150.38)
       
Grammatical 
Complexity3 
    <0.001 
(<0.001-0.58) 
 
Bolded values are statistically significant. 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
2 Model would not converge: quasi-complete separation of data detected. 
3 Grammatical complexity was not included in the final model, despite being statistically significant, because the 
model would not converge when it was included 
 Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio  
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Table G2. Results of multivariate logistic regression analyses of the association between positive 
emotional expressivity and dementia among individuals with low idea density (n=19), OR (95% CI) 
 Crude1 1B 1C 1D Full Final 
Variables       
High Positive EE 1.17 
(0.16-8.59) 
1.16 
(0.16-8.61)
1.52 
(0.19-14.63)
4.96 
(0.35-188.53)
2.44 
(0.15-97.19) 
1.73 
(0.19-19.66)
       
Age  1.01 
(0.79-1.27)
0.94 
(0.70-1.23)
0.80 
(0.49-1.14)
0.94 
(0.54-1.66) 
0.99 
(0.75-1.29)
       
Education (Master’s 
vs. Bachelor’s) 
  0.31 
(0.02-3.18)
0.04 
(<0.001-1.39)
0.10 
(<0.001-2.62) 
 
       
APOE-ε4 Status    34.14 
(1.76->999.99) 
9.62 
(0.50-906.31) 
8.98 
(0.98-216.40)
       
Grammatical 
Complexity 
    <0.001 
(<0.001-1.16) 
 
Bolded values are statistically significant. 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio  
 
 
 
Table G3. Results of multivariate logistic regression analyses of the association between negative 
emotional expressivity and dementia among individuals with low idea density (n=19), OR (95% CI) 
 Crude1 1B 1C 1D2 Full2 Final 
Variables       
High 
Negative EE 
0.31 
(0.03-2.24) 
0.26 
(0.02-2.13)
0.24 
(0.02-2.08)
<0.001 
(<0.001-1.12)
<0.001 
(<0.001-0.20) 
0.23 
(0.01-2.44)
       
Age  1.06 
(0.82-1.41)
1.01 
(0.75-1.36)
0.91 
(0.57-1.24)
1.58 
(0.68-5.03) 
1.05 
(0.79-1.39)
       
Education 
(Master’s vs. 
Bachelor’s) 
  0.32 
(0.02-3.19) 
<0.001 
(<0.001-0.91) 
<0.001 
(<0.001-0.39) 
 
       
APOE-ε4 
Status 
   >999.99 
(2.37->999.9) 
>999.99 
(0.41->999.9) 
8.74 
(0.91-222.29)
       
Grammatical 
Complexity 
    <0.001 
(<0.001-0.15) 
 
Bolded values are statistically significant. 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
2 Model would not converge: quasi-complete separation of data detected. 
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio  
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G.2 Sensitivity Analysis using the Subset Selected for the Analyses of AD: High Idea Density 
Table G4. Results of multivariate logistic regression analyses of the association between overall 
emotional expressivity and dementia among individuals with high idea density (n=66), OR (95% CI) 
 Crude1 1B 1C 1D Full Final 
Variables       
High Overall 
EE 
2.00 
(0.66-6.56) 
2.00 
(0.66-6.62)
2.30 
(0.73-8.01)
2.62 
(0.81-9.67)
3.01 
(0.89-11.84) 
2.72 
(0.72-7.94)
       
Age  1.07 
(0.92-1.26)
1.08 
(0.92-1.29)
1.07 
(0.91-1.28)
1.09 
(0.92-1.33) 
1.06 
(0.90-1.25)
       
Education 
(Master’s vs. 
Bachelor’s) 
  2.17 
(0.70-7.27) 
2.20 
(0.70-7.54) 
2.48 
(0.76-8.99) 
 
       
APOE-ε4 
Status 
   2.22 
(0.55-8.91)
2.63 
(0.62-11.44) 
2.19 
(0.54-8.64) 
       
Grammatical 
Complexity 
    0.36 
(0.09-1.40) 
 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio  
 
 
 
Table G5. Results of multivariate logistic regression analyses of the association between positive 
emotional expressivity and dementia among individuals with high idea density (n=66), OR (95% CI) 
 Crude1 1B 1C 1D Full  Final 
Variables       
High Positive 
EE 
1.36 
(0.46-4.13) 
1.40 
(0.47-4.31)
1.60 
(0.52-5.16)
1.64 
(0.53-5.37)
1.84 
(0.57-6.40) 
1.42 
(0.47-4.43)
       
Age  1.07 
(0.92-1.26)
1.08 
(0.92-1.28)
1.07 
(0.91-1.28)
1.08 
(0.92-1.31) 
1.06 
(0.91-1.26)
       
Education 
(Master’s vs. 
Bachelor’s) 
  2.04 
(0.67-6.72) 
2.05 
(0.66-6.84) 
2.31 
(0.72-8.18) 
 
       
APOE-ε4 
Status 
   1.84 
(0.47-6.77)
2.11 
(0.53-8.24) 
1.84 
(0.48-6.71)
       
Grammatical 
Complexity 
    0.40 
(0.10-1.47) 
 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio  
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Table G6. Results of multivariate logistic regression analyses of the association between negative 
emotional expressivity and dementia among individuals with high idea density (n=66), OR (95% CI) 
 1A 1B 1C 1D 1E  Final 
Variables       
High 
Negative EE 
1.06 
(0.36-3.21) 
1.05 
(0.35-3.22)
1.17 
(0.38-3.71)
1.38 
(0.43-4.78)
1.45 
(0.44-5.21) 
1.20 
(0.39-3.92)
       
Age  1.06 
(0.92-1.25)
1.07 
(0.92-1.27)
1.06 
(0.91-1.27)
1.07 
(0.91-1.29) 
1.06 
(0.91-1.25)
       
Education 
(Master’s vs. 
Bachelor’s) 
  1.92 
(0.63-6.22) 
1.98 
(0.64-6.58) 
2.19 
(0.69-7.75) 
 
       
APOE-ε4 
Status 
   1.99 
(0.49-7.77)
2.26 
(0.54-9.28) 
1.92 
(0.48-7.37)
       
Grammatical 
Complexity 
    0.43 
(0.12-1.55) 
 
1 Crude, 1B, 1C… etc. correspond to models represented in the analytic strategy (Table 2) 
Abbreviations: APOE-ε4= apolipoprotein E ε4 allele; CI= confidence interval; EE= emotional expressivity; OR= odds ratio 
